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Abstract 
Prp8 protein is a component of the nuclear pre-mRNA splicing machinery. Prp8p had 
previously been identified as a component of the US snRNP, and the U4/U6.U5 tri-snRNP of 
the spliceosome. The protein contacts the catalytic centre of the spliceosome, as detected by 
photochemical crosslinks of Prp8p with functionally important regions of the U5 and U6 
snRNAs, and with the 5' splice site, 3' splice site, and branchpoint of pre-mRNA. 
In this thesis I present further work on protein interactions between Prp8p and other 
splicing factors by using Prp8p partitioned strains. The Prp8p partitioned constructs allowed 
investigation of factors that associate with the N- or C-terminal regions of Prp8p by isolation 
of the sub-complexes associated with different Prp8 protein fragments. Thus, the US snRNP 
protein Snul 14p associates with Prp8p in the region 437-770, whereas fragmenting Prp8p at 
residue 2173 destabilises its association with Aar2p. 
The role of Prp8p in U5 snRNP assembly was investigated. Upon identification of 
the nuclear localisation signal of Prp8p, I further investigated the role of Prp8p in US snRNP 
assembly, and showed that Prp8p-Snul 14p-Aar2p-U5 complex formation happened in the 
cytoplasm, and that formation of the Prp8p-Snul 14p-Brr2p-U5 complex took place in the 
nucleus. Despite the fact that Prp8p remains nuclear localised, the association between Prp8p 
and Brr2p is disrupted by Prp8p C-terminal mutations that resemble human Prp8p mutations 
that result in retinitis pigmentosa type 13. In addition, I also identified that the importin, 
Kap95p, is needed for the nuclear import of Snul 14p and snRNA nuclear import. Based on 
the results above, a model of the yeast US snRNP assembly pathway is proposed. 
In this thesis, I also characterise a Prp8p co-purified protein, Spp382p. The 
characterisation of Spp382p showed that this protein binds to U2, US, U6 snRNAs, and 
excised intron, and interacts with Prp43p directly. Genetic-depletion of Spp382p results in 
excised intron accumulation, suggesting that this protein is needed for the late-stage of 
splicing. In addition, in Spp382p-depleted extract the US snRNP protein, Prp8p, is associated 
with 8-fold more U2 snRNA. Also, glycerol gradient analysis of snRNPs showed reduced 
levels of free US, and U6 snRNPs, but accumulation of U4/U6 di-snRNP, suggesting a 
defect in recycling snRNPs when compared to non-depleted cell extract. Interestingly, in the 
Spp382p-depleted extract, Prp43p was not able to pull down excised intron. Overall results 
suggest that Spp382p could be needed for disassembly of post-splicing complex and to 
mediate the association of Prp43p with excised intron. 
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1.1 Pre-mRNA splicing 
In 1970s, it was discovered that RNA in the nucleus of vertebrate cells was unusually long, 
compared with the shorter mRNA that emerged in the cytoplasm. This nuclear RNA had 
both a cap structure at its 5' end and a polyadenosine [poly(A)] tract at its 3' end, just like 
the shorter cytoplasmic niRNA. Resolution of these paradoxes occurred with the discovery 
of split genes and RNA splicing. Non-coding sequences (introns) are normally removed 
from newly transcribed RNA and the regions present in the mature RNA (exons) are joined 
in a process termed RNA splicing (Berget et al., 1977; Chow et al., 1977). Four different 
classes of RNA splicing are currently known, exemplified by the splicing of 1) group I, 2) 
group II, 3) nuclear precursor messenger RNA (pre-mRNA), and 4) tRNA introns (Dix and 
Beggs, 2001). 
Metazoan genes are estimated to average nearly 10 introns (Ares et al., 1999), which 
must be precisely removed to yield translatable mRNAs. The presence of multiple introns 
can allow the joining of different combinations of exons by alternative splicing and produce 
distinct mRNAs from identical pre-mRNAs, thereby increasing the informational capacity of 
the genome. Saccharomyces cerevisiae (budding yeast) is ideal as a model for pre-mRNA 
splicing analysis, as fewer than 250 of the more than 6200 annotated genes are known to 
have introns (Ares et al., 1999). However, the distribution of introns appears to be non-
random; about 70% of the highly expressed genes that encode ribosomal proteins contain an 
intron (Mayes et al., 2000). Most budding yeast nuclear introns are fewer than 600 
nucleotides, and are generally found towards the 5' end of the pre-mRNA, such that the first 
exon is small. However, there are exceptions, for example the DBP2 gene contains an intron 
that is more than 1000 nucleotides in length and lies 1273 nucleotides from the initiating 
AUG (SGD). Only a few budding yeast nuclear genes are known to have more than one 
intron, including TAD3, WMA9, SUS1, MA Tal , DYN2, RPL7A, RPL7B, and RPS22B (Mayes 
et al., 2000, SGD). 
Introns are highly divergent in sequence. However, three short regions of consensus 
sequence have been identified that define introns and contribute chemically reactive 
nucleotides to the splicing reaction: the 5' splice site, branchpoint, and 3' splice site (Figure 
1.1 & 1.2). Pre-mRNA splicing occurs via an ordered pathway involving two sequential 
1 
trans-esterification reactions (Figure 1.1). In the first trans-esterification step, the 
phosphodiester bond at the 5' splice site is cleaved as a result of nucleophilic attack by the 2' 
hydroxyl group of a conserved adenosine that lies in the intron towards the 3' splice site, and 
that is referred to as the branchpoint nucleotide. This yields two intermediates: exon 1 with a 
free 3' hydroxyl, and intron-exon2 in a branched-lariat structure, in which the 5' end of the 
intron is linked covalently to the branchpoint adenosine via a 2'-S'phosphodiester bond. In 
step 2, cleavage at the 3' splice site occurs as a result of nucleophilic attack by the free 3' 
hydroxyl of exon 1. The intron is released, and the exons are simultaneously joined via a 3'-
5' phosphodiester bond, producing the two products of the spliëing reaction: a mature 
messenger RNA (mRNA) and an excised intron-lariat (Figure 1.1). 
1.2 The spliceosome machinery 
Nuclear pre-mRNA splicing in yeast and metazoa is catalysed by a large ribonucleoprotein 
complex, the spliceosome. This is assembled onto each intron in an ordered, multi-step 
process from the snRNPs (small nuclear iboucleoroteins) Ui, U2, U4/U6, US, as well as 
non-snRNP proteins (Will and Luhrmann, 2001; Jurica and Moore, 2003), the exact nature 
and number of which has been unclear. The snRNPs are trans-acting factors with both RNA 
and protein components, and are named according to the snRNA each contains. The snRNA-
associated proteins fall into two groups. Seven core or Sm proteins (B, Dl, D2, D3, E, F, and 
G as originally defined in metazoa) are common components of the U!, U2, U4, and US 
snRNPs, while each snRNP also contains snRNA-specific proteins. 
This traditional view of spliceosome assembly involves the sequential interaction of 
snRNPs with the pre-mRNA in a highly ordered and stepwise manner (reviewed in Staley 
and Guthrie, 1998) (Figure 1.1). Assembly begins with the association of the Ui snRNP with 
5' splice site to form the Commitment Complex (CC). Neugebauer and Rosbash groups 
(Kotovic et al., 2003; Gornemann et al., 2005; Lacadie and Rosbash, 2005) have 
demonstrated that Ul recruitment to pre-mRNA appears to occur co-transcriptionally, 
requiring the presence of introns in the pre-mRNA. Subsequently, the U2 snRNP binds to 
the branchpoint sequence, via Watson-Crick base-pairing, forming the A complex. The two 
sequences are not completely complementary, resulting in the conserved adenosine residue 
at the branchpoint being unpaired and bulging out of the U2 snRNA-pre-mRNA duplex. This 
bulging of the adenosine residue allows it to attack the 5' splice site in the first step of 
splicing. 
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Figure 1.1. Schematic demonstrating the assembly of the spliceosome by ordered addition of 
snRNP particles onto the pre-mRNA. The Ui snRNP (brown) interacts with 5' splice site 
(5'ss) to form the Commitment Complex (CC). Following this, the U2 snRNP (grey) 
associates with an adenosine nucleotide in the intron (A), referred as branch-point (Bp) to 
form the A complex. Next, the U5.U41U6 tn-snRNP associates with the complex to create 
the pre-spliceosome or Complex B. Complex C is then produced by the rearrangements 
within the spliceosome, including the dissociation of the Ui snRNP and the U4 snRNP 
(green) from the U6 (purple). The splicing chemistry then occurs. In the first step, the 
2'hydroxyl group (OH) of the branch-point attacks the phosphodiester bond (p) at the 5' 
splice site. The bond breaks, and a new phosphocliester bond is formed (GpA). In the second 
step, the 3'OH group of the free 5' exon attacks the 3' splice site. The result is joined exons 
(the spliced mRNA) and excised intron. The spliceosome dissociates, releasing mature 
mRNA and the intron-lariat structure. snRNPs are then released and recycled back into the 
splicing pathway, while the lariat is debranched by the debranching enzyme (Dbrlp) and 
subsequently degraded (Adapted from Makarov el al., 2002 and Newman 2001). 
Following A complex formation, the U4/U6.U5 triple snRNP associates with the 
complex, forming the spliceosomal B complex. The addition of the U4/U6.U5 triple snRNP 
to the spliceosome results in a number of RNA:RNA re-arrangements. The formation of the 
active spliceosome (C complex) is promoted by the Prpi9p complex (NTC) (Chan et al., 
2003). Association of NTC with B complex causes destabilisation of the base pairing 
between U4:U6 snRNAs and formation of RNA-RNA interactions between U2 and U6 
(Umen and Guthrie, 1995). Also, Ui snRNA is displaced from binding to the 5' splice site 
by US and U6 snRNAs. Both the Ui and U4 snRNPs are thought to leave the spliceosome 
after these rearrangements, leaving the activated spliceosome based around the U2, U5 and 
U6 snRNPs. 
Following pre-mRNA splicing, the spliced RNA is released from the spliceosome 
through the action of Prp22p (Schwer and Gross, 1998), and the spliceosome subsequently 
disassembles, releasing the lariat intron, which is de-branched by Dbrlp and degraded. 
Prp43p is a putative RNA helicase that is important for releasing the lariat intron and U2, 
US, and U6 snRNPs (Arenas and Abelson 1997). It is thought that for another round of 
splicing to occur, the components have to be re-assembled. 
An alternative process of spliceosome formation has been proposed by Stevens et al. 
(2002), who suggested that in yeast a penta-snRNP complex forms independently of pre-
mRNA interaction. This proposal is supported by evidence using in vitro transcribed RNA, 
and penta-snRNPs purified from HeLa cell nuclear extracts, showing that Ui associated with 
the 5' splice site as part of a complex containing all five U snRNAs (Malca et al., 2003). 
In vivo newly synthesised transcripts are usually spliced during transcription or 
immediately thereafter. This presumes that pre-mRNA splicing occurs exclusively in the cell 
nucleus. However, Denis et al. (2005) reported the presence of functional spliceosomes and 
signal-dependent pre-mRNA splicing in the cytoplasm of platelets. However, whether the 
pre-mRNA splicing in the cytoplasm is limited to platelet cells, or whether it might also 
occur in cell types that contain a nucleus, or if pre-assembly of part of the spliceosome 
components could happen in the cytoplasm before import into the nucleus, is unclear and 
further investigation is needed- 
4 
13 Splicing complex regeneration 
Having performed the task of ligating exons and producing mRNA, the spliceosome must 
release the mRNA for export. Furthermore, the postcatalytic spliceosomal machinery must 
be reconfigured to allow a new round of splicing. The snRNP-bound lariat intron must be 
disassembled, allowing the excised lariat intron to be degraded and the snRNPs to be 
recycled. Release of mRNA, disassembly, and recycling all involve extensive RNA: RNA 
rearrangement. The base pairing of U6 to the 5' splice site, U2 to the branch point, and US to 
the exons must be severed. Moreover, the mutually exclusive pairings involving U2, U6, and 
U4 must be restored to their original conformations. 
Prp22p and Prp43p were shown to be required for post-splicing complex 
disassembly (Schwer and Gross, 1998; Arenas and Abelson, 1997; Martin et al., 2002). 
Prp43p has been shown to be required for disassembly of the spliceosome and release of 
spliced intron (Martin et al., 2002) by analysing dominant negative Prp43p mutants. Prp22p 
is needed for disassembly of the spliceosome, and release of excised intron and spliced 
mRNA (Schwer and Gross, 1998; Wagner et al., 1998). Both of these factors belong to the 
ATP-dependent DExH-box RNA helicase family. 
Prp24p, the Lsm proteins, and Aar2p were also shown to promote regeneration of 
pre-mRNA splicing activity. U4 snRNA is unwound upon the activation of the spliceosome, 
so must again be base-paired with U6 snRNA for the next round of splicing. Prp24p and the 
Lsm proteins (Lsm6p and Lsm7p) were shown to be required for re-annealing of U4 and U6 
snRNAs (Raghunathan and Guthrie, 1998; Verdone et al., 2004). When Prp24p, Lsm6p, or 
Lsm7p was absent, unpaired U4 and U6 snRNPs accumulated; with time, splicing became 
inhibited. 
In contrast to Prp24p and the Lsm proteins, Aar2p is associated exclusively with the 
simple form of the US snRNP (16S), which is required for in vivo splicing and later rounds 
of in vitro splicing (Gottschalk et al., 2001). Investigation of the Aar2-U5 snRNP by electron 
microscopy revealed that, despite its comparatively simple protein composition, the yeast 
Aar2p-U5 snRNP appears structurally similar to the human 20S US snRNP, and thus may be 
a core particle from which mature US snRNP and subsequently the U4/U6.U5 tri-snRNP are 
assembled (Gottschalk et al., 2001). 
1.4 Group II introns 
Group H introns have only been identified in chloroplasts, fungal mitochondria and in some 
eubacterial genomes. Like spliceosomal introns, group II intron splice via two sequential 
transesterification reactions that yield ligated exons and an excised lariat-intron. Self-
splicing group II introns and the splicesome share many conserved and functionally 
important structural features (Villa et al., 2002). Strikingly, the catalytically important group 
II intron domain S (D5) (Figure 1.2A) was found to be capable of replacing the 
intramolecular stem-loop (ISL) (Figure 1.213) of U6/U6atac in an in vivo functional assay 
(Shukia and Padgett, 2002). In addition, the overall similarity between group II intron 
splicing and the spliceosome in their catalytic cores (Valadkhan and Manley, 2001), and 
evidence for catalytic Mg2 ions bound to RNA moieties (Sontheimer et al., 1997; Gordon 
and Piccirilli, 2001; Villa et al., 2002) in both splicing machineries suggest a link between 
these 2 splicing processes. 
However, unlike pre-mRNA splicing, group II intron splicing reactions do not 
require a complex of splicing components. Although some group II introns self-splice in 
vitro, this reaction generally requires nonphysiological conditions, and in vivo, proteins (e.g. 
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Figure 1.2. Structural parallels between A) group II introns and B) spliceosomal snRNAs. 
Homologous structures in the two systems are highlighted in the same colour. Location of 
the AGC triad, branch site adenosine and Mg 2  binding site are indicated in both systems. 
Domain V and U6 ISL are in red, and the exon-binding sequence (EBS1, 2, and 3) and US 
are in orange. Exons are shown in magenta and branch site regions in the two systems are in 
blue and green. (Figure is taken from Valadkhan 2005). 
1.5 Exon definition 
The removal of introns in higher eukaryotes requires the spliceosome to accurately recognise 
the 3' and 5' splice sites. The basic exon definition model proposes that in pre-mRNAs with 
large introns, the splicing machinery searches for a pair of closely spaced splice sites in an 
exonic polarity. When such a pair is encountered, the exon is defined by the binding of Ui to 
the 5' splice site, as well as associated 3' splice site-recognising factor (U2AF and SC35 in 
human). Such an exomc perspective of splice site recognition has been termed "exon-
definition". Interestingly, SR proteins have not yet been found in budding yeast. The absence 
of SR proteins in budding yeast may not be surprising as this organism's introns are small, 
such that they might not use exon definition (Berget 1995). 
1.5.1 The Cis-acting Intron determinants 
Nuclear pre-mRNA introns lack conserved sequences, except for minimal elements at the 
splice site and the branchpoint, and between the branchpoint and the 3' splice site (Figure 
1.3). This lack of conservation is remarkable in view of the huge size of some metazoan 
introns, and presents these organisms with the problem of ensuring splicing fidelity. Intron 
sequence determinants have been identified through sequence comparisons of both yeast and 
mammalian introns (Mount, 1982), and their contribution to function was determined by 
mutation. 
1.5.2 The 5' splice site (U2-dependent introns) 
The general consensus of the 5' splice site is AG/GURAGU (where / denotes the cleavage 
site; Mount, 1982). In yeast, the 5' splice site is more highly conserved (consensus 
RIGUAUGU). This sequence is required for splicing (Green, 1986). Mutations within this 
sequence generally abolish splicing in yeast (Vijayraghavan et al., 1986; Fouser and Friesen, 
1986), or lead to alternative splice sites in mammalian systems (Aebi et al., 1986). In yeast, 
mutation of the invariant GU nucleotides often prevents lariat formation. As in mammals, 
this leads to the accumulation of lariat intermediates (Newman et al., 1985). Instances are 
known of point mutations in 5' splice sites (or 3' splice sites) in introns of genes such as 
7 
retinoblastoma, and cystic fibrosis trans-membrane conductance regulator, causing human 
genetic disease due to exon-skipping or cryptic site activation. 
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Figure 13. Schematic representation of conserved sequence within the iritrons of S. 
cerevisiae and mammals. The position of the 5' splice site, branch point and the 3' splice site 
are indicated, where Y represents conserved pyrimidines and R represents conserved purine 
residues. The conserved adenosine residue is underlined. The conserved sequence of 
mammalian U12-type introns is obtained from Will and LUhnnann, 2005. 
1.5.3 The Branchpoint 
Yeast introns contain the sequence UACUAAC (the branchpoint sequence), which is usually 
located 20-60 nucleotides upstream of the 3' splice site, and which is required for splicing 
(Pikielny et al., 1983). The 3'-most adenosine in this sequence (Figure 1.3, shown in bold) 
provides the nucleophile in step I and is the site of the lariat branch. In budding yeast, the 
sequence is almost completely conserved. Mutations within this sequence generally abolish 
splicing, although as with the 5' splice site, some mutations allow step I but not step II, 
resulting in the accumulation of lariat intermediates (Jacquier and Rosbash, 1986; 
Vijayraghavan et al., 1986). That mutations in a cis-acting sequence have this phenotype is 
suggestive of a proofreading mechanism, operating to ensure high fidelity in splicing. 
Mammalian introns contain a similar, although less strictly conserved branchpoint, 
of consensus UNCURAC. Compared to yeast, mutational analysis of mammalian introns 
suggests a far less stringent requirement for a sequence in mammalian introns conforming to 
this consensus. When the -globin branchpoint was deleted, multiple crytic sites were 
activated, although lariat formation always occurred at an adenosine, located 22-37 
nucleotides upstream of the 3' splice site (Ruskin et al., 1985). Competition between 
duplicated branchpoint sequences in introns, which otherwise lack cryptic sites, shows that 
base substitutions or deletions within this sequence abolish splicing in vitro, and promote 
cis-competition. Therefore, the mammalian branchpoint makes a significant contribution to 
splicing efficiency (Reed and Maniatis, 1988). 
1.5.4 The 3' splice site and polypyrimidine tract (U2-dependent introns) 
Both yeast and mammalian introns end in the dinucleotide AG. Mammalian introns have in 
addition, a preceding stretch of pyrimidine-rich sequence (the polypynmidine tract), and the 
splice site consensus is YnYAG (Y: pyrimidine bases) (Mount et al., 1983). The sequences 
around the yeast 3' splice site are not well conserved beyond the AG, except that in many 
cases the 3' splice site is preceded by pyrimidines. The distance between the branchpoint and 
the 3' splice site may be vary, but is usually 20-40 nucleotides. 
In mammalian introns, mutation of the polypyrimidine tract blocks the early steps of 
spliceosome assembly (Reed and Maniatis, 1985). Reed (1989) demonstrated that efficient 
lariat formation only occurred when the branchpoint was directly adjacent to a 
polypyrimidine tract. Introns with a short polypyrimidine tract (14 nucleotides) also required 
the AG dinucleotide for step I, whereas those with a long polypyrimidine tract (26 
nucleotides) underwent step I in the absence of an AG dinucleotide. In the latter type of 
intron, where the branch site is specified independently of the 3' splice site, there has been a 
suggestion that a scanning mechanism searches for the first AG downstream of the 
polypyrimidine tract, which is used as the 3' splice site (Smith et al., 1989). Consistent with 
this, stable secondary structures inserted after the polypyrimidine tract block step II, and 
when the AG is deleted, the next AG downstream is used as the 3' splice site (Smith et al., 
1989). 
In yeast introns, the branch site is specified primarily by the UACUAAC sequence, 
independent of pyrimidine-richness in the 3' region. A model substrate, truncated 
immediately after the branchpoint, underwent step I when ligated via its 3' end to a 
homopolymenc oligonbonucleotide of any sequence. The only requirement for lariat 
formation was intron length (at least 29 nucleotides following the branchpoint; Rymond et 
al., 1987). The polypyrimidine tract, though not strictly required, greatly enhances the 
efficient usage of an adjacent AG nucleotide in an alternative 3' splice site competition assay 
(Patterson and Guthrie, 1991). 
In summary, the view is of tripartite cis-acting elements in the 3' region of the 
intron. The sequences are recognised co-ordinately during early spliceosome assembly. 
Yeast and mammalian systems differ in that they have stringent requirements respectively 
for the branchpoint and a polypynmidine tract, but the function of elements in the 3' region 
is broadly similar. In both systems, step I can occur in the absence of a functional 3' splice 
site. 
1.5.5 U12 dependent splicing 
A rare class of introns, called AT-AC or U12-dependent introns, was identified a decade ago 
(Jackson 1991). The first set of U12-type introns identified contained the dinucleotides AT 
and AC (genomic DNA sequences) at their 5' and 3' ends, respectively, and for this reason 
they were originally referred to as ATAC introns. Subsequent studies, however, revealed that 
some U2-type introns also end in AT-AC and conversely that a large number of U12-type 
introns have dinucleotides GT and AG at their 5' and 3' ends, respectively (Dietrich et al., 
1997; Wu and Kramer, 1997) (Figure 1.3). In comparison to U2-type introns, consensus 
sequences delineating the U12-type 5' splice site -A(or G)UAUCCUUU- and branch site - 
UCCUUAACU- are longer and more tightly constrained. The U12-type 3' splice site is 
typically denoted by YAC/ or YAG/. However, in contrast to U2-type introns, there is no 
strict 3' splice site sequence requirement for U12-type introns; various other dinucleotides 
can serve as U12-type 3' splice sites (Dietrich et al., 2001; Levine and Durbin, 2001; 
Hastings et al., 2005). In addition, the average distance between the U12-type branch site 
and 3' splice site (12-15 nucleotides) appears to be shorter and more highly constrained than 
that observed with U2-type introns (18-40 nucleotides) (Levine and Durbin, 2001) and, 
similar to U2-type introns present in yeast, U12-type introns lack a polypynmidine tract. 
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1.6 Alternative splicing 
There are probably more than 100000 different proteins expressed at any one time in a 
human cell, but the report of only 32000 human genes (Venter et al., 2001) thus came as a 
surprise. This basic disparity indicated that the number of human expressed-sequence 
(mRNA) forms was much higher than the number of genes, suggesting a major role for 
alternative splicing in the production of complexity. Alternative splicing is observed among 
pre-mRNAs from over a third of protein-coding genes. This yields different mRNAs from 
one gene by altering one or all of the following: 1) the transcription start site, thus modifying 
the 5' end of the RNA, 2) the site of cleavage and polyadenylation, thus altering the 3' end 
of the transcript, 3) the definition of exons, providing for a different assortment of the coding 
information (Goldstrohm et al., 2001). Alternative splicing can be divided into four general 
categories. 1) The choice to remove or not remove an intron (Figure 1.4A). 2) The 
alternative use of 5' splice sites that will change the length of an exon (Figure 1.413). 3) The 
alternative use of 3' splice sites, which will also change the length of an exon by extending 
the 3' border of the exon (Figure 1.4C). 4) The choice between exon inclusion and exon 
skipping (Figure 1.4D). 
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Figure 1.4. Types of alternative splicing. A) The choice of an intron remove or not remove 
B) alternative 5' splice site. C) Alternative 3' splice site. D) Exon inclusion or exclusion. 
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1.7 Canonical Sm proteins 
In both yeast and metazoa, each snRNP particle (except for U6) is composed of an U 
snRNA, a set of specific proteins associated with each particular snRNP, and a set of Sin or 
core proteins shared by all snRNPs. Sm proteins were named after Stephanie Smith, the first 
patient in which the systemic lupus erythematosus-associated anti-Sm autoimmune 
antibodies were identified (reviewed in Khusial et al., 2005). The core protein is composed 
of Sin proteins B, B' (in mammals), Dl, D2, D3, E, F, and G, which assemble around the Sin 
site of the snRNA. However, in mammalian cells, SmB is replaced by an alternatively 
spliced variant 5mB' or by a different gene product, the SmN protein. The B and B' proteins 
are encoded by the same gene, and are produced by alternative splicing (Chu and Elkon, 
1991). In yeast, due to the lack of alternative splicing, there is no 5mB' protein. The protein 
SmN is structurally similar to the 5mB protein, however, is only found in neural tissue 
(Sharpe et al., 1990). 
snRNP Sm proteins share two evolutionarily-conserved sequence motifs which are 
involved in Sm protein-protein interactions, suggesting that the Sm proteins may have arisen 
from a single common ancestor (Hermann et al., 1995). These two regions were termed the 
Sin motifs; Sin motif 1 (32 amino acids long) and motif 2 (14 amino acids long). Sin motifs 
are essential for complex formation between B' and D3 in vitro (Hermann et al., 1995). The 
Sin proteins bind to the Sin site on snRNAs, which is a single-stranded structural motif 
consisting of the sequence RA(U)36GR (where R is a purine base), and is normally found 
between double hairpin loops (Branlant et al., 1982). Sm protein interaction with this 
sequence has proven to be resistant to mutation, with several mutations failing to disrupt the 
binding in vitro (Jones and Guthrie, 1990). 
The existence of a seven-member complex binding a single-stranded RNA has 
suggested the possibility that the Sin proteins might assemble in a ring, and the RNA might 
pass through this ring. Structural studies have proven that an Sm ring does form, but the 
nature of the RNA interaction with the ring remains unclear. Initial electron microscopy 
showed that the E-F-G sub-complex appeared as a ring, which was shown biochemically to 
contain two copies of the E, F, and G proteins (Plessel et al., 1997). 
The D1-D2 and the B-D3 sub-complexes have been crystallised, allowing the 
structure of these sub-complexes to be solved to atomic resolution (Kambach et al., 1999) 
(Figure 1.5A). Each Sm monomer appears to consist of a highly conserved fold, forming a 
barrel-type structure consisting of an N-terminal a-helix followed by a strongly bent five-
stranded p-sheet. This allowed the modelling of the structure of the complete Sm complex, 
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which suggested that the Sm proteins associate to form a seven-member closed ring structure 
with a positively charged central hole. This structure allows the possibility for single-
stranded, positive-charged RNA to pass through the central hole. Although this has not been 
demonstrated, Urlaub et al. (2001) have shown that RNA contacts the inner surface of the 
Sin ring. 














Figure 1.5. (A) Structural models of the Sin heptamenc ring. The left-hand side (a) 
represents the ribbon structure, with each subunit labelled. The surface representation is 
shown on the right (b) with electrostatic potential (blue, positive red, negative). The two 
orientations are identical. Figure taken from Kambach et al. (1999). (B) Schematic 
representation of the assembly of the Sin protein core onto snRNAs in mammalian cells. 
Firstly, D1-D2 and E-F-G complexes are formed, which assemble into a pentamenc complex 
in the absence of RNA, before binding to an U snRNA Sm site to form the subcore. Finally, 
a B-D3 dimer binds to the subcore, forming a proposed ring structure around the Sm site 
(Raker et al., 1996). 
13 
The demonstration that yeast snRNPs are immunoprecipitated by anti-Sm antibodies 
(Tollervey and Mauaj, 1987), and the observation that yeast snRNAs are able to assemble 
with Xenopus Sin proteins upon microinjection into oocytes suggested that yeast snRNPs 
contain a set of proteins homologous to the metazoan Sin proteins (Riedel et al., 1987). 
Biochemical studies indicated that the different yeast snRNPs contain polypeptides with 
sizes similar to those human core proteins. Some of these proteins (SmD1, SmD3, and SmE) 
were identified in the yeast genome sequence by homology to their human counterparts 
(Rymond 1993; Roy et al., 1995; Bordonne and Tarassov, 1996). Scanning the yeast 
genomic database revealed the presence of several putative Sin proteins, some of which 
turned out to represent canonical snRNP core proteins (Seraphin 1995). 
In higher eukaryotes, binding of snRNA to the Sm complex is required for the 
import of both RNA and proteins (reviewed in Kiss 2004). In yeast, the situation is less 
clear, and the Sin proteins may be imported separately, with the snRNA remaining nuclear 
and interacting with the Sm complex in the nucleus. Wherever the location of snRNP 
formation, the C-terminal tails of the Sm proteins are important for their nucleai localisation 
in both yeast and higher eukaryotes (Bordonne 2000; Girard et al., 2004). Initial 
investigations were carried out in S. cerevisiae (Bordonne 2000), and these experiments 
showed that the basic C-terminal tails of SmBlp and SmDlp appear to be essential for the 
nuclear import of the yeast Sin complex. Nuclear import of proteins in yeast requires 
Kap95p (Importin- in humans) (lovine et al., 1995) and Srplp (Importin-a in humans) 
(Enenkel et al., 1995). 
Srplp binds nuclear localisation signals in newly synthesised proteins in the 
cytoplasm, and then dimerises with Kap95p to enable nuclear import of the NLS-containing 
protein. Classical nuclear localisation sequences (NLS) contain clusters of basic residues 
(reviewed in Jans et al., 2000). Although SmBlp, SmDlp, and SmD3p do not contain a 
classical NLS, the C-termini of all three are rich in basic amino acids. Fusion of the C-
terminal tails of SmB1 and Dl to GFP resulted in localisation of the fusion protein to the 
nucleus, but SmD3p does not (in yeast). Examination of Sm protein NLS sequences in 
human cells were performed in a similar way. In contrast to yeast, human SmDlp and 
SmD3p, but not SmBlp, possess NLS properties (Girard etal., 2004). 
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1.8 Biogenesis of spliceosomal snRNPs 
Assembly of the metazoan U snRNPs is a multi-step process, following an ordered pathway. 
With the exception of U6, the major spliceosomal snRNAs (U!, U2, U4, and US) are 
synthesised by RNA polymerase II. In metazoa, after the transcription of snRNAs by RNA 
polymerase II, the precursor snRNAs, with a 5' -terminal 7-monomethylguanosine (m7G) cap 
structure and extra nucleotides at the 3' end, are assembled into a large export complex that 
includes the m7G-cap-binding complex (CBC), the phosphorylated adaptor for RNA export 
(P1-lAX) and the CRM1/RanGTP complex. In its phosphorylated form, PHAX functions by 
mediating the interaction between the CBC/U snRNA complex and the CRM1/RanGTP 
complex, allowing export from the nucleus. After export to the cytoplasm through the 
nuclear pore complex (NPC), PHAX becomes dephosphorylated, owing to GTP hydrolysis 
by Ran (Ohno et al., 2000). Which causing the complex to dissociate, and allowing PHAX to 
re-enter the nucleus via two NLS signals. This ensuring the directionality of U snRNA 
export, and allowing PHAX to be recycled (Segref et al., 2001; reviewed in Kiss 2004; 
reviewed in Will and Luhrmann, 2001) (Figure 1.6). 
In the cytoplasm, the survival of motor neurons (SMN) protein complex facilitates 
the association of pre-snRNA with a heteroheptameric ring of seven Sm proteins to form the 
snRNP core complex on the Sm site of the snRNA. The association of Sm proteins with 
snRNAs occurs in a stepwise manner. First, the D1-D2 and E-F-G complexes are formed, 
which assemble into a pentameric complex before binding to the U snRNA, forming the 
subcore. Then a B-D3 dimer binds to the subcore, forming a proposed heptameric ring 
structure around the Sm site (Raker et al., 1996) (Figure 1.513). This is followed by the 
hypermethylation of the snRNA m7G cap by a methylase to form a methyl- 2 ' 27-guanosine cap 
structure, and 3' end maturation of the snRNAs (Seipelt et al., 1999; reviewed in Kiss 2004). 
This binding also generates a bipartite nuclear localisation signal (NLS), composed of the 
Sm core complex and the snRNA cap structure, that permits the import of snRNPs to the 
nucleus. 
Competition experiments indicate that snRNPs are imported by specific receptors, 
and that U snRNP import is mediated by importin-, which functions in this process without 
the NLS-specific importin-cz receptor. In metazoa, snurportini enhances the m 3G-cap-
dependent nuclear import of U snRNPs. This importin a-like adapter recognises only the 
m3G cap but not the Sm core NLS, indicating that at least two distinct import receptors 
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Figure 1.6. Assembly of U snRNPs in higher eukaryotes. Newly transcribed U snRNA 
acquires a methyl guanosine (m 7G) cap in the nucleus, to which the cap binding complex 
(CBC) binds. This then associates with phosphorylated PHAX which in turn binds to CRM1 
(Xpol in budding yeast) which associates with Ran-GTP. This complex is exported to the 
cytoplasm where complex dissociates, owing to PHAX desphosphorylation and GTP 
hydrolysis by Ran. Assisted by SMN, which binds the snRNA after nuclear export, Sm 
proteins then assemble around the Sin site of the U snRNA, which leads to hypennethylation 
of the m7G cap, forming an m2 ' 2 ' 7G cap. This enables immature snRNP re-import into the 
nucleus via snurportini and importin-ft Once there, the U snRNP associates with snRNP-
specific proteins, probably in Cajal bodies, forming a mature U snRP complex (Figure is 
taken from Kiss, 2004). 
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However, the m3G cap structure plays a differential role in the nuclear import of 
distinct snRNAs in Xenopus oocytes: it is an essential signal component for Ui and U2 
snRNAs, whereas U4 and US snRNAs can enter the nucleus without being hypermethylated 
(Fischer et al., 1991). In yeast, tri-methylGuanosine Synthase (TGSJ), which is essential for 
hypermethylation of the m7G caps of both snRNAs and snoRNAs is located in the nucleolus. 
Surprisingly, this gene is not essential. 
Deletion of TGS1 confers a cold-sensitive phenotype and accumulation of Ui in the 
nucleolus, suggesting that the hypermethylation of the m 7G cap structure takes place in the 
nucleolus (Mouaikel et al., 2002). The assembly of the Sm proteins on the Sm sites is a pre-
requisite for cap hypermethylation, since snRNA mutants lacking the Sm site (Mattaj 1986), 
or genetic depletion of yeast SmD1 and SmD3 proteins, leads to inefficient recognition of 
the snRNAs by anti-TMG antibodies (Rymond, 1993; Roy et al., 1995). 
After re-entering the nucleoplasm, the import proteins dissociate and the newly 
imported snRNPs transiently accumulate in Cajal bodies (Sleeman and Lamond, 1999). In 
the Cajal bodies, the Ui, U2, U4, and US snRNAs undergo site-specific pseudouridylation 
('I') and 2'-O-methylation (m) directed by small Cajal body RNAs (scaRNAs), which 
specifically accumulate in Cajal bodies (Jady et al., 2003). In addition to common Sm core 
proteins, the mature Ui, U2, U4, and US snRNPs also contain snRNA-specific RNP 
proteins. Since the snRNP-specific proteins appear to concentrate in Cajal bodies, they are 
believed to associate with core snRNPs in this organelle. Finally, mature spliceosomal 
snRNPs accumulate in the interchromatin region in structures called splicing speckles. 
Usually, speckles are located close to actively transcribed genes. They probably provide 
storage sites for snRNPs or function in snRNP recycling (Lamond and Spector, 2003). 
In contrast to the Pol-II-specific Sm snRNAs, biogenesis of the Pol-III-transcribed 
U6 snRNA is confined to the nucleus. Before accumulating in the nucleoplasmic splicing 
speckles, the maturing U6 snRNA visits the nucleolus and Cajal body. Synthesis of U6 
snRNA terminates with a short U stretch that serves as a transcription termination signal for 
Pol III. The 3' -terminal U stretch of the newly synthesised U6 transiently associates with the 
La protein, which provides stability for the nascent RNA and facilitates snRNP assembly 
(Wolin and Cederv all, 2002). Later, the La protein is replaced by the doughnut-like 
heteromer of seven Sm-like proteins (Lsm2, Lsm3, Lsm4, LsmS, Lsm6, Lsm7, and Lsm8) 
(Achsel et al., 1999; Mayes et al., 1999). 
In contrast to other U snRNAs, U6 RNA is not thought to leave the nucleus (Vankan 
et al., 1990; Boelens et al., 1995; Pante et al., 1997), apart from one study which detected 
U6 snRNA transiently in the cytoplasm of mouse fibroblasts (Fury and Zieve, 1996), and a 
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heterokaryon assay in yeast that found that all small nuclear RNAs tested passed through the 
cytoplasm (Olson and Siliciano, 2003). Wheat germ agglutinin is used to inhibit nuclear 
import of proteins that contain a classical NLS. In Xenopus oocytes, U6 RNA injected into 
the cytoplasm is imported into the nucleus, and this import is inhibited by wheat germ 
agglutinin, suggesting that U6 import occurs by the same pathway as protein import (Fischer 
et al., 1991; Michaud and Goldfarb, 1992). 
During its maturation, the U6 snRNA also undergoes site-specific pseudouridylation 
and 2'-O-methylation. However, in contrast to Sin snRNAs, which are modified by scaRNPs 
in the Cajal body, 2'-O-methylation and probably also pseudouridylation of U6 snRNA is 
directed by snoRNAs, which reside in the nucleolus. This indicates that the U6 cycles 
through the nucleolus to undergo snoRNA-mediated modifications (Lange and Gerbi, 2000). 
The mature U6 and U4 snRNPs associate via RNA:RNA interaction to form the U4/U6 di-
snRNP, that also binds the U5 snRNP to form the U4/U6.U5 tri-snRNP. The recent finding 
that p110 (Prp24p in budding yeast), a protein factor facilitating U4/U6 di-snRNP formation, 
is localised to the Cajal body, suggests that this process may take place in this organelle 
(Stanek et al., 2003). 
Recent evidence has provided an insight into the formation of the tri-snRNP in 
mammalian cells (Schaffert et al., 2004). RNAi-based depletion of the human homologues 
of Prp3lp and the U5 snRNP protein Prp6p resulted in a decrease in tri-snRNP levels and 
accumulation of U4/U6 di-snRNP and free U5 snRNP. The di-snRNP RNAs accumulated in 
Cajal bodies, while free U5 snRNP accumulated in the speckles, suggesting that U5 transport 
to Cajal bodies is important in tri-snRNP formation. 
The finding of Olson and Siliciano (2003) of U6 shuttling in yeast in heterokaryon 
assays contradicts previous evidence that the U6 snRNA is not exported from the nucleus 
under normal conditions (Boelens et al., 1995), as well as the recent suggestion that S. 
cerevisiae snRNAs might not be exported (Mouaikel et al, 2002). Because of this, and 
because the RNAs appeared to transfer simultaneously, it was suggested that the shuttling 
observed in heterokaryon assays might be due to a global leaking of RNA. However, 
reduced transfer of Ul snRNA in a leptomycin-treated crml -1mb strain, and the fact that all 
RNAs not only appeared outside the nucleus, but were actively taken up by the second 
nucleus suggests that a mechanism exists for export and re-import of snRNAs in S. 
cerevisiae (Olson and Siliciano, 2003). 
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1.9 Prp8p 
Lee Hartwell and co-workers first identified RNA8 in 1967, through a genetic screen to 
isolate temperature-sensitive (ts) mutations in S. cerevisiae (review in Grainger and Beggs, 
2005). RNA8 was later renamed PRP8 (PRP: pre-mRNA processing, Vijayraghavan et al., 
1989). Temperature sensitive prp8-1 cells accumulated RPL59 (ribosomal protein 59) pre-
mRNA (Larkin and Woolford, 1983) and were also defective in splicing in vitro of ACT1 
pre-mRNA (Lustig et al., 1986), identifying Prp8p as an essential pre-mRNA splicing factor. 
Yeast PRP8 was cloned by complementation of the heat-sensitive growth defect of 
the prp8-1 mutation (Jackson et al., 1988). The 7.4-kb transcript was detected at 
approximately one copy per yeast cell, with a product size of 280 kDa (SGD). Prp8p exhibits 
a high degree of conservation throughout all eukaryotes, with 61% identity overall between 
yeast and humans in its 2413 amino acids sequence (Hodges et al., 1995; Luo et al., 1999, 
Grainger and Beggs, 2005). Twenty-eight full-length sequences of PRP8 from 26 eukaiyotic 
organisms are currently available (Grainger and Beggs, 2005). In plants, Arabidopsis 
thaliana has two copies of PRP8, one on chromosome 1, and the other on chromosome 4, 
that encode proteins with 92% identity (Grainger and Beggs, 2005). Nicotiana tabacum L. 
(tobacco) Prp8p (>200 kDa) was also detected by Western blot using Prp8p antibodies raised 
against yPrp8p (Kulesza et al., 1993). In humans Prp8p is encoded by a single gene with 42 
exons (McKie et al., 2001). Presumably, human Prp8p's function in pre-mRNA splicing is 
required in all tissues, and its expression is notably higher in skeletal and cardiac muscle 
(Luo et al., 1999). However, the mouse Prp8p is detected most strongly in mouse testis and 
ovary (Takahashi et al., 2001). 
The use of Prp8p antibodies (Beggs and co-workers) has further identified its role in 
pre-mRNA splicing (Jackson et al., 1988; Anderson et al., 1989; Whittaker et al., 1990; 
Brown and Beggs, 1992). Immunodepletion of Prp8p with 8.1 antibodies (against amino 
acids 682-1122) from yeast extracts caused loss of splicing activity, and this antibody 
precipitated US snRNP and disrupted the U5.U4/U6 tri-snRNPs (Jackson et al., 1988; 
Lossky et al., 1987). In contrast, incubation of yeast splicing extracts with 8.4 antibodies 
(against aa1922-2410) or 8.6 antibodies (against aa2-35) (Brown and Beggs, 1992) resulted 
in co-immunoprecipitatiofl of U4, US and U6 snRNAs, and the following spliceosomal 
complexes: pre-mRNA, excised-intron-exon2, and excised-intron. These data indicate that 
Prp8p is present in the spliceosome during the first and second steps of pre-mRNA splicing, 
and in a post-splicing complex (Jackson et al., 1988; Whittaker et al., 1990, Brown and 
Beggs, 1992). Polyclonal antibodies raised against the C-terminus of human Prp8p (70R and 
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K05), immunoprecipitated both the U2 and U12 spliceosomes, indicating that Prp8p is 
present in both major and minor spliceosomes (Hinz et al., 1996; Luo et al., 1999). 
Budding yeast Prp8p N-termini contain proline-rich regions (Brown 1995, Grainger 
and Beggs, 2005). By yeast 2-hybrid analysis, only the Snu40/yLin1 protein (a non-essential 
U5 snRNP protein) (Giaever et al., 2002, SGD) was shown to interact with the N-terminus 
of yeast Prp8p (Bialkowska and Kurlandzka, 2002). The yeast strain with Prp8p proline-rich 
region deleted is viable, and shows no temperature-sensitive phenotype, but grows slowly in 
comparison to the wild type strain. Micro-array analysis (Barrass and Beggs, unpublished 
data) of a yeast strain with the proline-rich region deleted has a splicing defect, as it 
accumulated pre-mRNA in vivo when compared to the wild-type yeast strain. On the other 
hand, Prp8p N-terminal (aa2178-2310 in yeast) contains a Jabl/MPN domain that binds 
directly to ubiquitin (Bellare et al., 2006). Prp8p mutations in its Jabl/MPN domain (prp8-
602 and prp8-603) not only reduced the binding of Prp8p to ubiquitin, but also reduced tn-
snRNP formation (Bellare et at., 2006), suggesting a functional link between ubiquitin and 
the pre-mRNA splicing machinery. 
Yeast Prp8p was found to cross-link to unifonnly-labeled wild-type pre-mRNA 
substrates, but not to RNAs with mutations in the 5' splice site or branch point that 
prevented spliceosome assembly (Whittaker and Beggs, 1991). To identify sites in pre-
mRNA where Prp8p bound, cross-linking reagents were incorporated at specific sites in pre-
mRNA substrates. Human Prp8p was found to contact the pre-mRNA (at -7, -3, -2, +3, but 
not -17 or -27, with respect to the 5' splice site, review in Grainger and Beggs, 2005). Yeast 
Prp8p was also found cross-linked at 5' splice site ( at positions -1, -2, -8, but not at +4 in the 
intron, before step one, Teigelkamp et al., 1995). Photo-crosslinking analysis at the 3' splice 
site showed that yeast Prp8p cross-linked to S1J  at the exomc 3' splice site +1, but was not 
detected in a Prp2p-depleted extract that was stalled prior to step one. When purified yeast 
Prp2p was added back to the Prp2p-depleted reaction, the Prp8p-3' splice site interaction 
was restored, indicating that this contact was initiated during or subsequent to step one 
(Teigelkamp et al., 1995). 
In reconstituted yeast US and U6 snRNPs, the whole 5' stem-loop system of yeast 
US snRNA, including the invariant loop 1 nucleotides U 96-U99 and the internal loops ILl and 
1L2 (Figure 1.6) were cross-linked to yeast Prp8p (Dix et al., 1998). Also, Prp8p cross-
linked to U6 (at U54), which is in the conserved region that contributes to the catalytic core 
of the spliceosome (Vidal et al., 1999). Both US snRNA loop 1 and Prp8p can be cross-
linked to the 5' and 3' splice sites in HeLa or yeast extracts, and these contacts occur at 
similar stages in the splicing reaction (Newman and Norman, 1992; Teigelkamp et al., 1995; 
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O'Keefe et al., 1996; Dix et al., 1998; Segault et al., 1999; Alvi et al., 2001; McConnell and 
Steitz, 2001; O'Keefe 2002). U5 snRNA was proposed to anchor and align the ends of the 
exons in spliceosome catalysis (O'Keefe el al., 1996). Surprisingly, U5 loop 1 is not 
essential for splicing in HeLa nuclear extract (Segault et al., 1999), and is only required for 
step two in yeast extracts (O'Keefe et al., 1996; O'Keefe and Newman 1998). Interestingly, 
cross-linking of yeast Prp8p to the 3' splice site occurred even in the absence of US loop!, 
(Dix et al., 1998) suggesting that Prp8p may anchors the exons in the spliceosome, acting in 
conjunction with U5 loop 1 to align the ends of the exons for the second trans-esterification 
reaction (Dix et al., 1998; O'Keefe and Newman 1998). 
Newman and co-workers have developed a new proteolytic mapping approach to 
characterise contacts between yeast Prp8 and catalytic core RNAs (Turner et al., 2006). 
Short peptide tags, containing protease sites using a custom-built Tn5-based transposon, 
were randomly inserted into yeast Prp8p. This strategy allows regions of Prp8p that cross-
linked to RNA to be narrowed down after TEV protease digestion. The mapping data from 
cross-linking analysis revealed the sites of RNA interactions in the central region of Prp8p 
(Figure 1.7). 
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Figure 1.7. Regions of Prp8 that contact RNA in snRNPs and spliceosomes. 
Schematic representation of Prp8 protein and RNA crosslinks. Cross-linked residues are 
circled, short-range cross-links using uridine and 4-thio-undine (green circle). Extensive 
Prp8p cross-links with U5 snRNA are also represented, as is the U6 residue 54. Both the U5 
and U6 cross-links were only demonstrated in snRNPs. All numbering relates to S. 
cerevisiae. (Figure adapted from Grainger and Beggs, 2005, and regions of Prp8p that 
crosslink with 4-thio-uridine (orange and blue circles) were referred to Turner et al., 2006.). 
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1.10 Retinitis pigmentosa 
Retinitis pigmentosa (RP) is a heterogeneous group of inherited bilateral retinal pigmentary 
dystrophies, which is linked primarily to night-blindness, followed by progressive loss of 
peripheral vision, reduced central visual sharpness and acquired colour vision defect (Peter 
Herse, 2005). The progressive demise of the photoreceptors also precipitates other 
pathological symptoms in the retina, including the attenuation of the retinal vasculature and 
the accumulation of intra-retinal pigment deposits, from which the disease gets its name 
(reviewed in Kennan et al., 2005). 
So far, twelve loci have been linked to autosomal dominant forms (adRP) of the 
disease, and 4 of these genes are related to pre-mRNA splicing (Table 1.1). However, 
additional loci are yet to be identified. 
Table 1.1 The known adRP genes 
Gene Protein product Locus Locus Protein function Expression 
symbol  name  profile 
CA4 Carbonic anhydrase IV RP17 17q22 Reversible hydration Choroid and 
of carbon dioxide widespread 
CRX Cone-rod homeobox protein  19q 13.3 Transcription factor Photoreceptors 
FSCN2 Retinal fascin 17q25 Actin bundling in the Photoreceptors 
connecting cilium  
IMPDH1 Inosine monophosphate RP10 7q32.1 Guanine nucleotide Photoreceptors 
dehydrogenase type 1  synthesis & widespread 
NRL Neural retina leucine zipper RP27 14q1 1.2 Transcription factor Photoreceptors 
protein 





PRPF3 Prp3p RP18 1q21.1 
PRPF'8 Prp8p RP13 17pl3.3 
PRPF31 Prp3lp RP11 
RDS Retinal degeneration slow RP7 6p2l.1- Outer segments disc Photoreceptors 
protein  cen structure  
RHO Rhodopsin RP4 3q22.1 Photo-sensitive Photoreceptors 
pigment 
RPJ Retinitis pigmentosa RP1 RP1 8q1 1- Structure of Outer Photoreceptors 
protein q13 segments disc & 
axonema  
(Table adapted from Kennan et at, Z(JU) 
The four known splicing factors genes that have been identified as being mutated in 
adRP: PRPF3, PRPF8, PRPF31, and PAP-1 (Pim-1 associated protein)) (Chakarova et al., 
2002; McKie et al., 2001; Vithana et al., 2001; Martinez-Gimeno et al., 2003; Maita et al., 
2004; Maita et al., 2005). All these factors were shown to be part of the tri-snRNP complex, 
and only PAP-1 has no homologue in budding yeast. 
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PRPF8 mutations causing adRP were found clustered in a 14-codon stretch within 
the last exon of the 7 kb transcript. The altered amino acid residues at the C-terminal exhibit 
a high degree of conservation across species as diverse as humans, Arabidopsis, 
trypanosome, and Saccharomyces cerevisiae (McKie et al., 2002). 
Truncated PRPF3 1 proteins significantly inhibited pre-mRNA splicing of intron 3 of 
the RHO gene (Yuan et al., 2005). Analysis in cell culture has offered some evidence of 
reduced protein solubility for PRPF31 proteins that incorporate missense mutations (A 194E 
and A216P). Both point mutations affecting PRPF31 proteins impede, but do not entirely 
prevent its translocation from cytoplasm to nucleus. A high proportion of the expressed 
mutant protein was insoluble, which could be due to the protein mis-folding, resulting in 
accumulation of insoluble aggregates in the cytosol (Deery et al., 2002). 
The identification of PRPF8 and PRPF31 led Chakarova and co-workers to screen 
HPRP3 as a candidate for causing adRP. Indeed, two different missense mutations are 
clustered within a two-codon stretch in the 1 1th  exon of the HPRP3 gene. One of the 
mutations (T494M) is seen repeatedly in apparently unlinked families, raising the possibility 
of a mutation hot spot (Chakarova et al., 2002). Adjacent to these mutations is the C-
terminal region that is required for association of Prp3p with PAP-i. Both Prp3p and PAP-i 
were found to be components of the U4/U6.U5 tri-snRNP complex (Maita et al., 2004). The 
H137L mutation of PAP-1 had no effect on splicing, while the other (13170G) resulted in 
both a defect in splicing activity and a decreased proportion of phosphorylated PAP-1 (Maita 
etal., 2004). 
The mutations of splicing factors that relate to adRP suggest a link between 
spliceosome formation and adRP. Rather than these mutations causing a dominant-negative 
effect, the disease phenotype might relate to thresholds in the level of splicing. In other 
words, photoreceptors might survive until the level of splicing of rhodopsin, or other 
mRNAs, drops below a crucial level, at which point the cell would be irrevocably damaged, 
eventually leading to apoptosis. 
1.11 US snRNP 
The US snRNP is an active central component of both the U2- and U12-type spliceosomes 
(Grabowski and Sharp, 1986; Frilander and Steitz, 2001), and has the same protein 
composition in both spliceosomes (Will et al., 1999) (Table 1.2). The gene encoding the S. 
cerevisiae US snRNA, SNR7, was initially identified on the basis of a 9-nucleotide (nt) 
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sequence element (nt 93 to101) (US loop 1) that is invariant in all U5 snRNA sequences 
(Patterson and Guthrie, 1987). Studies in vivo in HeLa (Segault et al., 1999) and in vitro in 
yeast argue that the U5 loop 1 sequence affects splice site selection, particularly for introns 
with non-ideal 5' splice sites (Newman and Norman, 1991). 
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Figure 1.8. Yeast US snRNA secondary structure. (Figure adapted from Chanfreau et al., 
1996). 
US is proposed to contact the 5' splice site prior to the first splicing step and then 
maintain its hold, later aligning the ends of the exons for ligation in the second step (Umen 
and Guthrie, 1995; O'Keefe and Newman 1998). The highly conserved US loop 1 cross-links 
to the upstream exon prior to the first step, and to both exons during the second step of 
splicing (O'Keefe and Newman, 1998). In the yeast in vitro system, some loop mutations 
prohibited the second step of splicing (O'Keefe et al., 1996; O'Keefe and Newman, 1998). 
However, the same region of US surprisingly proved to be dispensable for splicing in HeLa 
nuclear extract (Ségault et al., 1999). The 2 forms of US snRNA (S & L) (Figure 1.8) are 
generated by 3'-end processing by RNase III enzymes. The USL is generated by Rntlp, but 
the factor that is responsible for USS generation is so far unknown (Chanfreau et al., 1996). 
The reason for two forms of US snRNAs being recruited into the spliceosome still remains a 
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mystery, but yeast cells possessing only U5S were shown to be able to support cell growth 
(Seraphin et al., 1991). 
Prp8p or h220K (in human) (Grainger and Beggs, 2005) contacts both the 5' and 3' 
splice sites in the pre-mRNA (Whittaker and Beggs, 1991; Teigelkamp et al., 1995). At 
least two forms of U5 snRNPs have been isolated so far; the simple form of U5 snRNP that 
was isolated by two-step affinity purification. First, all snRNPs is isolated by utilizing anti-
bodies specific for the tri-methylguanosine (m3G) cap, then Aar2p with a deca-histidine tag 
at its C-terminus was purified with Nickel-NTA column (Gottschalk et al., 2001). A more 
complex form of US snRNP that was also purified by affinity chromatography using a strain 
that possesses a Brr2 protein tagged with a polyoma epitope at its carboxy-terminus (Stevens 
et al., 2001). The Aar2p-U5 snRNP consists of Aar2p, Prp8p, Snul 14p, Sm proteins, and 
US snRNA. On the other hand, Brr2p-U5 snRNP consists of all the components of Aar2p-
U5 snRNP (except Aar2p) (Table 1.2), in addition to Snu40p, Prp28p, and Dibip. Of the six 
US snRNP-specific proteins (from the Brr2p-U5 5nRNP), three are NTPases (Brr2p, Prp28p, 
and Snul 14p). 
Table 1.2 US snRNIP-associated proteins 
Human homologue Accession number Sequence motifs Yeast homologue 
U5-220K gi13661610 Jabl/MPN Prp8p 
U5-200K gi14586 1372 2 DEXH Brr2p 
U5-116K gi141152056 G-domain Snull4p 
U5-102K gi140807485 TRP repeats Prp6p* 
U5-100K gi141327771 DEAD, RS Prp28p 
U5-52K giI5 174409 GYF domain Linip 
U5-40K gi14758560 WD40 No homologue 
U5- 15K gi15729802 Thioredoxin fold Dibip 
*Pi.p6p is associated with S. cerevisiae tri-snRNP complex, but not with US. (Table adapted 
from Will and Luhrmann, 2005). 
Brr2p and Prp28p are members of the DEXD/H box family. The NTPases of the US 
snRNP are involved in the critical switch in which Ui is replaced by U6 at the 5' splice site. 
This is an important stage in spliceosome activation, and contributes to the fidelity of 5' 
splice site recognition. The two unwinding events, that disrupt U1:5' splice site base-pairing, 
and U4:U6 base-pairing, allow the 5' splice site, U6 and U2 catalytic core structure to form 
(Brow 2002). Under normal conditions, Prp28p is an essential protein in yeast but becomes 
dispensable when Ui C protein (a factor that stabilises the U 1:5' splice site interaction) is 
mutated. This implicates Prp28p in disrupting the U1C interaction, either directly acting 
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against the protein or by disrupting the U1: 5' splice site helix that forms its site of interaction 
(Chen et al., 2001). Disruption of the U1:5' splice site interaction is accompanied by the 
release of U6 from U4. The U4/U6.U5 tri-snRNP contains the base-paired U4:U6 structure. 
In humans, h200K (Brr2p in yeast) is capable of unwinding RNA helices, including a base-
paired U4:U6 complex (Laggerbauer et al., 1998). Furthermore, it has been shown that a 
mutation in the ATPase domain of Brr2p (brr2-1) inhibits the ATP-dependent disruption of 
U4/U6.U5 tri-snRNPs in yeast cell extracts (Raghunathan and Guthrie, 1998). 
Snul 14p is the sole GTPase identified in the spliceosome to date and is related to 
translation elongation foctor EF-2 (Fabrizio et al., 1997). As a homolog of elongation factor 
G, Snul l4.p contains three domains (III-V) predicted to undergo a large rearrangement 
following GTP hydrolysis (Brenner and Guthrie, 2005). Studies using a Snul 14p mutant that 
switched specificity from GTP to XTP showed that stalled spliceosome would only unwind 
the U4: U6 helices when supplied with hydrolysable XTP (Bartles et al., 2003), implying that 
Snul 14p has a role either in unwinding of U4:U6 or, more probably, in controlling the action 
of Brr2p. 
The human Prp8p (h220K) forms a stable RNA-free complex with several US-
specific proteins, including an RNA unwindase (h200K), hi 16K, and a WD-40 protein 
(h40K in humans, no homologue in yeast). The hi 16K and h40K show the strongest 
association to h220K, which is stable in 0.4 M sodium thiocyanate (NaSCN). On the other 
hand, the interaction between h220K and h200K was preserved under 0.2 M NaSCN 
centrifugation conditions (Achsei et al., 1998). 
1.12 Links between pre-mRNA splicing and other mRNA processing 
Messenger RNA production requires synthesis of a pre-mRNA by RNA Pol II and 
processing of a nascent pre-mRNA by 5' capping, splicing of introns, 3' 
cleavage/polyadenylation to make mature mRNA. All these reactions have been found to be 
coupled to one another, such that protein(s) involved in one step also participated in another 
(Bres et al., 2005; Gornemann et al., 2005; Proudfoot et al., 2002; Robert et al., 2002; 
Gunderson et al., 1998), suggesting a cross-talk among mRNA processing complexes. 
Transcription and splicing. Although transcription and splicing were discovered 
independently, recent evidence has shown that these two reactions closely influence one 
another (Proudfoot et al., 2002). The finding that spliceosome U snRNPs interact with 
human transcription elongation factor TAT-SF1 (Cus2p in yeast; a splicing factor that is 
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associated with the U2 snRNP, Yan et al., 1998), and that the inclusion of splicing signals in 
nascent transcripts further stimulates transcription, suggests that, the recruitment of U 
snRNPs near elongating polymerase is important for transcription (Fong and Zhou, 2001). In 
addition, human splicing factor, SKIP (Prp45p in yeast), was also shown to associate with P-
TEFb and enhances transcription elongation by MV-1 Tat (Bres et al., 2005), supporting the 
fact that splicing factor(s) could serve in both transcription and splicing pathways. However, 
the feed back mechanism of efficient splicing to pre-mRNA transcription levels has so far 
not been demonstrated. 
Capping and splicing. The first pre-mRNA processing step occurs after about 20-
30 nucleotides have been synthesised. First, an RNA 5' triphosphatase (RTP) hydrolyses the 
triphosphate of the first nucleotide to disphosphate. Then, a 'guanylytransferase catalyses the 
fusion of a GMP moiety from GTP to the first nucleotide of the pre-mRNA via an unusual 
5'-5' triphosphate linkage. Finally, a methyltransferase methylates the N7 position of the 
transferred GMP. This initial cap structure is recognised by the cap binding complex 
(CBC20p and CBC80p) (Proudfoot et al., 2002). Surprisingly both CBC20 and CBC80 are 
dispensable in yeast (Fortes et al., 1999). However, chromatin immunoprecipitation (CHIP) 
analysis showed that, in the absence of CBC20p and CBC80p, US snRNP binding to pre-
mRNA was nearly abolished. This indicates that CBC is required for proper coupling of 
splicing to transcription in yeast (Gomemann et al., 2005). 
Polyadenylation and splicing. The 3' end of almost all eukaryotic mRNAs 
comprises a homopolymer of 20-250 adenosine residues called the poly(A) tail. The poly(A) 
tail is added to pre-mRNA in the nucleus by cleavage and polyadenylation. The coupling of 
polyadenylation and splicing is integrally linked to exon definition (Berget 1995), 
particularly the definition of the last exon of a pre-mRNA, which involves protein-protein 
interactions across the exon, between splicing factors at the 3' splice site, and components of 
the polyadenylation complex at the polyadenylation signal (Cooke et al., 1999; Cooke ad 
Alwine, 2002). In humans, Ui snRNP binding to the 5' splice site results in inhibition of 
polyadenylation via a direct interaction between Ui 70K and poly(A) polymerase 
(Gunderson etal., 1998). 
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1.13 The Aim of the current studies 
Prp8p is one of the most conserved proteins among eukaryotes, both in its sequence and in 
its large size (280 kDa). But Prp8p is unique, having no obvious homology to other proteins. 
Research so far has placed Prp8p as the only protein close to the catalytic centre of the 
splicing machinery. As it is unknown whether pre-mRNA splicing is catalysed by RNA(s) or 
protein(s), it is important to further investigate the role of this protein. Beside Prp8p, the 
proteins that are associated with Prp8p in the U5 snRNP (such as Snul 14p and Brr2p) are 
also highly conserved. In addition, the fact that mutation of human Prp8p results in retinitis 
pigmentosa type 13 has emphasized the importance of further analysis of this protein. 
In order to understand more about this protein, this study has employed protein 
purification methods combined with genetic dissection of Prp8p, to analyse the association 
of Prp8p with other splicing factors. This approach allowed me to confirm the association of 
Prp8p (aa436-770) with Snul 14p that is independent of Aar2p, and that dissection of Prp8p 
at aa2173 disrupts the association between Prp8p and Aar2p. 
The strategy was extended with a bioinformatics approach to identify possible 
domains of Prp8p. This led me to identify the functional nuclear localisation signal (NLS) of 
yeast Prp8p that is located at its N-terminus (aa96-1 17). Further analysis of the Prp8p NLS 
showed that, upon its deletion, Snul 14p and the U5 snRNA were delocalised from the 
nucleus to the cytoplasm, but remained associated with Prp8p. Additionally, Aar2p showed 
increased association with deleted-NLS-Prp8p when compared to full-length Prp8p. 
However, for the other US snRNP component, Brr2p, nuclear localisation was not affected. 
This allowed me to propose that Prp8p associated with Snul 14p, Aar2p, and U5 snRNA in 
the cytoplasm before entering the nucleus; and that Prp8p forms a complex with Brr2p in the 
nucleus. 
By site-directed mutagenesis, I have created the yeast Prp8p mutants (rp) that 
resemble the human Prp8p mutations that cause retinitis pigmentosa type 13. Despite the 
fact that Prp8p-rp nuclear localisation was not affected by the mutations, Prp8p-rp and Brr2p 
association was disrupted. At the same time, the Prp8p-Aar2p association was increased. 
This finding is consistent with the previous results of deleted-NLS-Prp8p analysis. Despite 
the fact that the Prp8p-Snul 14p-Aar2p complex that forms in the cytoplasm was able to 
enter the nucleus, this complex was increased due to the disruption of association between 
Prp8p-rp5 and Brr2p. In addition, the identification of importin Kap95p (Importin-13 in 
human) that functions in U2, US, and U6 snRNPs nuclear import supports the proposal that 
the US snRNP has a cytoplasmic phase. 
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Spp382p was co-selected with Prp8p or vice versa (Chapter 3 & 5; Boon et al., 
2006). The characterisation of Spp382p showed that this protein is spliceosome-associated. 
The protein binds to U2, US, U6 snRNAs, and excised intron, and interacts with Prp43p in 
the absence of other yeast proteins. Genetic-depletion of Spp382p results in excised intron 
accumulation, suggesting that this protein is needed for the late-stage of splicing. In 
Spp382p-depleted extract the U5 snRNP protein, Prp8p, is associated with 8-fold more U2 
snRNA and glycerol gradient analysis of snRNPs also showed reduced levels of free US and 
U6 snRNPs, but accumulation of U4/U6 di-snRNP, suggesting a defect in recycling snRNPs 
when compared to non-depleted cell extract. Overall results suggest that Spp382p could be 
needed for disassembly of post-splicing complexes and for promotion of re-generation of a 
new round of splicing. However, more experiments are needed to prove this assumption. 
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Chapter 2 
Materials and Methods 
2.1 General reagents 
Chemicals were purchased from the following sources, except where stated otherwise: 
Amersham, Fisher, Invitrogen, Roche, Sigma. 
Restriction enzymes, DNA and RNA polymerases and other enzymes were 
purchased from Roche, or New England Biolab. 
2.1.1 Bacterial and yeast growth media 
All growth media were autoclaved and stored at room temperature or 4 °C. For solid media, 
2% (w/v) Bacto agar was added prior to autoclaving. 
Table 2.1 Bacterial and yeast growth media 
Medium Components 
Drop-out powder 2g of the following amino acids: adenine, alanine, arginine asparagines, aspartic 
acid, cysteine, glutamic acid, glutamine, glycine, bistidine, isoleucine, lysine, 
methionine, phenylalanine, proline, serine, threonine, tyrosine, tryptophan, uracil, 
valine and 4g of leucine were ground for complete mixing. For specific drop-out  
powder, _the _relevant _amino _acids _were _omitted. 
Luria-Broth (LB) 1% (wiv) Bacto-tryptone, 0.5% (wlv) Yeast extract, 0.5% (w/v) NaCl. pH 
adjusted to 7.2 with NaOH. 
Sporulation 1% (w/v) Potassium acetate, 0.1% (w/v) Yeast extract, 0.05% Glucose 
medium 
YMGR Drop-out 0.67% (w/v) Yeast nitrogen base without amino acids, 2% (w/v) Galactose, 2% 
(w/v) Raffmose, 0.2% (w/v) drop-out powder, pH adjusted with 1 pellet of NaOH 
per 500 ml. 
YMrvl Drop-out 0.67% (w/v) Yeast nitrogen base without amino acids, 2% (w/v) Glucose, 0.2% 
(wlv) drop-out powder, pH adjusted with 1 pellet of NaOH per 500 ml. 
YPDA 1% (wlv) Yeast extract, 2% Bacto-peptone, 2% (wlv) Glucose, 0.003% (w/v) 
Adenine sulphate. 
YPGR 1% (wlv) Yeast extract, 2% Bacto-peptone, 2% (w/v) Galactose, 2% (w/v) 
Raffinose,_0.003%_(w/v) Adenine sulphate. 
YPR 1% (w/v) Yeast extract, 2% Bacto-peptone, 2% (wlv) Raffinose, 0.003% (w/v) 
Adenine sulphate. 
5-FOA 0.67% (w/v) Yeast nitrogen base without amino acids, 2% (w/v) Glucose, 0.2% 
(w/v) —U drop-out powder, 0.005% (wlv) Uracil, 0.1% (w/v) 5-FOA (Toronto 
Reseach Chemicals), 0.5% (w/v) ammonium sulphate, pH adjusted with 1 pellet 
of NaOH per 500 ml. (5-FOA powder was dissolved in 1420 and filter-sterilised, 
then mixed with the other constituents of the medium which had previously been 
autoclaved). 
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2.1.2 Commonly used buffers 
Table 2.2 Commonly used buffers 
Buffer Solution / Litre 
AGK buffer 
(0.5L) 
10 ml 0.5M I{EPES (pH7.0), 0.75 ml 1M MgCl,, 50 ml 2M KCI, 50 ml Glycerol, 
389.25 ml H20. 
50x Denhardt' s 
reagent (0.5L) 
5 g of Ficoll (Type 400), 5 g of polyvmylpyrodine, 5 g of bovine serum albumin 
(Fraction V) dissolved in 500 ml 11 20. Solution was filtered and stored at -20°C. 
Buffer B 0.1 M potassium phosphate pH7.4, 1.2 M sorbitol. 
Dialysis buffer 
(1.5L) 
60 ml 0.5M HEPES (pH7.0), 37.5 ml 2M KC1, 0.6 ml 0.5M EDTA, 300 ml 
Glycerol, 0.75 ml 1M DTT, 1.1 L H20, 1 protease inhibitor cocktail tablet 
(Sigma Cat no: 1873580). 
GG buffer 20 	m HEPES (pH 7.0), 100 	m KC1, 0.2 mM EDTA 
lx 1PP 150 6 	m HEPES, pH 7.9,0.15 M NaCl, 2.5 MM  MgC12 , 0.05 % (v/v) Nomdet P40. 
lx EPP300 6 	m IIEPES, pH 7.9, 0.3 M NaCl, 2.5 MM  MgCl2 , 0.05 % (v/v) Nonidet P40. 
lx IPP500 6 	m HEPES, pH 7.9,0.5 M NaCl, 2.5 mM MgC12 , 0.05 % (v/v) Nonidet P40. 
2x 1PP300 12 mM HEPES, pH 7.9,03 M NaCl, 5 MM  MgC121  0.1 % (v/v) Nomdet P40. 
2x IPP6N 12 	m FIEPES, pH 7.9,0.6 M NaCl, 5 MM  MgCl2 , 0.1 % (v/v) Nonidet P40. 
2x IPPIOOO 12 mM HEPES, pH 7.9, 1 M NaCl, 5 	m MgCl2 , 0.1 % (v/v) Nomdet P40. 
20x MOPS 1 M MOPS (3-N-morpholine) propane sulfomc acid, 1 M Tris, 2% (w/v) SDS, 
20.5 mM EDTA. 
NTN,J 150 mlvi NaCl, 50 	m Tris-HC1, pH 7.5, 0.1 % (viv) Nonidet P40. 
NTN30  300 mM NaCl, 50 mM Tris-HC1, pH 7.5, 0.1 % (vlv) Nomdet P40. 
NTN ® 500 	m NaCl, 50 	m Tris-HC1, pH 7.5, 0.1 % (v/v) Nomdet P40. 
lx PBS 137 mM NaCl, 2.7 mM KC1, 4.3 mM Na 2HPO4, 1.5 mM KH2PO4 , pH adjusted 
to 7.4 with Ha. 
lx PBST 137 mM NaCl, 2.7 mM KC1, 4.3 mM Na 21-1PO4, 1.5 mM KH2PO4 , pH adjusted 
to 7.4with HC1, 0.1%_(v/v) Tween-20. 
20x SSC 3 M NaCl, 0.3 M sodium citrate, pH 7.0. 
20x SSPE 3.6 M NaCl, 200 	m NaH2PO4 , 20 mM EDTA, pH adjusted to 7.4 with NaOH. 
50x TAE 2 M Tris, 50 mM EDTA, 5.7% (v/v) Acetic acid. 
lOx TBE 0.9 M Tris-borate, 20 mM EDTA. 
lOx TBST 0.5 M Tns-HC1, 1.5 M NaCl, 1% (v/v) Tween-20, pH adjusted to 7.5 with HC1. 
lOx Western 
Transfer buffer 
200 mM Tris Base, 1.5 M Glycine. 
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2.1.3 Oligonucleotides 
Oligonucleotides that were used in this study are listed below. All oligonucleotides were 
purchased from MWG Biotech. The abbreviation of YCPCR stands for yeast colony PCR. 
The name of primers, such as F-Aar2-703, refer to forward primer for the AAR2 gene at a 
position 703 nucleotides after the start codon. 
Table 2.3 Oligonucleotides 
Name 	I 	 Sequence (5' —3') 	 Notes or Used for  




5' Fitc modified 
U1Fish2 AATCTCCGTCAAAAACTAAAATGGCACGCTAGA 
GAAAAGTAGTCAAAAAGAATGCCTCTACAAAG  
5' Fitc modified 
U2Fishl TFGGACATAAACGGCFCGGAAAGACAGGGAAG 
AGTATGAAGCAAA  
5' Cy3 modified 
U2Fish2 AGAAGACGAGCGAAGAAATCAACAATAAGAGC 
GCCCCATCCGCACTA  
5' Cy3 modified 
U3A ATFCAGTGGCTCFIfIGAAGAGTCAAAGAGTGA 
CGATI'CCTATAGAAATGA 
5' Cy3 modified; M. 
Spiller, Beggs lab 
USFishl GGTAAAAGGCAAGAACCATGTTCGTTATA 5' Cy3 modified 
U6Fishl TGATCATCTCTGTATFGTVI'CAAATI'GACCAAAT 
GTCCA  
5' Cy3 modified 
Northern Probes  
G8102 CACGCCYFCCGCGCCGT U! snRNA 
G8103 CFACACTFGATCTAAGCCAAAAG U2 snRNA 
G6568 AGGTATFCCAAAAATFCCC U4 snRNA 
U5-7wtsmnr AAGTFCCAAAAAATATGGCAAGC US snRNA 
U6 _knockout ATCTCI'GTATFGTFTCAAATFGACCAA U6 snRNA 
AAR2  










F-Brr2-(-339) GAGCCCAATGAACTGAGACT YCPCR 
R-Brr2- 142 GTGATAmCCGCATCCC YCPCR 
F-Brr2-6 100 ACrGATI'CACAGCTFGCG YCPCR 



















Lsm8f3 CGAAAATGAGCATGTAATATGGGAAAAAGTGT TAP cassette 
ACGAATCAAAGACAAACGGATCCCCGGGTFAAT amplification, M. 
TAA Thompson, Beggs Lab. 
Lsm8r2 TFAYFATFATFATFATI'ATFATFATFATFA'IVFACT TAP cassette 
ATTATFGCAACTATAGAATFCGAGCTCGmAA amplification, M. 
AC Thompson, Beggs Lab. 
XbaLsm8f CGTCTAGAATGTCAGCCACCTFGAAAGACTACF YCPCR, M. Spiller, 
TAAATAAA Beggs lab. 
PRP8  
-380-60PRP8-F GATGAAACCGTGAAGGCTA YCPCR 
F-PRP8-938 GGTFATCAACGCCAFTAGAG YCPCR 
F-PRP8-33 10 ATACGCGGGTFGAAGTFC YCPCR 
F-PRP8-3523 GAAGAAGATGAGGGAGAGGA YCPCR 
F-PRP84 182 TGGTGGGTFGGGTATGAT YCPCR 
F-PRP8-5296 ATGTATCCCTCCCCAACA YCPCR 
F-PRP8-5802 CGTCACAAGAAAGGCAATGCTF YCPCR 
F-PRP8-6335 AAGAAGCTGCAGGTGCATCAA YCPCR 
F-PRP8-6522 TGAYITCGTGGAGGAACAGA YCPCR 
F-PRP8-6876 AAITIITICCACCCCGGGAT YCPCR 
R-PRP8-451 AGGCCATGTCACI'GTGAGTAT YCPCR 
R-PPP8-1956 ACCATCTGCTAACFGGAAGG YCPCR 
R-PRP8-4 154 GGTGGAAATCYFGTfGGC YCPCR 
R-PRP8-4876 GCACCAAGAAACCGACAT YCPCR 
R-PPP8-5655 AGATGCCCAGTVVFGGA YCPCR 
R-PRP8-5878 CTGTFGGCcTGATFGCTA YCPCR 
R-PRP8-6689 AATFGAGGTACCAGCACAACAGTC YCPCR 
R-PRP8-7233 TACATCGA1TFGTFCGGCCr YCPCR 
R-PRP8-(+ 174) TFCATAGTGCGGAAAGCGTAG YCPCR 
R1-PRP8 ATATCTATGAAATAACAGATFCCAGTVFATFGG PFA6a-HIS3-3HA 
GGAATATATFCAGAArFCGAGCTCGTITAAAC amplification for PRP8 
C-terminal insertion 
F2-PRF8 GCGGGGGACGAAGAGTFAGAGGCCGAACAAAT PFA6a-HIS3-3IA 
CGATGTAYVFAGCCGGATCCCCGGGTFAATFAA amplification for PRP8 
C-terminal insertion 
F4-PRP8 GTGCGATFGA ACTFCCITCC AAAAAAAAAA pFA6a-KanIvD(6-P- 
TAGCGTCAAA GAAAG GST cassette 
GAATFCGAGCTCGTTFAAAC amplification 
R4-(D78Prp8) TAATFCTA(TVFCITIICFGCTVFAGTCFCTAATC pFA6a-KanMX6-P- 
(Deletion aal- ATCTAGACCACGCGGAACCAGATCCGATT' GST cassette 
78 of Prp8p)  amplification 
R4-Prp8 GCTGTCCTCFTCAAAACCAGGAGGTGGGGGCGG pFA6a-KanMX6-P- 
TAGTCCACTCAT ACGCGGAACCAGATCCGATF GST cassette 
amplification 
F-P8-439-TAP TCCTGTCTCTFATACACATCTCAACCATCATCGA TAP cassette 
TGAATFCTGAC TCCATGGAAAAGAGAAG amplification for PRP8 
aa439 insertion 
R-P8-43 9-TAP CTATGAAATAACAGATTCCAGTVFATFGGGGAA TAP cassette 
TATAYFCAGTCATACGACFCACTATAGGG amplification for PRP8 
aa439 insertion 
Prp8-Tap-F GCGGGGGACGAAGAGTFAGAGGCCGAACAAAT TAP cassette 
CGATGTAYVFAGCTCCATGGAAAAGAGAAG amplification for C- 
terminal PRP8 insertion 
Prp8-Tap-R TATATATCTATGAAATAACAGATFCCAGTTrATT TAP cassette 
GGGGAATATATFACGACFCACTATAGGG amplification for C- 
terminal PRP8 insertion 
Prp8-770-F ITcTrGAGTrACGAAACTCGGTCATGGATGACAT I pAW28 amplification 
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1TFAGAAATGATATCATCGATGAATFCTGACT and insertion at aa770 of 
PRP8 
Prp8-770-R TGTFGCAGTATAGTFCYFGCC1TITICTGTCGAA pAW28 amplification 
TACTCFCAGGCCTGAAGCYFAAGQJGAGCT and insertion at aa770 of 
PRP8 
Prp8-2173-F FAATACAC1ATFATA1TrGAGGTFAAAAAACA pAW28 amplification 
rrrATGmcGGATcATcGATGAATFCrGCT and insertion at aa2 173 
of PRP8 
Prp8-2 173-R T11u1GGAAGGACGTAAACATICTGTFCCFCCA pAW28 amplification 
CGAAATCATCACTGAAGCTFAAGGGAGCF and insertion at aa2 173 
of PRP8 
F-rp5 CFATAATGAGATGCATAAGCCAGTACACTITII Oligonucleotides use to 
ACAG1TFAGCG create pJU204-rp5 
R-rp5 CGCFAAACTGTAAAAAGTGTACTGGCTFATGCA Oligonucleotides use to 
TCTCATFATAG create pJU204-rp5 
F-rp6 CFATAATGAGATGCATGGTCCAGTACACTFITI' Oligonucleotides use to 
ACAG1TI'AGCG create pJTJ204-rp6 
R-rp6 CGCT'AAACTGTAAAAAGTGTACIGGACCATGCA Oligonucleotides use to 
TCTCA1TATAG create pJU204-rp6 
F-rp7 ATGAGATGCATCGTCCAGTACACTFATTACAGT Oligonucleotides use to 
TFAGCG create pJU204-rp7 
R-rp7 CGCT'AAACTGTAATAAGTGTACTGGACGATGCA Oligonucleotides use to 
TCTCAT create pJU204-rp7 
F-NLS-P8-352 AYFACATGGAATGACCAAAAAGGCAAAGAGAA Deletion of Prp8p aa96- 
GCAA1TFATATCTCC 117 in pJU204 
R-NLS-P8-285 CVF1T1GGTCATFCCATGTAATFCTACTflC1[ Deletion of Prp8p aa96- 
CFGC1TFAGTC 117 in pJU204 
F-Xbal-aa96- TGCTC[AGAAAGAGAAAATFGGACATAGGAAA Insertion of Prp8p aa96- 




CCGCTCGAG1T1T1T1GCACGCVFCTFGA1 	1 Insertion of Prp8p aa96- 
1 17-Xhol CGAGTGACGAAAGTATCVU1'CCTATGTCCAA 117 into PGFP-N-FUS 
TFCTCTITCTAGAGCA 
SMB1  
F-SMB1-ProtA CCFCAAACAAGGAAGTfFCAGCCCCCACCAT Protein A cassette 
mAAAAGAAAAAAGCTGGAGCTCAAAAC amplification 
R-SM01-ProtA AAAAAGTATACGGAAACFATATFAGACTACACT Protein A cassette 
ACATCAACCYFATACGACTCACTATAG( amplification 
F-SMB1--398 CGGGAAAGATCGCTAAAC YCPCR 
SMD1  
F-SMD1-ProtA CGCGAT1T1GGTGCACCAGCGAATAAAACCA Protein A cassette 
AGAAGAGGTCFAAAGCTGGAGCTCAAAAC amplification 
R-SMD1-ProtA AGTAATGGTGACAGTGAAGATGACCGACAC Protein A cassette 
CAGCAGCGAATCATACGAC1CACTATAG amplification 
F-SMD1-373 GACCCCAGCAAAAAGAGA YCPCR 
SMEJ  
F-SME1-ProtA ATCCTGTrGAAAGGCGATAATATCACAGATA Protein A cassette 
ACATCAGCGACAAGCTGGAGCrCAAJC amplification 
R-SME1-ProtA GTCACUGCGAAUGTAYFCTCGCCCC Protein A cassette 
fIT ICTVFCATACGACTCA CFATAGGG amplification 
F-SME1- 105 CGGCATAAGAATCAAGGG YCPCR 
Snul14  
F-Snull4-2863 AAACCCGCACCTATCAAC YCPCR 
F-Snull4-TAP TAP cassette 
GGCflAGTACCGTCCATGGAAAAGAGG amplification 
R-Snul 14-TAP AATATFGTGGACATA1FG 	FAATICVFATGCGC TAP cassette 
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I CAAGAIIIICATACGACTCACTATAGGG 	I amplification 
YKRO22CINTR2  
F-YKRO22C- GAGAAAATCATCACGCCC YCPCR 
769  
F-YKRO22C- TI'GGAAAAATCFAAAGCAAGCCTAATAAATAAG TAP cassette 
TAP CTCATFGGTAACICCATGGAAAAGAGAAG amplification 
R-YKRO22C- 1TF11AATAGTACAGCGATFAAAAAAATAACAT TAP cassette 
TAP GATFAACGTrCATACGACTCACTATAGGG amplification 
YLR424WISPP382  
F-Xbal- TGCTCTAGAGAGGATFCGGACFCCAACAC YLR424W amplification 
aa2YLR424W for pGFP-N-FUS 
insertion 
R-Xhol- CCGCTCGAGCTAGAGGTCAAGCIGCCCATA YLR424W amplification 
aa7O9YLR424 for pGFP-N-FUS 
W  insertion 
Fl-424 CAACCGAGAGAGGTCGAAGAACTTAAGCCrTCA Nat cassette 
GTACGCCAAAACCGGATCCCCGGGTFAATFAA amplification for 
YLR424W deletion 
R1-424 ATATATAAATCGTGCCTATCTCACCTCHTIATA Nat cassette 
GGTACITFCTA GAATFCGAGCTCG1TTAAAC amplification for 
YLR424W deletion 
F4-424 CAACCGAGAGAGGTCGAAGAACTFAAGCCTFCA pFA6a-KanIvlX6-P- 
GTACGCCAAAACGAATTCGAGCTCG1TFAAAC 311A cassette 
amplification 
R3-424 TVFGAAAAAGAACIITIIATCFGTGTTGGAGTCC pFA6a-KanMX6-P- 
GAATCCTCCATGCACfGAGCAGCGTAATCTG 31-IA cassette 
amplification 
F-YLR424W- TCCAGTGGGACCVFTAAGCCAA1TFA1TFATGG TAP cassette 
TAP GCCCTFGACCTCTCCATGGAAAAGAGAAG amplification 
R-YLR424W- ATATATAAATCGTGCCFATCTCACCTCTTIIATA TAP cassette 
TAP GGTACITTCrATACGACFCACTATAGGG amplification 
F-299-424W TGAACATAAAAGTFGAGCATCGG YCPCR 
F-1805-424W TGGAAACACAAGTGATCGACG YCPCR 
R-549-424W AACAACGCTTCGCCTAAAAC YCPCR 
R-2565- 1TfAGTGAGCTAAAAACFCCA YCPCR 
45YLR424W  
F-URA3 AGAGAATCAGCGCFCCCCAT YCPCR 
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2.1.4 Plasmid vectors and constructs 
Table 2.4 Plasmid vectors and constructs 
Plasmid Description Reference 
M529 Modified 	pRS3 14; 	contains 	PRP8 
coding sequence with N-terminal 
Protein A and C-terminal FLAG tag 
and interrupted by Iransposon with 
selective marker (KanMX4) after codon 
436.  
A. Newman, Cambridge 
p283 Modified pGEM1: 	Contains 	ACT] 
template under the regulation of the T7 
promoter. 
O'Keefe et al., 1996 
pAW28 CEN-URA3 A. Newman, Cambridge 
pBS 1365 CEN-ProteinA-URA3 Puig et al., 1998 
pBS 1479 CEN-TAP-TRPJ Rigaut et al., 1999 
pBS 1539 CEN-TAP-URA3 Rigaut etal., 1999 
pFA6a-HIs3MX6-PGAL1-3HA CEN-HIS3-pGAL1-3HA Longtine et al., 1998 
pFA6a-kanMX6-PGAL1-GST CEN-HIS3-pGAL1-GST Longtine et al., 1998 
pFA6a-His3MX6-3HA CEN-HIS3 Longtine et al., 1998 
pFA6a-natMX6 CEN-Nat Goldstein & McCusker, 
1999 
pGEX-4T-2-424 GST-Spp382p expression plasmid This work 
pGFP-N-FUS CEN-URA3-P 57GFP Niedenthal et al., 1996 
pGFP-N-424 CEN-URA3-P-GFP-YLR424W This work 
pGFP-N-NLS CEN-URA3-P M -GFP-prp8aa96-1 17 This work 
pJU204 CEN-HIS3 Umen and Guthrie, 1995 
pJU204ANLS CEN-HIS3 This work 
pJU204-rp5 CEN-HIS3 This work 
pJU204-rp6 CEN-HIS3 This work 
pJU204-rp7 CEN-HIS3 This work 
pJU204-Y1542A CEN-HIS3 This work 
2.1.5 E. coli strains 
DH5a was routinely used for plasmid cloning and propagation steps. 
Table 2.5 E. coli strains 
Strain Genotype Source 
BL21 F, ompT, hsdSB, (rB, mB), gal, dcm (DE3) Stratagene 
DH5a lacZPvu15 (1acZYA-argF) recAl endAl hsdRl 7('rk , me ) 




2.1.6 Saccharomyces cerevisiae strains 
Table 2.6 Saccharomyces cerevisiae strains 
Strain Genotype Source 
BMA38 (2n) MATa/ct, his3Lt200, leu2-3,112, ura3-1, lrpli.11, ade2-1, 
can]-100 
B. Dujon, Institute  
Pasteur. 
BMA38a MATa, his34200, leu2-3,112, ura3-1, trpli.11, ade2-1, 
can]-100  
Albers et al., 2003  
BY4741 MATa, his4l, leu2AO, metlSLW, Ura3i.10 Mouaikel et al., 2002 
ANMD5 nmd5::nat, otherwise as BY4741 Anita Hopper 
ATGS1 MATa, histil, leu2L0, metJSLtO, Ura3z.t0, 
YPLJ57W::KanMX4  
Mouaikel et al., 2002 
csel -1 or 
1706  
csel -1 Mata, ura3-52, ade2-101, his3-1 1, l5trpl Molly Fitzgerald 
RG8T PRP8:TAP-TRPI, otherwise as BMA38a R. Grainger, Beggs lab 
RG8T/2173 PRP8(1 -21 73):Tn:PRP8(21 73-2413):TAP-TRPJ, otherwise 
as BMA38a  
R. Grainger, Beggs lab 
KL8TG HIS3-PGA,,-HA3:PRP8:TAP-TRP1, otherwise as BMA38a This work 
KL8H PRP8:3HA-HIS3, otherwise as BMA38a This work 
KL8TG/436 His3-P GAL1-HA3.PRP8(l -439):Tn:PRP8(437-2413):TAP- 
TRP1, otherwise as BMA38a  
This work 
KL81V436 PRP8(1 -439):Tn:PRP8(437-2413):3HA-HIS3, otherwise as 
BMA38a  
This work 
KL8HJ436T PRP8(1 439):TAP-URA3:Tn:PRP8(437-2413).3HA-HIS3, 
otherwise as BMA38a  
This work 
KL8T1770 PRP8(1770):Tn:PRP8(771-2413):TAP-TRP1, otherwise as 
BMA38a  
This work 
KL1 Kan-P-GST:prp8Aaa1-78, otherwise as BMA38a This work 
KL1-Snull4 SNUJ14:TAP-URA3, otherwise as KU This work 
KL1-Brr2 BRR2:TAP-URA3, otherwise as KL1 This work 
KL1-Aar2 AAR2:TAP-URA3, otherwise as KL1 This work 
KL1-1,sni8 LSM8:TAP-URA3, otherwise as KL1 This work 
KL2T YKRO22C: TAP- URA3, otherwise as BMA38a This work 
K13 TRPI- PGALI-GST:PrP8, otherwise as BMA38a This work 
KL3-Brr2 Brr2:13Myc-Hph, otherwise as KL3 This work 
KL3-SmB1 SMB1:ProteinA-URA3, otherwise as KU This work 
KL3-SmD1 SMD1:ProteinA-URA3, otherwise as KL3 This work 
K13-SmE1 SMEJ:ProteinA-URA3, otherwise as KL3 This work 
KL4F YLR424W::nat, [pGFP-N-424], otherwise as BMA38a This work 
KL4G Kan-PG -3HA:YLR424W, otherwise as BMA38a This work 
KL4G2T YKRO22C:TAP-URA3, otherwise as KL4G This work 
KL4T YLR424W:TAP-TRPJ, otherwise as BMA38a This work 
PSY870 MATa, rnal-1, ade2, ade3, leu2, ura3, MAT a carrying 
pPS714 
Koepp et al., 1996 
Kap95ts 
PSY871 
MATa, rnal-1, rsll-1, ade2, ade3, leu2, ura3, carrying 
pPS714 
Koepp et al., 1996 
W303a MATa, ade2-1 trp]-1 leu2-3,112 his3-11,15 ura3-1 R. Rothstein 
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2.1.7 Antisera 
Table 2.7 Antisera 
Antibody Description Source 
Anti-8.6 (batch: R1689) Anti-Prp8p.aa2-35, Rabbit IgG, primary This work 
Anti-Aar2p Rabbit IgG, primary Gottschalk et aL, 2001 
Anti-GST (Z-5) Rabbit IgG, primary Santa Cruz Biotechnology 
Anti-HA (Y- 11) Rabbit IgG, primary (Western blotting) Santa Cruz Biotechnology 
Anti-HA high affinity 
(3F10) 
Rat IgG, monoclonal antibody, primary 
(Immunofluorescent staining)  
Roche Applied Science 
Anti-Myc (A-14) Rabbit IgG, primary (Western blotting) Santa Cruz Biotechnology 
Anti-Myc (9E10) Mouse IgG, primary (Immunofluorescent 
staining)  
Abcam Ltd. 
Anti-Nopip Mouse IgG, primary J. Aris 
Anti-Protein A Rabbit IgG, primary Sigma, P-3775 
Anti-Prp43p Rabbit-IgG, primary Lebaron et al., 2005 
Anti-Snul 14p Rabbit IgG, primary Bartels et al., 2003 
Anti-TMG (1(121) Mouse IgG, primary Calbiochem, NA02 
Goat Anti-Mouse IgG Alexa Fluor 594 conjugated, secondary Molecular Probes, A-i 1005 
Goat Anti-Mouse IgG, 
Highly cross-absorbed  
Alexa Fluor 488 conjugated, secondary Molecular Probes, A- 11029 
Goat Anti-Mouse IgG Peroxidase conjugated, secondary Amershain Biosciences, 
NA931 
Goat Anti-Rabbit, IgG 
Highly cross-absorbed 
Alexa Fluor 594 conjugated, secondary Molecular Probes, A-i 1307 
Goat Anti-Rabbit Peroxidase conjugated, secondary Amersham Biosciences, 
NA934V 
Goat Anti-Rat, IgG Alexa Fluor 594 conjugated, secondary Molecular Probes, A-i 1007 
Peroxidase-anti- 
peroxidase (PAP) 




All size markers were obtained from Invitrogen life technologies: 
Marker Description 
1 kb plus DNA Ladder 100 bp - 12 kb 
BenchMarkTM Protein Ladders 10-220 kDa 
SeeBlue®  Plus2 Pre-stained Standard 4-250 kDa 
MagicMarkTM  Western Protein Standard 20— 120 kDa 
2.2 Microbiological methods 
Propagation and storage of bacteria 
Growth and storage of E. coli, preparation of competent E. coli and transformation were 
followed as in Sambrook and Russell (2001). 
Propagation, storage, and transformation of yeast 
Yeast was grown and stored as described in Methods in Yeast Genetics (2000). Yeast 
transformation was carried out by the Lithium Acetate method (Gietz et al., 1991). 
2.3 Nucleic acid methods 
Many standard DNA and RNA manipulations were carried out either according to Sambrook 
and Russell (2001) or manufacturers' instructions. These include: quantification of nucleic 
acids by spectrophotometric; deproteimsation of nucleic acids solution with 
phenol/chloroformllso-amyl alcohol (25:24:1) (P/C/1); precipitation of nucleic acids with 
ethanol; restriction endonuclease digestion of DNA; agarose gel electrophoresis of DNA; 
isolation of plasmid DNA from E. coli: isolation of DNA fragments from agarose gels; 
filling recessed 3' ends of DNA; dephosphorylation of DNA; ligation of DNA fragments. 
2.3.1 Yeast genomic DNA preparation 
Yeast genomic DNA was prepared using a modified method based on Hoffman and Winston 
(1987). Ten ml yeast culture was grown in YPDA overnight at 30°C in a shaking incubator, 
then sedimented by centrifugation and resuspended in 10 ml SE buffer (0.9 M sorbitol, 0.1 
M EDTA, p118.0). Again, cells were sedimented by centrifugation and resuspended in 0.5 ml 
SE buffer. 50 1.d of 20 mg/ml lyticase (Sigma) was added into the SE buffer and incubated 
30 min at 30°C on a rotating wheel. The spheroplasted cells were spun down (3500 rpm, 5 
mm) and resuspended in 500 l of Lysis buffer (0. 1M Tns-C1, p118.0, 50 mM EDTA, 1% 
SDS). 200 .l glass beads (150-212 I..m in diameter) and 32 .t1 of 4 M NaCl were added. 
Then the tube was vortexed for 30 s and subsequently spun down at 3500 rpm for 2 mm. The 
liquid was purified twice by P/C/I extraction. The DNA was precipitated by adding 900 i.tl 
ice-cold 100% ethanol, and then pelleted by centrifugation, and subsequently washed with 
70% ethanol. The pellet was air dried and resuspended in 50 .tl TE buffer. 
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23.2 Extraction of RNA from yeast 
RNA was isolated according to Schmitt et al. (1990). Ten ml culture was grown in YPDA to 
an 0136w  of 0.25-0.5, the cells were harvested by centrifugation and resuspended in 400t1 of 
AE (50mM Na acetate pH 5.3, 10mM EDTA) buffer. The resuspended cells were transferred 
to a 1.5 ml microcentrifuge tube and 40 .tl of 10% SDS was added. The suspension was 
vortexed, and then an equal volume of fresh phenol was added. The mixture was again 
vortexed and incubated at 65°C for 4 mm. After that, the mixture was rapidly chilled in a dry 
ice/ethanol bath until phenol crystals appeared, and then centrifuged for 2 min at maximum 
speed in a micro-centrifuge to separate the aqueous and phenol phases. The upper, aqueous 
phase was transferred to a fresh micro-centrifuge tube and extracted with phenol/chloroform 
Iso-amyl alcohol (25:24:1) at RT for 5 minutes. The extracted aqueous phase was then 
brought to 0.3 M Na acetate, pH 5.3, by adding 40 R1 of 3 M Na acetate pH 5.3, after which 
2.5 volumes of ethanol from total volume were added to precipitate the RNA. After washing 
with 80% ethanol, the pellet was dried and resuspended in 20 tl of sterile water and stored at 
—70°C until used. 
2.3.3 Radioactive ladders preparation 
The reaction mix was assembled in a 1.5 ml eppendorf tube in the following order: 1 JAg 
DNApBR322 Msp I digested (NEB, N3032S), 2 .tl dNTP mix (A, T, G in 2.5 mM []),2 i.l 
20 p.Ci a[32P]dCTP, 1 .ti lox Kienow buffer, 1 p.1 DNA polymerase I large (Klenow) 
fragment (Promega, M2201), 3 p.1 H 20 and incubated at RT for 10 mins. The reaction mix 
was made up to 100 p.1 with H20. Subsequently, 33 p.1 Ammonium Acetate (10 M) and 0.5 
p.1 tRNA were added and then subjected to Phenol/Chloroformllsoamyl-alcOhol 
precipitation. The precipitated nucleic acids were re-suspended in 50 p.1 TE buffer (10 mM 
Tris-HC1 (pH 8.0), 1 mM EDTA). 
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2.3.4 In vitro transcription 
DNA was digested by appropriate restriction endonucleases. After overnight digestion, 
followed by inactivation, complete DNA digestion was confirmed by agarose gel 
electhrophoresis, and then the DNA was purified by PCR purification kit (Qiagen). The 
transcription mix was assembled in a 1.5 ml eppendorf tube with the following order: 
Linearised template DNA 	 2 p.1. 0.01 ug/p.1 
Distilled H20 	 6 p.1 
5mM rNTP solution 	 2 p.1 
- rNTP solution containing 5mM of rGTP, rCTP and rUTP and 0.2 mM rATP 
4)100 mM DTT (dithiot.hreitol) 	 2 p.1 
1 O transcription buffer 	 2 p.1 
- 400 mM Tris-Ci (pH 7.5), 60 mM M902, 20 mM spermidine HCl and 50 mM NaCl 
1 p.1 10.0 MM  m7GpppG 	 1 p1 
2 p.1 10 mCi/ml (a-32P) rATP. 	 20 
The components were mixed by gently tapping the outside of the tube. Then the following 
were add: 
Placental RNase inhibitor (1 Ounits) 	 10 
T7 RNA polymerase 	 10 
The reaction mixture was incubated for 30 minutes at 37°C, and terminated by 
putting the reaction mix on ice. The reaction mixture was diluted with distilled H 20 to 220 
p.1, then purified twice by P/C/I extraction and ethanol precipitation (in ammonium acetate 
with final concentration of 2.0-2.5 M). The transcript RNA was resuspended in 10 0 of 
RNase-free H20 and 10 0 100% formamide was then added. Full-length transcripts were 
purifed by running on a 6% (w/v) denaturing aciylamide gel, the full length transcript gel 
band was cut out (visualised by autoradiography) and eluted using a unidirectional electro-
elutor (model UEA; IBI) according to the manufacturer's instructions. 
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2.3.5 In vitro splicing 
A splicing reaction mixture was prepared as follows: 
0.6 M KPO4 , pH 7.0 111 
25 mM MgC12  
3)20mM ATP 1 	l 
4)30% (w/v) PEG8000 1 i.tl 
Splicing extract 4 jil 
Radiolabelled transcript (- 1000 cpm) 2 jil 
The reaction mixture was incubated at 24°C for 25 min and terminated by placement 
on ice. Three 1.d of Proteinase K solution (1 mg/ml Proteinase K, 50mM EDTA, 1% (w/v) 
SDS) was added to the reaction mixture and the sample was incubated at 37°C for 45 mm. 
Subsequently, 200 jil of splicing cocktail (50 mM NaOAc, pH 5.3, 1 MM EDTA, 0.1% (w/v) 
SDS, 25jig/nil E. coil tRNA) was added and followed by 2 times P/C/1 extraction and one 
ethanol precipitation (by placing in —70°C for 30 mm), and centrifuged at 14000 rpm for 20 
min at 4°C. Then the sample was washed with 70% ethanol. 
The RNA pellet was dried at RT and resuspended in 5 .i.l distilled water, 
subsequently 5 .tl 1 X loading buffer (100% formanride + bromophenol and cyanole blue) 
was added and heated at 90°C for 3 min before loading on 7% (w/v) denaturing 
polyacrylaimde gel at a setting of 24 W for 1 h in 1 X TBE and visualised by 
autoradiography. 
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23.6 Co-immunoprecipitation of snRNAs/spliceosome 
Preparation of antibody-bound PAS (Protein A Sepharose, CL-413) beads preparation: 35 jil 
of pre-hydrated protein A Sepharose beads were washed 3 times in 1 ml NTN 1 . The beads 
were mixed with 300 p.! of NTN and incubated with appropriate amount of antibody on a 
rotating wheel at 4 °C overnight. Incubated solution was taken off, antibody-bound beads 
were washed 3 times in 1 ml of NTN 150 and were then incubated in 100 p.l blocking solution 
(100 p.g/ml BSA, 100 jig/ml Glycogen, 100 p.g/ml tRNA) for 1 hour on a rotating wheel at 
room temperature. Then the beads were washed 4 times with 1 ml NTN and once with lx 
IPP1 (6 mM HEPES, pH 7.9, 150 mM NaCl, 2.5 MM MgC12, 0.05 % (vlv) Nomdet P40). 
The lx IPP 1 was taken off and 50 p.1 of 2 x IPP3  (12 mM HEPES, pH 7.9, 300 mM NaCl, 
5 mM MgC12, 0.1 % (v/v) Nomdet P40) and 0.5 p.1 RNAsin were added to the beads. 
This was followed by immunoprecipitation. Fifty p.1 splicing extract (for snRNA co-
IP) or 50 p.1 splicing reaction mix (for spliceosome co-IP) was mixed with IgG-agarose or 
antibody-bound PAS (in 50 p.1 2 x IPP300 and 0.5 p.1 RNAsin). Samples were incubated on a 
rotating wheel for 2 hours at 4°C. After that, the beads were washed twice with 1 ml of 
NTN150  and once with 1 ml NT (150 mM NaCl, 50 mM Tns-Hcl, pH 7.5). The buffer was 
taken off, then 50 p.1 of proteinase K digestion mix (50 mM Tris-Hcl, pH 7.5, 5 mM EDTA, 
1.4 % (w/v) SDS, 2 p.g/pl Proteinase K) was added to the beads, followed by 30 minutes 
incubation in 37°C. Beads with bound immunoprecipitates were subjected to P/C/I extraction 
and ethanol precipitation. Pellets were vacuum dried and resuspended in RNAse free water, 
then samples were electrophoresed on a 6% polyacrylamide gel and analysed by Northern 
blotting. 
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2.3.7 Northern blot analysis of snRNAs 
The RNA was transferred electrophoretically to Hybond-N nylon membrane at 60 V for 1 
hour in 0.5 x TBE. Following transfer, RNA was cross-linked to membrane by Stratagene 
UV Stratalinker with "Autocrosslink" to immobilise the RNA on the membrane. 
End-labelling of oligonucleotides - Oligonucleotides were labelled in a 20 .d 
reaction mixture by T4 polynucleotide Kinase (PNK) at 37 °C for 45 minutes. The reaction 
mixture was as follows: Oligonucleotide 10 pmol/.tl (1tl), 10 x PNK buffer (2 .tl), T4 PNK 
(10 U/1il) (0.5 .tl), [Y-32  PIATP (3000 Ci/mmol) (2 l), 14.5 R I distilled II20. 
End-labelled oligonucleotides were totaled up to 1 ml with hybridisation buffer (mix 
15 ml of 20 x SSPE with 5 ml of 50 x Denhardt's reagent, 2.5 ml of 10 % SDS and 1 ml of 
10 mg/ml ss-DNA, and the mixture solution was made up to 50 ml with 24 ml of distilled 
1­120, giving a final concentration of 6x SSPE, Sx Denhardt's reagent, 0.5 % SDS and 0.2 
mg/nil ss-DNA) and was passed through 2 p.m filter. The filter was rinsed through with 2 x 1 
ml hybridisation buffer. 
Hybridisation of 5' End-labelled Oligonucleotide Probes to RNA; Purified end-
labelled oligonucleotides (from 20 p.1 reaction mixture) were hybridised to RNA on the 
nylon membrane in 50 ml hybridisation buffer, at 37°C overnight. The membrane was 
washed 4 times with 6 x SSPE (pre-warm 6 x SSPE at 42°C for 20 minutes each). The results 
were visualised by autoradiography. 
2.4 Protein Methods 
2.4.1 Crude protein extract preparation for Western blotting 
An overnight yeast culture was measured at OD 600 and a total of 3 OD were spun down. The 
cell pellet was resuspended in 0.5 ml of 0.2 M NaOH and left on ice for 10 mm. After that, 
55 p.1 of 50% TCA was added to the mixture which was left on ice for 10 mm. The pellet 
was spin down at 14000 rpm for 1 mm. The cell pellet was resuspended in 35 p.1 of 
dissociation buffer (100 mlvi Tris buffer (pH 6.8), 4 mlvi EDTA (pH 8.0), 4% SDS, 20% 
glycerol, 2% -mercaptoethanol and trace amount of bromophenol blue), followed by adding 
15 p.1 of 1 M Tns buffer (non-adjusted pH). Then the sample was heated at 95°C for 10 mm. 
The sample was ready for loading on a gel or stored at —20°C. 
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2.4.2 Yeast splicing extract preparation 
200 ml of overnight yeast culture was used as a starter culture. Six litres of medium were 
inoculated with starter culture to OD 600 approximately 0.1, and cells were harvested when 
cell density reached 0.8 OD 600 by centrifugation in JLA 10.500 rotor (5000 rpm, 5 mm, 4°C). 
The cell pellet was resuspended in 50 ml of cold AGK buffer and sedimented by using 
Mistral 1000 centrifuge at 3500 rpm, 5 mm, RT. This step was repeated by resuspending the 
cells pellet in 30 ml cold AGK buffer. 
The supemate was removed and yeast pellet was weighed. Cells were resuspended 
in 0.4 volume of the cell pellet weight (i.e. 4 ml for 10 g of cells) in cold AGK buffer, and 
DTT was added to a final concentration of 2 mM. The yeast suspension was then frozen by 
adding drop-wise into liquid nitrogen. The frozen cell pellets could be either processed 
immediately or stored for up to 12 months at —80°C. The cell pellets were then added to a 
mortar containing liquid nitrogen and ground for 20-25 mins with occasional additions of 
liquid nitrogen to ensure the pellet did not thaw. The frozen powder was transferred into a 
pre-chilled beaker and thawed on ice. The completely thawed cell powder was stirred gently 
on ice for 2-3 minutes, then the supernate was transferred into a pre-chilled polycarbonate 
centrifuge tube and centrifuged in a JA 25.50 rotor (17000 rpm, 30 mm, 49C). 
The supernate was then transferred to a pre-chilled polycarbonate centrifuge tube. 
The top layer of the supernatant containing lipid was avoided as much as possible during the 
transfer. This was then centrifuged in a 70.1 Ti rotor (40000 rpm, 60 mm, 4 9C). The resulting 
supemate was transferred to dialysis tubing with a molecular weight cut-off of 10 kDa. This 
was placed in 1.5 L of pre-chilled dialysis buffer and dialysed for 3 hours at 4°C. It was then 
placed in pre-chilled Eppendorf tubes and snap frozen in liquid nitrogen. The frozen tubes 
were stored at —80°C until use. 
45 
2.43 Co-immunoprecipitation from yeast protein extracts 
Antibody-bound PAS (Protein A Sepharose, CL-4B) beads preparation: 30 p.! of pre-
hydrated protein A Sepharose beads were pelleted by 4 seconds pause centrifugation and 
washed in 1 ml NTN150 3 times. The beads were mixed with 300 p1 of NTN 150 and incubated 
with appropriate amount of antibody (15 p1 for 8.6 antibody) on a rotating wheel at 4°C for 2 
hours or overnight. Incubated solution was taken off and antibody bound beads were washed 
twice in 1 ml of NTN 150 and once in 1 mlix IPP1 . 
For IgG agarose beads, the beads were washed twice in 1 ml NTN, m and 1 ml Ix 
IPP1 , then these steps were as followed: 50 p1 of 2x IPP 300 and 50 p1 splicing extracts were 
added to the beads and incubated at 4°C for 2 hr on a rotating wheel. The beads were washed 
3 times with 1 mlix IPP1 , and the final ix 1PP 150 solution was removed carefully. The 
pellet was resuspended in 20 p1 1 x SDS loading buffer. The sample was vortexed and 
heated at 95°C for 5 minutes. The samples were used for SDS-PAGE and Western blotting. 
2.4.4 TAP tag purification 
The TAP tag purification protocol is according to the Séraphin Lab's method (Rigaut et al., 
1999), with some modifications. The splicing extract preparation was according to section 
2.4.2. 
IgG column preparation: First, the bottom of the column (Econo-column, Bio-
Rad) was snap-opened, then 200 p1 of IgG agarose bead suspension (SIGMA A2909) was 
added to the column and washed with 5inl of 1PP 150 (10mM Tns-Cl pH8.0, 150mM NaCl, 
0.1% NP40). The bottom of the column was subsequently closed with a stopper. 
Binding of IgG beads: Before adding the splicing extract to the column, each ml of 
splicing extract was adjusted with 10 p1 of IM Tris-Ci pH 8.0, 25 p1 4M NaCl, and 10 p.1 
10% NP40 (to give a final concentration of 10 mM Tris-Cl pH 8. 0, 100 mM NaCl, and 0.1% 
NP40). After that, 2 ml of splicing extract were added into the column and the top of the IgG 
column was closed. Subsequently, the IgG column was rotated for 2 hours at 4°C. After that, 
the top plug of the column was removed, followed by removal of the bottom plug to allow 
the IgG column to drain by gravity flow. The drained IgG column was washed with 60 ml 
IPP15O and 20 ml TEV cleavage buffer (10mM Tris-Cl pH8.0, 150 mM NaCl, 0.1% NP40, 
0.5 mM EDTA, 1 mM DTT). 
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TEV cleavage: The bottom of the IgG column was closed and 1 ml of TEV 
cleavage buffer and 60 Unit of TEV enzyme (Invitrogen) were added. The top of the IgG 
column was closed and rotated for 2 hr at 18°C. 
Calmodulin column preparation: While waiting for the 2 hr incubation time 
above, a new column bottom was snap-opened and then 200 Rl calmodulin bead suspension 
was added (STRATAGENE, #214303). Then the column was washed with 5 ml CBB (10 
mM Tris-Cl pH8.0, 150 mM NaCl, 1 mM Mg-acetate, 1 mM imidazole, 2 mM CaC1 2, 0.1% 
NP40, 10mM BME) and the bottom of the calmodulin column was closed with a plug. After 
2 hr, the top and bottom plugs of the IgG column were removed and the eluate from the IgG 
column was collected into the calmodulin column by gravity flow. The solution remaining in 
the IgG column dead-volume may be eluted with an additional 200 JAI of 1EV cleavage 
buffer, this gives a total of 1.2 ml elution. 
Binding to, and elution from, Calmodulin beads: To the previous 1.2 ml eluate, 3 
volumes of CBB (3.6m1) and 4.8 R1 of 1M CaC1 2 were added into the calmodulin column to 
give a final concentration of 1 mM CaC1 2. The top of the calmodulin column was closed, and 
rotated for 2 hour at 4°C. After binding, the liquid was allowed to drain by gravity flow. The 
calmodulin column was then washed with 60m1 CBB. After that, the bottom of the 
calmodulin column was closed and the complex bound to the beads was incubated 10 mins 
with CEB (Calmudulin elution buffer; 10 mM Tris-Ci pH8.0, 150 mM NaCl, 1 mM Mg-
acetate, 1 mM imidazole, 50 mM EGTA, 0.1% NP40, 10 mM BME). The elute was then 
collected in a 1.5 ml eppendorf tube. 
TCA precipitation: The eluate was adjusted to 20% TCA with addition of 500 IAI of 
60% TCA, mixed and placed on ice for 30 mm. The precipitate was spun down at 14000g 
for 30 min at 4°C. The supernate was removed and the pellet was washed once with 200 il 
ice-cold acetone and twice in 200 til ice-cold 80% ethanol (14000g for 5 min at 4°C). Wash 
solutions were removed and the pellet was air-dried. The pellet was resuspended in 20 p.1 lx 
SDS loading buffer (sample can be stored at -20 °C at this point). 
2.4.5 Production and purification of GST-tagged recombinant protein from E. coli 
LB broth (5 ml) containing 100 p.g/ml ampicilin was inoculated with a single colony of E. 
coli (131,21) containing the expression plasmid and grown overnight at 37°C with agitation. 
This was then used to inoculate 40 ml of LB broth with 100 p.g/ml ampicilin. This culture 
was then grown at 37°C to an OD6w  of 1.6-1.7. To induce expression of the recombinant 
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protein, IPTG was added to a final concentration of 0.75 mM. The culture was then 
incubated for 2 days at 15°C. Cells were then harvested (3500 rpm, 5 mins, 49C). 
Preparation of protein extract: Cells were resuspended in 4 ml of Lysis Buffer A 
(50 mM Tris-HC1 (pH7.5), 250 mM NaCl, 10% (w/v) Sucrose). Lysozyme was added to a 
final concentration of 0.2 mg/mi and the extract was stirred on ice for 45 mins. Tntion-X-
100 was added to a final concentration of 0.1% (v/v) and the extract stirred on ice for a 
further 5 mins before being transferred to a polypropylene centrifuge tubes and centrifuged 
(10000 rpm, 10 mins, 4°C; Beckman JA25.5 rotor). The supernatant was transferred into an 
eppendorf tubes and stored at -80°C until required. 
Purification of GST-tagged Recombinant Protein from E. coli: 200 .tl of 
Glutathione Sepharose 4B (Amersham) were washed 3 times with 10 ml of 1X PBS in poly-
prep chromatography column (Biorad, catalog 731-1550). The supernate was then removed 
and 2 ml of the thawed protein extract was added before incubation (1 h, 4°C). The supernate 
was drained off from the column. Then, the beads were washed 3 times with 10 nil 1X PBS 
before incubated with 200 .d Elution buffer (20 mM Glutathione in 50 mM Tns-HC1 pH8.0) 
for 10 mins at RT. The eluate was placed in dialysis unit (Slide-A-Lyzer, 7 KDa cut-off, 
Pierce) and dialysed against 500 ml of BC100 (20mM Tris-HC1, pH8.0, 100 Mm KC1, 20% 
(w/v) glycerol) for 3 h. After dialysis, protein extract was kept in an eppendorf tube and 
stored at —80°C). 
2.4.6 Co-immunoprecipitation of E. coli recombinant protein 
Recombinant protein (4 jig of GST-Spp382p) purified from E. coli. (section 2.4.5) was mixed 
with an equal amount of lOHis-Prp43p (4 g) and incubated in 1X 1PP 150 buffer (section 
2.1.2) in the total volume of 100 IAL The protein mix was then incubated with 20 RI pre-
washed (3 x 1 ml NTN150 buffer and 1 x IPP 150 1 ml) glutathione-sepharose beads for 2 hr on 
a rotating wheel at 4°C. The protein mix (supernatant) was then removed and kept. The 
glutathione-sepharose beads were washed two times with 1 ml NTN 150 buffer and 1 time 1 
ml NT 150  buffer. The glutathione-sepharose beads were then resuspended in 25 tl of 1 x 
SDS buffer. Samples were then incubated in 65°C for 10 mins, fractionated in 4-12% PAGE 
gel and Western blotted with desired antibodies. 
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2.5 Primer design, PCR and DNA sequencing 
Yeast colony PCR Primers were designed by using primer design software in S. cerevisiae 
Database (http://seq.yeastgenome.org/cgi-binlweb-primer) . The optimum primer melting 
temperature was selected as 50°C. The optimum GC content selected was 50%. 
The 20 p.1 PCR reaction was as follows: 2 p.1 lox LA PCR buffer II (Magnesium2 
plus) from TAKARA, 3.2 p.1 dNTPs mix (dATP, dCTP, dGTP and dTTP, 2.5 mM each), 
0.20 p.1 Forward primer (100 pmol/p.l), 0.20 p.1 Reverse primer (100 pmol/p.l), 14.2 p.1 H 20, 
trace amount of yeast colony, 0.2 p.! Roche Taq. The PCR mixture was run in MJ Research, 
PTC-200 PCR machine using the PCR program as follows: 
Step 1 - Denaturing 95°C 6 mins 
Step 2— Denaturing 94°C 20 seconds 
Step 3— Annealing 50°C 50 seconds 
Step 4— Extension 72°C 1 mm I kb 
34 cycles of Step 2 to Step 4 
Step 5— Final extension 72°C 6 mins 
DNA sequencing 
Sequencing reactions were performed with the BigDye Terminator Cycle Sequencing Ready 
Reaction. The sequencing mix was set up as follows: 
Template DNA 	2 1.d 
Primer 	 1 p.1(1.6 pmol/p.l) 
BIG Dye 	 4p.1 
Water 	 3 p.1 
The following sequencing program was run for 40 cycles: 
Step 1 	96°C for 30 seconds 
Step 2 	50°C for 15 seconds 
Step 3 	60°C for 4 mins 
The sequencing samples were run by the SBS Sequencing Service, Ashworth Laboratories, 
University of Edinburgh. 
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2.6 Site-directed mutagenesis by whole plasmid synthesis 
The oligonucleotide primers, each complementary to the opposite strand of the vector and 
containing the desired mutation(s) or deletion, are extended during temperature cycling by 
PFU DNA polymerase (Figure 2.1). The 50 p.! PCR reaction was as follows: 5 p.1 lOx PFU 
(High fidelity) buffer, 2.5 p.! dNTPs mix (dATP, dCTP, dGTP and dTTP, 10 mM each), 0.25 
p.1 Forward primer (100 pmol/p.l), 0.25 p.1 Reverse primer (100 pmol/pi), 1 p.1 plasmid 
template (pJU204) from miniprep, 39 p.1 H20, 2 p.! High fidelity PFU. The mixture was run 
with the PCR program as follows: 
Step 1 - Denaturing 92°C 2 mins 
Step 2— Denaturing 92°C 0.5 mm 
Step 3— Annealing 53°C 0.5 mm 
Step 4— Extension 68°C 32 mins 
12 cycles of Step 2 to Step 4 
Step 5— Final extension 68°C 10 mins 
After the completion of the PCR reaction, the template (methylated DNA) was 
digested with DpnI. Then the PCR product was purified with Qiagen PCR purification kit 
and confirmed with agarose gel electrophoresis. The mutated plasmid was then transformed 
into E. coil (DHScz competent cells), grown, isolated, and confirmed with sequencing. 
2.7 Yeast sporulation and tetrad dissection 
Diploid yeast cells to be sporulated were streaked onto the sporulation plate. The cells were 
incubated at 30°C for 5-7 days. The cells were examined microscopically to determine tetrad 
formation. A loop of yeast colonies was resuspended gently into 100 p.1 H 20, then 3 p.1 of (-
glucuromdase (10 U/p.1, Sigma #G-0751) was added and cells were incubated at RT for 25 
mins. Using a pipettor, 20 p.1 of the cells were transferred to a tilted YPDA plate, allowing 
the droplet of cell suspension to run down the sloping agar surface. Then a loop was used to 
make streak lines of -glucuromdase treated cells. Tetrads were dissected using a Singer 
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Figure 2.1 Site-directed mutagenesis by whole plasmid synthesis 
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2.8 Glycerol gradient sedimentation 
Glycerol gradients were made and run essentially as described in Martin et al. (2002) and 
Bartels et al. (2003). 80 .tl splicing extract was added to 120 p1 GG buffer (20 mM HEPES 
(pH 7.0), 100 mM KC1, 0.2 mM EDTA) in order to dilute the glycerol concentration of the 
splicing extract from 20% to 8%. Then the diluted sample (200 tl) was layered onto 10-30% 
glycerol gradients (11 ml) containing GG buffer. 
After sedimentation at 37000 rpm for 17 h in a SW40 Ti rotor (Beckman) at 4°C, 
fractions of 400 p1 were collected and stored at —70°C. To analyse the snRNA distribution, 
collected fractions were deproteimsed, then extracted with an equal volume of phenol 
chloroform and ethanol precipitated, then subjected to Northern analysis. 
To analyse the protein distribution, the odd fractions were extracted by 400 p1 
phenol/chlorofonnhlsoamyl-alcohol. The aqueous phase was removed, the protein layer and 
phenol/chloroform/Isoamyl-alcohol was acetone precipitated by adding 1000 p1 ice-cold 
acetone, mixed, and was placed at -20°C for 1 hr. The solution was spun at 14000g for 10 
min at 4°C, and the supemate was removed. The protein pellets were washed 1 time with 1 
ml cold 70% ethanol, and spun at 14000g for 5 min at 4°C. The supernate was removed and 
the pellet was dried in a speed vac for 10 mins. The pellet was resuspended in 15 p1 1X SIDS 
loading buffer, and then subjected to SDS-PAGE and Western blotting. 
2.9 Immunofluorescent staining 
In order to compare the ma distribution profile in mutants and WT yeast strains, all tested 
yeast strains and their WT were grown, fixed, immunostained and viewed under the same 
light exposure. Cells were grown in 10 mis of YPDA to 0D 6® 0.3 to 0.5 and fixed by the 
addition of 1/10 volume of 37% formaldehyde. The culture with fixative was kept in a 50 ml 
falcon tube and rotated for 40 mins at RT. Cells were then recovered by centrifugation at 
3500 rpm for 5 mins, and washed gently with 1 ml of Buffer B (1.2M sorbitol, 100 MM 
KPO4 , pH7.0) 3 times. To spheroplast, cells were resuspended in 500 p1 of Buffer B 
containing 10 mM DTT, and 20 1AI lyticase (20 mg/nil). The suspension was incubated at 
30°C on a rotating wheel. 
As soon as the settled cell pellet had lost its creamy, yellow colour and become 
translucent (about 30mins), cells were recovered, washed once with Buffer B and 
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resuspended in 100 i.tl of Buffer B. A drop of cell suspension was placed on a poly-L-lysine 
coated slide, allowed to sit for 20-30 mm, and then excess solution was aspirated. (One 
additional step is needed for detection of tubulin: the cells were fixed with methanol for 5 
min and subsequently fixed with acetone for 30 seconds at RT). PBST containing milk (5% 
wlv) was added to the samples, which were blocked for 20 min at RT. The cells were 
covered with PBST-5% milk containing the primary antibody. 
The slide was set in a humidity chamber and incubated at 4°C overnight. Following 
this, excess solution was aspirated. The cells were washed with PBST twice for 20 mm, and 
then cells were covered with PBST-5% milk containing secondary antibody. The slide was 
then set in a humidity chamber at RT for 1 hr, and excess solution was aspirated. The cells 
were washed 3 times with PBST for 20 mm, and mounting solution (containing DAPI) was 
placed on the cells. A coverslip was placed on top and sealed with nail polish. Slides were 
stored at —20°C until examination. 
2.10 Flourescent in situ hybridization 
In order to compare the ma distribution profile in mutants and WT yeast strains, all tested 
yeast strains and their WT were grown, fixed, hybridised and viewed under the same light 
exposure. The protocol was adapted from the Singer lab protocol: In situ hybridization of 
yeast cells (http:://www.singerlab.org/protocols/insitu —yeast.htm). Yeast cells were grown in 
36 ml cultures in the appropriate media until reaching early log phase (OD 600 between 0.2-
0.4). Cells were fixed for 10 mins at RT by directly adding to the medium 8 ml of 20% 
formaldehyde, 50% acetic acid. The fixative was removed by three rounds of washing in 10 
ml of ice-cold buffer B (1.2 M sorbitol, 100 mM KPO 4 , pH 7.0), followed by centrifugation 
(5 mins at 3500 rpm, 49C). 
Spheroplasting: cells were resuspended in 500 d of Buffer B, 1 mM DTT, 20 d 
lyticase (20mg/mi) and subsequently incubated at 30°C on a rotating wheel for 30 mins. 
Cells were then centrifuged for 2 mins at 3500 rpm at 4°C, and washed once with ice-cold 
buffer B. Cells were further resuspended in 500 .tl of buffer B, and 100 1.d was added to a 
poly-L-lysine coated slide. Cells were then left to adhere to the slide by incubating them 30 
nuns at 4°C. Slides were washed once with ice-cold buffer B, and then stored in 70% ethanol 
at -20°C (the slides can be stored for weeks). 
Hybridization: cells were rehydrated for 5 mins at RT, in 2x SSC (300 mM NaCl, 
30 mM sodium citrate, pH 7.0), 50% formamide. Cells were hybridized overnight in 40 itl 
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(hybridisation buffer) of a mixture containing 10% dextran sulfate, 0.02% RNAse-free BSA, 
40 i.g E. coli tRNA, 2 x SSC, 50% formamide, 1 i.tl RNAsin and 1 .tl 100 pmol/.d probe 
(Hybridisation temperature: 37°C for U2, U3, and U6 probes, 42°C for U5 probe). For U5 
and U6 probes, additional 0.1% NP40 (v /v) is added in hybridisation buffer. Then the cells 
were washed twice for 20 mins in 3x SSC, 50% formamide in 37°C (U2, U3, and U6 probes) 
or 42°C (U5 probe). Cells were then mounted with vectashield containing DAPI. 
2.11 Prp8p (8.6) antibody production 
8.6 antibodies against the N-terminal peptide of yeast Prp8p were first raised by A. Gordon, 
Beggs lab. The sequence, apart from the first cysteine residue, corresponded to aa2-35 of 
Prp8p. The purpose of adding the cysteine that contained a free sulfhydryl group was for 
peptide conjugation. The peptides were conjugated with PPD (purified protein derivative of 
Mycobacterium tuberculosis), and subsequently were used to produce the 8.6 antibodies 
(batch name: 666). As the amount of 666 antibodies was low in the Beggs lab, I decided to 
re-raise the 8.6 antibodies. 
The peptides were synthesised by Sigma Genosys Ltd., but conjugated with KLH 
(Keyhole Limpet Hemocyanin). This was because the PPD was no longer commercially 
available. From Diagnostics Scotland, I obtained pre-immune serum from ten rabbits and 
tested for antigemcity to yeast crude extracts. Two rabbits (R1689 and R1703) that showed 
low reaction with yeast proteins were chosen to raise the antibodies, and the injection of 
antigen and bleeding of the rabbits were performed by Diagnostics Scotland. In this thesis, 
only serum from rabbit R1689 was used. 
Chapter 3 
Prp8p Partitioned Reveals Protein-protein Interactions 
3.1 Introduction 
A genetic screen by Andrew Newman's group (Cambridge) showed that Prp8p could be 
partitioned into several domains using a custom-built TnS-based transposon (Figure 3. 1A). 
This system allows expression of Prp8p as two contiguous polypeptides (Figure 3. 1B), 
capable of trans-complementation and supporting the cells viability. Thus, four functional 
domains can be defined in the 2413 residue Prp8p, with boundaries in the regions 416-436, 
770-773 and 2170-2173. The central region of the protein has so far resisted dissection by 
this approach. The partitioned constructs allowed investigation of factors that associate with 
the N- or C-terminal regions of Prp8p by isolation of the sub-complexes associated with 
different lrp8 protein fragments. Thus, the U5 snRNP protein Snul 14p associates with 
Prp8p in the region 437-770, whereas fragmenting Prp8p at residue 2173 destabilises its 
association with Aar2p. 
3.2 Partitioned Prp8p 
Strains with PRP8 partitioned at aa770, and aa2173 were constructed on the genome by 
insertion of pAW28 through homologous recombination (Figure 3.1C). The clones that 
survive on —Ura dropout plates were tested by yeast colony PCR. For PRP8 partitioned at 
aa436, the PCR insertion fragment was generated from plasmid M529, which encoded prp8 
with insertion of the transposon at aa436 (Figure 3. 1B). PRP8 partitioned at aa436 construct 
was expressed as two polypeptides (aal-439, aa436-2413), which contained three amino 
acids repeat that are essential for cell viability (Section 3.4). The aa436 partition clones were 
selected under G418 geneticin, and tested by yeast colony PCR. Subsequently, the size of 
Prp8p C-terminal fragments produced in WT and partition strains were confirmed by 
Western blotting (Figure 3.2A). 
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Figure 3.1 Structure of the gene dissection transposon and partitioned Prp8p 
A) The transposon was custom-built from 3 main components: 1) a fragment of the PRP8 
gene 3' UTR containing signals for the transcription termination and poly-adenylation and 
stop codons in all 3 reading frames; 2) KanMX4 cassette (Wach et al., 1994) conferring 
Kanamycin-resistance in E. coli and G418-resistance in yeast; 3) a fragment of the PRP8 
gene 5' UTR containing signals for initiation of trancription and translation. The transposon 
is flanked by 19 bp Mosaic End' sequences (CTGTCTCTTATACACATCT) recognised by 
Tn5 transposase (ME). B) Formation, structure and expression of a dissected prp8 gene 
resulting from insertion of a transposon into the open reading frame (not to scale). The 
transposon terminates transcription of the upstream prp8 gene sequences and drives 
expression of the prp8 gene sequence downstream. Prp8p is therefore expressed as two 
contiguous protein fragments via translation of two separate mRNAs. Each fragment is 
tagged at its N-terminal with a SV40 Nuclear Localisation Signal (NLS) to ensure targeting 
to the nuclear compartment. In the case of partitioned Prp8p after codon 436, transcription 
introduced a 9 bp Direct Repeat (DR) of the target sequence flanking the transposon (upper 
section of diagram). For partition after codon 770 and 2173, the transposon was generated in 
such a way as to avoid the 9 bp repeat (lower section of diagram). 
kDa 	1 	2 	3 	4 	5 
 
aal-24 13-TAP 





51 - 	 —aa2174-2413-TAP 
18°C 	23°C 	30°C 	37°C 














Western blotting to detect the Prp8p C-terminal polypeptides. Prp8p C-terminal 
fragments were first pulled down by horse IgG agarose and then fractionated in a 4-12% 
PAGE gel, blotted and probed with Peroxidase anti-peroxidase (PAP) antibody. Lane 1) 
RG8T, 2) BMA38a, 3) KL8T/H436, 4) KL8T/770, 5) RG8T/2 173. 
Prp8p WT and Prp8p partition strains were plated on YPDA or YPGR plates with initial 
of cells OD, 0.4, and growth at 18°C, 23°C, 30°C, and 37°C for 7 days before being 
photographed. KL8T1770, KL81-1/436, and KL8H/436T were shown heat sensitive. 
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3.3 Partition strain growth phenotypes 
I investigated the effect of Prp8p partitions on the strains. The WI strain BMA38a (Albers et 
a!, 2003), RG8T (full length Prp8p C-terminal TAP tag), RG8T/2173 (Prp8p C-terminal 
TAP tag and partitioned at aa2173), KL8T/770 (Prp8p C-terminal TAP tag and partitioned at 
aa770), KL8H (Prp8p full length with C-terminal triple HA tags), KL8H1436 (Prp8p C-
terminal triple HA tags and partitioned at aa436), KL8H1436T (Prp8p C-terminal triple HA 
tags, partitioned at aa436, and TAP tag at the C-terminal of aal-436 fragment) were grown 
in YPDA broth and plated on YPDA plates in serial dilutions. Then the plates were 
incubated at different temperatures; 18, 23, 30, 37°C. BMA38a, RG8T, RG8T/2 173, KL8H 
showed growth at all the temperatures, but KL8T/770, KL8111436, and KL8H1436T were 
heat sensitive (Figure 3.213). All the Prp8p partitioned strains showed slow growth when 
compared to un-partitioned Prp8p strains. 
I have tried to create a Prp8p aa436 partition strain in host RG8T, but I failed to 
obtain any positive clones by insertion of the transposon generated from pAW28 (refer to 
Section 3.4). This could be due to the Prp8p C-terminal TAP-tag, as the TAP-tag may 
disrupt the function of Prp8p when combined with the aa436 breakpoint. However, the 
insertion of the transposon into Prp8p aa436 was achieved with no difficulty in strain BH8T 
(PRP8:TAP-TRP1, HIS3-GJ-3HA:PRP8, otherwise as BMA38a). This is possibly due to 
over-expression of aal-439 Prp8p stabilising the association of Prp8p aa436-2413 TAP-tag 
polypeptides. This strain showed a better growth rate compared to KL81V436, and 
KL8H/436T, but this construct did not rescue the heat sensitive phenotype caused by Prp8p 
aa436 partitioning (Figure 3.213) 
3.4 Requirement for 3 amino acids repeats and Mosaic End sequences for cell viability 
in the Prp8p aa436 partition strain 
For Prp8p partitioning at the aa436 region, a total of 796 yeast colonies transformed by 
insertion of PCR product from pAW28 that grew on —Ura dropout plates were screened. All 
the colonies that were screened yielded PCR product from non-insertion regions or both the 
non-insertion and insertion regions. Western blotting identified the size of Prp8p in these 
clones, which showed no reduced size of Prp8p in the clones tested. Apparently the clones 
were false positives, and the presence of both positive and negative insertion PCR products 
could be due to the duplication of genomic PRP8 that caused by mutationed. 
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A) Tetrad dissection of clone derived from BMA38 (2n) with transposon inserted at PRP8 
aa436. B) Yeast colony PCRs for URA3 insertion confirmation over PRP8 in BMA38 (2n) 
transfonnants and its haploid cells. (U: ycPCR from upstream insertion region to URA3, y: 
ycPCR before and after the insertion). C) The transposon inserted diploid cells and its 
surviving haploid cells were plated on YPDA and —Ura dropout plates. BMA38 (2n) without 
transposon insertion served as negative control and transposon inserted BMA38 (2n) cells 
served as positive control over the surviving haploid cells after the tetrad dissection. 
As partitioning of Prp8p at the aa436 region by inserting pAW28 construct might 
cause cell lethality, transformation was performed on diploid BMA38. Clones showing 
positive insertion of URA3 gene after yeast colony PCR screening were sporulated, and 
tetrads were dissected. Two clones were picked for the sporulation and tetrad dissection 
tests. Results showed only two surviving spores after the tetrad dissections (Figure 33A). 
The surviving colonies were tested by yeast colony iB  (ycPCR) for URA3 insertion 
(Figure 3.313) and plated on both YPDA and —Ura dropout plates (Figure 3.3C). Results 
show that URA3 is undetected in ycPCRs, and the failed of grown of colonies plated on —Ura 
dropout plates confirmed this. These indicate that partitioning of PRP8 at the 436 aa region 
by insertion of pAW28 transposon PCR product is lethal to the cell. 
Partitioning of Prp8p at the aa436 region caused cell death was rather surprising. 
Our collaborator, Dr. Andrew Newman obtained a collection of clones, in which Prp8p was 
partitioned at region aa416-436 by using the transposon techniques. One difference between 
our partitioned strains is that, Dr. Andrew Newman Prp8p aa416-436 region partition clones 
contained 3 amino acids (aa) repeats (for example: Prp8p aal-439, aa437-2413), and Mosaic 
End sequences. 
A plasmid (M529) that contained prp8 with transposon insertion at aa436 was 
obtained from Dr. Andrew Newman. Transformation PCR product was generated by using 
M529 as template. Before the transformation, the PCR product was digested with Dpnl in 
order to digest the methylated PCR template (M529) that could potentially cause false 
positive insertion. By using this strategy, I succeeded in obtaining clones with Prp8p 
partitioned at aa436: KL8TG/436, KL811/436, and KL81 ­11436T. 
3.5 TAP-tag purification of Prp8p complexes 
To determine the extent to which Prp8p complexes were intact or were disrupted by the 
dissection, extracts from parent (RG8T) and dissected strains, KL8T/770 and RG8T/2 173, 
were subjected to the TAP affinity-selection procedure and the co-selected proteins were 
separated by SDS-PAGE and analysed by mass spectrometry. Proteins that were co-selected 
with full-length Prp8p included Aar2p, Brr2p, Prp3p, Prp4p, Prp6p, Snul 14p and several Sin 
and Lsm proteins (Figure 3.4A). These represent a subset of the proteins that were 
previously shown to be components of the U5 snRNP or U4/U6.U5 tri-snRNP. The 
Prp8T/770p C-terminal fragment (Prp8p C-terminal TAP-tagged and partitioned at aa770) 
co-selected Aar2p, Brr2p, Prp3p, Prp4p, Prp6p, and Spp382p. The Prp8T/2173p C-terminal 
(2174-2413) co-selected a protein similar in size to Brr2p, whereas other co-selected proteins 
were in very low abundance due to the reduced stability of the complex. 
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Figure 3.4 TAP purification of Prp8p-associated proteins 
A) TAP-purified proteins were fractionated in a 4-12% PAGE gel, stained overnight with 
Sypro ruby protein stain and analysed by mass spectrometry. B) TAP-purified proteins 
associated with Prp8p dissected residue 2173 (lane 1) or 770 (lane 2) were fractionated in a 
4-12% PAGE gel, blotted and probed with anti-8.6 antibodies. C) Effect of salt on the 
association of the pairs of dissected Prp8 polypeptides. Splicing extracts were incubated with 
IgG-agarose in the presence of 150, 300 or 500 mM NaCl. The pull-down proteins were 
fractionated by 4-12% PAGE gel, blotted and probed with anti-8.6 antibodies. Lane 1) Non-
tagged full-length Prp8p, 2) Full-length Prp8p with TAP tag at the C-terminus, 3) TAP-
tagged Prp8p dissected at residue 770, 4) TAP-tagged Prp8p dissected at residue 2173. 
Proteins were fractionated, blotted and probed with anti -8.6 antibodies. 
Interestingly, Snul 14p, which was co-selected efficiently with full-length Prp8p, was 
hardly detectable in association with Prp8T/770p. In contrast, the amount of Aar2p 
associated with Prp8TI770p was increased compared to the full-length Prp8p. Aar2p was 
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previously found associated with a 16S form of yeast U5 snRNP that contained Prp8p, 
Snul 14p and the Sin proteins but lacked the majority of known Prp8-associated proteins, 
including Brr2p, and it was suggested that this Aar2-U5 snRNP complex represents an 
intermediate particle in US snRNP biogenesis. In addition, Spp382p was associated with 
Prp8T/770p, but was not detectably associated with full-length Prp8p or with Prp8T/2173p. 
Spp382p has been affinity-selected previously with Prp8p and other splicing factors (Hazbun 
et al., 2003; Gavin et al., 2002), but is not known to be a stable component of US snRNPs. 
Thus, Prp8T/770p produced a different profile of co-selected proteins compared to full-
length Prp8p. This presumably represents more than one Prp8p complex, and likely includes 
the Aar2p-U5 snRNP precutsor complex related to that described by Gottschalk et al. 
(2001). The profile of TAP-purified proteins visualised by Sypro ruby staining (Figure 3.4a) 
suggested that this procedure efficiently separated the N-terminal and C-terminal fragments 
of Prp8p dissected at positions 770 and 2173. Nevertheless, using Western blotting with anti-
8.6 antibodies specific for the N-terminus, the N-terminal fragments (1-770 and 1-2173) 
were detectable in the TAP-purified fraction, albeit at a low level, as shown in Figure 3.413. 
In order to establish conditions that gave complete separation of the N-terminal and C-
terminal Prp8p fragments, the effects of different salt conditions on the association of Prp8p 
N- and C-terminal polypeptides were tested in a single-step precipitation. The Prp8p C-
terminal TAP-tagged fragment was affinity-selected using IgG agarose beads, and the 
presence of the Prp8p N-terminal fragment in co-precipitates was investigated by Western 
blotting with anti-8.6 antibodies (which recognise the N-terminal fragments of Prp8p but 
also interact with the protein A moiety of the TAP-tag on the C-terminal fragments). This 
single-step affinity-selection in the presence of 150 mM or 300 mM salt did not disrupt the 
association of the N- and C-terminal Prp8p fragments, however, with 500 mM salt, only C-
terminal TAP-tagged Prp8p polypeptides were selected (Figure 3.4C). 
3.6 Co-immunoprecipitation of Snull4p and Aar2p with Prp8p 
As the Prp8p polypeptide pairs can be dissociated in 500 mM NaCl, the association of 
different fragments of Prp8p with other splicing factors was investigated in this condition. 
The TAP-tagged C-terminal Prp8p fragments were pulled down with IgG-agarose, the 
supemates were then incubated with anti-8.6 antibodies to pull down the N-terminal of Prp8 
polypeptides (Figure 3.4A), and these immune precipitates were analysed by Western 
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Figure 3.5 Detection of proteins associated with the N- or C-terminal fragments of 
Prp8p. A) Splicing extracts were first incubated with horse IgG agarose in 500 mM NaC1 to 
pull-down only the C-terminal Prp8p fragments (lanes 1 to 4). The supernates were then 
transferred into new tubes and incubated with anti-8.6-adsorbed protein A Sepharose beads 
in the presence of 500 mM NaCl (lanes 6 to 8). After PAGE, Prp8p fragments that bound to 
the beads were detected by Western blotting, using anti-8.6 antibodies. Lanes 1 & 6) full-
length TAP-PrpS protein; lanes 2 & 7) full-length non-tagged Prp8p; lanes 3 & 8) 
Prp8TI436p; lanes 4 & 9) Prp8T/770p; lanes 5 & 10) Prp8TJ2413p. The blot from a) was 
stripped and reprobed B) with anti-Snul 14 antibodies or C) with anti-Aar2p antibodies. D) 
Splicing extracts from strains producing non-tagged full-length Prp8p (lane 1), Prp8T/770p 
(lanes 24), Prp8T/2173p (lanes 5-7), and full-length Prp8Tp (lanes 8-10) were incubated 
with IgG-agarose in the presence of 150 mM NaCl. The precipitates (Co-IP), 10% total, and 
10% supernates (Sup) after the pull-down (only precipitate from non-tagged Prp8p) were 
analysed by Western blotting with both anti-8.6 and anti-Aar2p antibodies. 
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blotting for the presence of Prp8p N-terminal fragments (Figure 35A), Snul 14p (Figure 
3.513) or Aar2p (Figure 3.5C). Snul 14p was detected associated with TAP-tagged full-length 
Prp8p (Figure 3.513, lane 1) and with C-terminal Prp8p polypeptide 437-2413 (Figure 3.513, 
lane 3), but not with Prp8p 771-2413, Prp8p 2174-2413 or with full-length untagged Prp8p 
that served as a control, (Figure 3.513, lanes 4, 5 and 2). Following the precipitation with 
anti-8.6 antibodies, Snul 14p was found associated with non-TAP-tagged Prp8p (Figure 
3.513, lane 7), and with N-terminal polypeptides 1-770 and 1-2173 of Prp8p (Figure 3.513, 
lanes 9 & 10). The amount of Snul 14p pulled down with full-length TAP-tagged Prp8p, and 
with N-terminal amino acids 1-439 of Prp8p was low (Figure 3.513, lanes 6 & 8), as most 
Snul 14p had already been pulled out of these samples during the first-round precipitation of 
the TAP-tagged C-terminal polypeptides (Figure 3.513, lanes 1 & 3). Thus, Snul 14p 
associates with the region 437-770 of Prp8p. 
The same blot was stripped and re-probed with anti-Aar2p antibodies. Aar2p was 
present in precipitates with TAP-tagged, full-length Prp8p, and with Prp8p residues 437-
2413, and 771-2413 (Figure 3.5G. lanes 1, 3, & 4), but not with untagged Prp8p, or with 
Prp8p amino acids 2174-2413 (Figure 3.5C, lane 2 & 5). Unfortunately, the presence of 
Aar2p in the N-terminal Prp8p pull-downs was obscured by the presence of antibodies. 
However, even when the Prp8T/2173p (Prp8p C-terminal TAP-tagged and partitioned at 
aa2 173) immunoprecipitation was performed under conditions (150 mM NaC1) that did not 
disrupt the association of the N- and C-terminal Prp8p fragments, Aar2p was not co-
precipitated (Figure 3.5D, lane 7). 
In addition, centrifugation through a 10-30% glycerol gradient (100 mM KC1) showed 
that Aar2p mostly co-fractionates with full-length Prp8p and Snul 14p (Figure 3.6A, lanes 5-
11), although some Aar2p was also detected near the top of the gradient (Figure 3.6A, lane 
25) as was observed previously by Gottschalk et al. (2001). In contrast, the Aar2p in 
Prp8T/2173 extract was mostly found in the lower density fraction (Figure 3.613, lane 25) 
and only a trace amount was detected in a higher density fraction (Figure 3.613, lane 7), after 
the film was over-exposed. Thus, dissecting of Prp8p at position 2173 disrupted the 
interaction between Aar2p and Prp8p. 
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Glycerol gradient fractionation of Prp8p, Snul 14p and Aar2p. RG8T cell extract containing 
full-length Prp8p-Tap (A) and RG8T/2173p extract containing Prp8TI2173p (B) were 
fractionated in 10-30% glycerol gradients. Alternate gradient fractions were acetone 
precipitated and proteins were analysed by Western blotting with anti-Snul l4p and anti-
Aar2p antibodies. Asterisk (*) indicates the presence of Aar2p near the top of the gradient 
(Figure 3.6A and B, lane 25). 
3.7 Discussion 
Yeast Prp8p is highly conserved in both its sequence and its size, being 61% homologous to 
human Prp8p. Besides the MPN (Mpr-1, Pad-1, N-terminal; residues 2173-2310) and RRM 
(RNA Recognition Motif; 1059-1151) domains that were predicted by bioinformatic 
approaches, and a functionally proven nuclear localisation signal (Chapter 4), there is no 
other obvious structural domain within this huge protein. By functional, genetic 
classification, Brow and colleagues (Kuhn et al., 2002) designated 5 domains (Region a: 
residues 233-365, Region b: residues 608-687, Region C: residues 785-864, Region d: 
residues 1091-1197, and Region e: residues 1621-1878). 
The results presented here show that Prp8p can be dissected into four functional 
domains: residues 1-439,437-770, 771-2173, and 2174-2413. The dissection points near the 
C-terminus of Prp8p (2170-2179) lie precisely at one boundary of the predicted MPN/JAB 
domain (2173-23 10). This is consistent with the notion that these transposon insertions may 
be tolerated because they have targeted a 'linker' sequence upstream of this functional 
module. Furthermore, the Prp8p NLS, and genetically defined Region a are within residues 
1-439, Region b is within 437-770, and the RRM and Regions c, d, e are within 771-2173. 
The failure to obtain viable constructs with transposon insertions in the 771-2173 region of 
Prp8p may indicate that Regions c, d, e and the RRM function as one indivisible unit. 
The combination of Prp8p partition and TAP affinity-selection were used to reveal the 
potential regions of protein interaction between Prp8p and other splicing factors. By 
increasing the salt concentration to 500 mM, the associations of the N- and C-terminal Prp8p 
polypeptides were disrupted. Therefore, using a two-single-step immunoprecipitation 
strategy (Figure 3.5), the association of Snul 14p with Prp8p was found to require Prp8p 
residues 437-770. This in close agreement with two-hybrid interaction data in which 
Snul 14p as bait selected multiple Prp8p fragments that had amino acids 420 to 464 in 
common (Dix and Beggs, unpublished results). The strong association of Prp8p and Snul 14p 
is not surprising, as Achsel et al., (1998) showed that human Prp8 and Snul 14 proteins 
remained associated in 0.4 M of the chaotropic salt sodium thiocyanate. 
Interestingly, even at moderate salt concentrations (150 mM NaC1 or 100 mM KC1) 
the association of Aar2p was disrupted by dissecting Prp8p at residue 2173. Previously, 
Gottschalk et al. (200 1) purified yeast Aar2p associated with Prp8p and Snul 14p. Here I 
show that Prp8p/771-2413p could co-select Aar2p in the absence of Snul 14p (Figure 3.5C, 
lane 4), and Prp8T/2173p could co-select Snul 14p in the absence of Aar2p (Figure 3.513, 
lane 10 and Figure 3.513). This suggests that the associations of Snul l4.p and Aar2p with 
MOO 
Prp8p are not interdependent. 
Although Prp8p has been dissected into pairs of functional polypeptides in this work, 
each of these disruptions was detrimental to growth; the 2173 dissection caused slow growth 
and the 436 and 770 dissections resulted in heat sensitivity. For the 2173 dissection at least, 
the integrity of Prp8p's interaction with another protein was apparently reduced stability of 
the complex. This confirms the functional significance of the very large size of this highly 
conserved protein that has been proposed to function as a scaffold for molecular interactions 
in the spliceosome. 
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Chapter 4 
US snRNP assembly, from cytoplasm to nucleus 
4.1 Introduction 
In yeast, the function of the UsnRNP-specific proteins in the completion of the biogenesis of 
U snRNPs is still poorly understood. In this study, I have identified the nuclear localisation 
signal (NLS) domain of Prp8p by sequence alignments and confirmed it by biochemical test. 
Subsequently, the role of Prp8p in U5 snRNP biogenesis, and the effect of deleting the Prp8p 
NLS on other U5 snRNP protein localisations and association were investigated. This is the 
first report that proposes that yeast US snRNA travels to the cytoplasm, where it forms a 
Prp8p-Snul 14p-Aar2p US complex, before re-entering to the nucleus and forming the 
mature U5 snRNP with Brr2p and other US-specific proteins. The C-terminal region of 
Prp8p is important for Brr2p association (van Nues and Beggs, 2001), and mutations 
resembling those in human Prp8p that cause retinitis pigmentosa type 13 decreased the 
association between Prp8p and Brr2p. Furthermore, the importin Kap95p has been identified 
to be essential for Snul 14p, and snRNA (U2, US, and U6) nuclear import. 
4.2 Prp8p NLS identification 
By using the ProteinPredict server (Rost et al., 2003), a nuclear localisation signal (NLS) 
was identified at aa96-1 17 of yeast Prp8p. To validate the prediction, firstly I investigated 
the localisation of Prp8p with aa96-1 17 deleted compared to WT Prp8p. In the second step, I 
looked into the localisation of GFP fused to Prp8p aa96-1 17 compared to GFP alone. 
To delete aa96- 117 from the full-length Prp8 protein, I employed site-directed 
mutagenesis (as mentioned in section 2.6) on plasmid pJU204 (CEN-HIS3; a plasmid that 
harbours full-length PRP8 with its own promoter and encoding a triple-HA tag at the C-
terminus of the protein) (Umen and Guthrie, 1995). The deletion of aa96-1 17 in the pJU204 
sequence was confirmed by sequencing. Full-length pJU204 and pJU204iNLS were 
transformed into KL1 (yeast strain with genomic PRP8 under regulation of PGj),  and 
selected on —His YMGR plates. Both strains that contained pJU204 and pJU204iNLS were 




staining. The immunoflurescent staining to detect the triple-HA tag of plasmid-based Prp8p 
showed that the full length Prp8p was localised in the nucleus (Figure 4. 1A). However, the 
Prp8p with deletion Aaa96-1 17 was present in both nucleus and cytoplasm (Figure 4.1 B). 
A plasmid (pGFP-N-NLS) that encodes aa96- 117 fused to GFP was constructed 
from PGFP-N-FUS. PGFP-N-FUS (CEN-URA3-P M -GFP) is a plasmid that expresses 
GFP under control of MKT25 promoter (Niedenthal et al., 1996). Both the pGFP-N-FUS and 
pGFP-N-NLS were transformed into yeast cells separately and selected on YMM (-Met, - 
Ura) dropout plates. The transformed clones were then grown on YMM (-Met, -Ura) broth 
until log-phase, and subsequently the cells were harvested and examined microscopically. 
GFP without insertion was distributed throughout the cell (Figure 4.IC). However, when 
GFP was fused with aa96- 117 of Prp8p, the fluorescence was concentrated in the nucleus 
(Figure 4. 1D). This confirmed that aa%- 117 of yeast Prp8p encodes a functional NLS. 
Figure 4.1. Localisation of Prp8p. A) Full length Prp8p B) Deletion- NLS-Prp8p. The full 
length Prp8p was sub-nuclear localised, but the deletion-NLS-Prp8p was detected in both the 
nucleus and cytoplasm. C) Localisation of GFP and D) OFF fused to the Prp8p NLS (aa96-
117 Prp8p). GFF was found distributed throughout the cells, but concentrated in the nucleus 
when fused to aa96- 117 of Prp8p. 
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One interesting finding was that KL1 strain that contained ANLS-Prp8p grew slowly 
on YPDA plates, but survived. In addition, the strain showed no temperature-sensitive or 
cold-sensitive phenotype (Figure 4.2A). The efficiency of splicing in vitro from KL1-
pJU204ANLS was reduced, but no step 1 or 2 defect was observed when compared to the 
strain KL1-pJU204 (Figure 4.213). Another interesting finding was that, LNLS Prp8p 
immunoprecipitated reduced levels of U4 and U6 snRNAs, but comparable levels of U5 to 
the full-length Prp8p immunoprecipitates (Figure 4.2C), despite the fact that a portion of 
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Figure 4.2. The effect of deletion-NLS-Prp8p on cells. A) The plasmid (pJU204) 
containing full length PRP8 and deletion-NLS-prp8 constructs were transformed into KL1 
and plated on -His dropout plates. The transformants were restreaked on YPDA and 
incubated at different temperatures (14°C, 23°C, 30°C, and 37C). Cells containing deletion-
NLS-Prp8p showed slow growth compared to cells with full-length Prp8p, but it has neither 
TS nor CS phenotype. B) In vitro splicing was performed on extracts derived from cells with 
full length Prp8p or deletion-NLS-Prp8p. Deletion-NLS-Prp8p extract showed a reduced rate 
of splicing in vitro when compared to full length Prp8p extract, but no accumulation of step I 
or step II products was observed. C) Iminunoprecipitation of Prp8p showed that deletion-
NLS-Prp8p precipitated less U4 and U6 snRNAs, but comparable amounts of U5 snRNA 
when compared to full length Prp8p precipitation. 
We 
A more surprising finding is that aa96-1 17 of yeast Prp8p shows low homology to 
Prp8ps from other species (Figure 4.3). This suggests that the aa96-1 17 sequences could be 
exclusively present in budding yeast. By using PSORII (Nakai and Horton, 1999), Grainger 
and Beggs (2005) showed a potential bi-partite NLS is located at aa96-156. This indicates 
that the additional NLS that located at aal 18-156 of yeast Prp8p might responsible for the 
nuclear import of the deletion aa96-117 Prp8p. However, whether the aall8-156 of yeast 
and other eukaryotic Prp8ps serve as a functional NLS is yet to be confirmed. 
M.muscul us --------------------------------------- MAG--VFPYRGPGNPVP ---- 15 
norveqicus --------------------------------------- MAG---VFPYRGPCNPV" ---- 15 
H. sapiens --------------------------------------- MAGVFPYRG9GNPVP ---- 15 
x. laevis --------------------------------------- MAG--VFPYRPQAPPMP ---- 15 
D.melanogaster _MSIPPYMIPQNAW.AQLMAQQAYAAAHAQQAQLHAQQQMANQ-IQQIPPPGAPLPPAGG 58 
A.thaliana MWNNN-------DGMPLAPPGTGGSMMPPPPAAHPS-YTALPPPSNPTP 	41 
S.pombe --------------------- MASLPPGNP ---- PPPPPPPGF-EPPSQPPPPPPP 30 
cerevisiae MSGLPPPPPGFEEDSDLALPPPPPPPPGYEIEELDNPMVPSSVNEDTFLPPPPPPPSNFE 60 
M.musculus ------------ GP ----- LAPLPDYNSEEKLQEKP,.RKWQQLQ ----------------- 41 
R.norvegicus ------------GP-----LAPLPDYMSEEKLQEKARKWQQLQ------------ -----41 
H.sapi ens ------------ GP ----- LAPLPDYMSEEKLQEKAP.KWQQLQ ----------------- 41 
X.laevis GP-----PSVTPDYMSEEKLQEKARKWQQLQ ----------------- 41 
D.melanogaster HTNGIPIPVGGQGPGLGQIPTPKPDILTEEKLQEKALKWQHLQ---------- -------101  
A.thaliana ------------- P ----- VEPTP-EEAEAKLEEKARKWMQLN ----------------- 65 
S.pombe GYVKKRKNXTPAQSGNLEKQLNERARKWRASQ ----------------- 62 
S. cerevisiae IN --------- AEEIVDFTLPPPPPPPGLDELETKAEKKVELHG 	Y :DGYDT.T 	S 111 
M.inusculus --- 	I YAEKRKFGFVDAQKEDMPPEHVRXIIRDHGDMTN 	FRHDRVYLGALKYNPHA 98 
R . norvegi cus --- YAERKFGFVDAQKEDMPPEHVRXIIRDHGDMTNRXFRHDKRVYLGKThP 	98 
H. sapiens ---. 	 YAEKRKFGFVDAQKEDMPPERVRKI IRDHGDMTNRKFRF3DKRVYLGALKYNPHA 98 
K. 1 aevi s --- YAEKRKFGFVDAQKIDMPPEHVRKI IRDHGDMTNRKFRHDKRVYLGALKYMPHA 98 
D.mel anogaster ---S 	FAEKRKFGFVDTQKEDMPPEHIRKI IRDHGDMTSRXYRHDKRVYLGALKYMPHA 158 
A. thaliana ---S 	YGDKFGFVETQKEDMPPEHVRKIIRDHGDMSSKKFRHDVYLGKrvP 	122 
S. poinbe --- S FGVKRKQGYVQTEKADLPPEHLRKIMKDRGDMSSRKFRADKRSYLGALKYLPHA 119 
S. cerevisiae MTKXAKP.SNLYTPKAEMPPEHLRKI INTHSDMASKNYNTDKKAFLGALKYLPHA 171 
Figure 4.3. Alignments of N-terminal of Prp8 orthologs. 
All sequences aligned using ClustaIW to aligned the N-terminal regions. The polyproline 
tract of S. cerevisiae is underlined and the NLS sequence is highlighted. (numbers refer to 
the amino acid residues). 
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4.3 Effect of Prp8p delocalisation on localisation of other US components 
The 16S and 20S forms of the US snRNP were identified by the Luhrmann and Abelson 
groups. The 16S U5 snRNP was isolated by pulling down Aar2p (Gottschalk et al., 2001), 
and consists of Prp8p, Snul 14p, Sm proteins, Aar2p, and U5 snRNA. The 20S U5 snRNP 
was isolated by using Brr2p as bait, and consists of every component of 16S U5 snRNP, 
except Aar2p, and also includes Prp28p, Snu40p, and Dibip (Stevens et al., 2001). 
To investigate the effect of iNLS Prp8p on localisation of US snRNP components, 
plasmids encoding full-length Prp8p and ANLS-Prp8p were transformed separately into 
KL1-Aar2 (KL1 with Aar2p TAP tag), KL1-Brr2, KL1-Snull4, KL1-Lsm8, KL3-SmB, 
KL3-SmD1, and KL3-SmE yeast strains. In both KL1 and KL3 yeast strains, genomic PRP8 
is regulated by the PGJ  promoter. After that, the yeast cells that harboured the plasmid were 
grown in YPDA broth. Subsequently, TAP-tagged proteins were immunofluorescent stained 
and observed microscopically as mentioned in the materials and methods (2.9). 
Firstly, the localisation of the common components in both 16S and 20S US snRNPs 
were investigated. The results showed that Snul 14p is in the nucleus in the WT strain 
(Figure 4.4A) and was delocalised to the cytoplasm in the iNLS Prp8p strain (Figure 4.413). 
5mB ip, and SmDlp (that contain their own NLS (Bordonne, 2000)) are consistently in the 
nucleus in both WT and the ANLS Prp8p strains (Figure 4.4E, F, G & H). SmEip showed a 
slight increase in the cytoplasm (Figure 4.4J) in the ANLS Prp8p strain when compared to 
the WT Prp8p strain (Figure 4.41). Strikingly, US showed increased signal in the cytoplasm 
in the ANLS Prp8p strain (Figure 4.4P), when US was mainly detected in the nucleus in the 
WT Prp8p strain (Figure 4.40). 
Aar2p, that is present in 16S US snRNP, was found in both cytoplasm and nucleus in 
the WT Prp8p strain (Figure 4.4C). In the ANLS Prp8p strain, Aar2p appeared to be slightly 
increased in the cytoplasm, but this may not be significant (Figure 4.41)). Brr2p (present in 
20S US snRNP) (Figure 4.4K & L), and other non-US snRNP components: U2 (Figure 4.4M 
& N), U6 (Figure 4.4Q & R), and Lsm8p (Figure 4.4S & T) were found to be consistently 
nuclear regardless of the localisation of Prp8p. 
To further analyse the level of US that is bound to Aar2p associated complex, cell 
extracts derived from KL1-Aar2-pJU204 and KL1-Aar2-pJU204NLS grown in glucose 
medium were utilised. Results showed that Aar2p in ANLS Prp8p yeast strain precipitated 
increased levels of US (S & L) when compared to WT Prp8p yeast strain (Figure 4.SA). 
This suggests an increased level of 16S US snRNP when Prp8p is delocalised to the 
cytoplasm. 
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Figure 4.4. The effect of deletion-NLS-Prp8p on localisation of other splicing 
components. The splicing factors under investigation were either TAP-tagged or protein-A-
tagged in yeast strains (KL1 or KL3) with genomic PRP8 under PGAL promoter. Plasmid 
encoding full length Prp8p or deletion-NLS-Prp8p construct were transformed into genomic-
PRP8-regulated cells and selected on -His dropout plates. The transformants were grown in 
YPDA broth and probed with rabbit anti-Protein A primary antibodies, then probed with 
anti-rabbit antibodies conjugated with Alexa fluor 594 dye. For snRNA localisation analysis, 
KL1 containing either full length Prp8p or deletion-NLS-Prp8p was grown in YPDA and 
flourescent in situ hybridised with Cy3-labeled probe. A) Snul 14p was shown to be nuclear 
localised in full length Prp8p background, but delocalised to the cytoplasm when the Prp8p 
NLS was deleted (B). SmEip (J) and U5snRNA (P) showed increased cytoplasmic signals in 
deletion-NLS-Prp8p background. C & D) Aar2p was present in both cytoplasm and nucleus. 
SmBlp(E&F),SmDlp(G&H),Brr2p(K&I),U2(M&N),U6(Q&R), and U6core 
protein Lsm8p (S & T) are nuclear in both full length Prp8p or deletion-NLS-Prp8p cells. 
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4.4 Prp8p mediates Aar2p nuclear localisation 
Aar2p is present in both nucleus and cytoplasm when Prp8p is endogenously expressed 
(Figure 4.4C). To investigate the localisation of Aar2p in relation to the expression level of 
Prp8p, strain KL1-Aar2 was utilised. KL1-Aar2 was derived from BMA38a, with Aar2p-
TAP and PRP8 regulated under the PGJ  promoter. When Prp8p was over-expressed (in 
galactose medium), Aar2p was observed to be nuclear localised (Figure 4.513, upper panel). 
When Prp8p was depleted by growth in glucose medium for 12 hours, the localisation of 
Aar2p was observed in both cytoplasm and nucleus (Figure 4.513, lower panel), resembling 
the observation in strain expressing endogenous Prp8p (Figure 4.41). 
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Figure 4.5. A) Immunoprecipitation of Aar2p from splicing extracts derived from full length 
Prp8p or deletion-NLS-Prp8p. Increased levels of US snRNA were precipitated by Aar2p in 
a deletion-NLS-Prp8p cell extract. B) Yeast strain KLI, with genomc PRP8 under FG 
promoter and Aar2p TAP tagged, was first grown in YPGR (galactose and raffinose 
medium) and the Aar2p was detected by rabbit anti-Protein A antibodies, followed by Alexa 
fluor-anti-rabbit secondary antibodies (upper panel). The cells were then shifted into YPDA 
(glucose medium) for 12 h, and Aar2p was detected throughout the cells (lower panel). 
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4.5 Retinitis pigmentosa type 13 in yeast 
By using the published results from McKie et al. (2002), the residues in yeast Prp8p 
according to the mutations in human Prp8p that cause retinitis pigmentosa type 13 were 
mutated (Figure 4.6A). By using pJU204 (plasmid encoding full-length Prp8p), three 
separate prp8 point mutation plasmids were created; R2388K (rp5), R2388G (rp6), and 
F2392L (rp7), and confirmed by DNA sequencing. 
The wild-type and mutated plasmids were then transformed separately into KL3-
Brr2 (a yeast strain with genomic PRP8 regulated by the PG1  promoter and with Brr2p C-
terminally tagged with 13-Myc tag). Transformed yeast cells were first selected on a —His 
dropout plate, and subsequently plated on YPDA. The plated yeast cells were grown at 14°C, 
23°C, 30°C, and 37°C. Wild type and rp7 showed growth at all the temperatures, but rp5 and 
rp6 were heat sensitive (Figure 4.613). All the rp mutation strains showed slow growth when 
compared to wild-type Prp8p strains. The localisation of the mutated Prp8p was analysed by 
immunoflourescent staining. The yeast strains were grown in YPDA broth at 30°C. The 
localisations of these mutated Prp8ps were consistently nuclear (Figure 4.6C), resembling 
the localisation of wild-type Prp8p (Figure 4.1A). However, when rp5 was grown at 37°C, 
Prp8p was detected in both the nucleus and cytoplasm (Figure 4.9C). 
4.6 Prpsp, Aar2p, Brr2p and U5 snRNA associations 
To facilitate the analysis of associations of Aar2p, Snul 14p, Brr2p, and Prp8p, the yeast 
strain KL3-Brr2 was used, in which Brr2p is tagged at the C-terminal with 13-Myc. Splicing 
extracts derived from this strain (KL3-Brr2) that contained either: pJU204 (WT, PRP8-
3HA), pJU204ANLS, pJU204-rp5, pJU204-rp6, or pJU204-rp7 were grown in YPDA broth 
and analysed by immunoprecipitation. All mutated or deleted-NLS-Prp8p tested 
immunoprecipitated increased amounts of Aar2p when compared to the wild-type Prp8p 
(Figure 4.7A, lanes 6-10). Despite the fact that Brr2p levels were comparable, or increased 
in the input of tested mutated Prp8p extracts (Figure 4.7A, lanes 1-5), the pull-down of Brr2p 
by these mutated Prp8ps was obviously decreased (Figure 4.7A, lanes 6-10). 
In addition, the association between mutated Prp8p and snRNAs were tested. An 
interesting finding is that mutated Prp8p (rp5) precipitated mainly one species of U5 L, and 
the U5S snRNA was present only in trace amounts (Figure 4.713, lane 6). The reduced pull- 
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PRP8 C-terminal Alignment 
Homo sapiens 	 2291 N - YE Q N:EYHEHSW --N ...QEGE.YS.DDY 2335 
Saccharomyces cerevisiae 2369 EGDYN Y.YG: LEFBR?VRFLQFSELGO-EELEAEQD S 2413 
Rattus novergicus 	2569 	 2613 
Xenopus bevies 2291 2335 
Drosophila mebanogaster 2351 N YELQLANPKErEZLffRTSHFLLFSNLEDGGGAGADRZD.L 2396 
Caenorhabditis elegans 2284 ;- FDVCLSNPEYYREDHRPVHFHNFKAEDDPLGTGSADRD 	2329 
Arabidopsisthaliana 	2290 S :NYSLTLGTPKEYYHQ.1 PTHFLQFSK ED---LD5DDS 	2332 
Encephalitozoon cuniculi 2133 	 ------ 2172 
Retintis pigmentosa mutation 	 f 










Figure 4.6. Prp8p C-terminus alignment, mutations, growth phenotype, and 
localisations. A) The sequences were identified using NCBI BLAST and then aligned using 
Clustal_W (1.82). The conserved amino acids are indicated with *; semi-conserved ones 
with (:) or (). Yeast Prp8p mutations (rp5:R2388K; rp6:R2388G, and rp7:F2392L) were 
created (according to human Prp8p mutations that resulted in Retinitis Pigmentosa type 13) 
by site-directed mutagenesis of the pJU204 plasmid that encodes full-length Prp8p. B) The 
WT, rp5, rp6, and rp7 plasmids were transformed into KL3-Brr2 yeast strain and plated on - 
His dropout plates. The transformants were restreaked on YPDA plates and incubated at 
different temperatures (14°C, 23°C, 30°C, and 37C). WT, and rp7 mutant grew at all tested 
temperature, but rp5 and rp6 were heat sensitive. C) The localisation of mutated Prp8p was 
investigated by indirect immunoflourescent staining. The nuclear localisation of Prp8p was 
not affected by the Prp8p C-terminus mutation and was identical to WT Prp8p (Figure 4. 1A). 
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down of U4 and U6 snRNAs by mutated Prp8p (rp5) was most probably caused by weak 
association between Brr2p and Prp8p (Figure 4.7A, lane 8). The association between Brr2p 
and Prp8p to form the mature U5 snRNP (Stevens et al., 2001) is required prior to the 
formation of tri-snRNP. The observation that only U5-L snRNA is precipitated by mutated 
Prp8p (rp5) suggests that Prp8p can distinguish these two forms of U5 that are incorporated 
into the U5 snRNP. A similar finding was observed in another Prp8p C-terminal point 
mutation strain (prp8-1, G2347D). The prp8-1 mutation not only disrupted the association 
between Prp8p and Brr2p (van Nues and Beggs, 2001), but the pull down of prp8-1 protein 
showed no co-precipitation of U4, US, or U6 snRNAs (Brown, 1992). The result of the 
ANLS-Prp8p snRNA precipitation was consistent with the previous co-IP assay (Figure 
4.2C). 
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Figure 4.7. Immunoprecipitation of Prp8p revealed association between Prp8p and 
other US snRNP proteins and other snRNAs. A) The associations of Aar2p, Brr2p (13-
Myc tagged at C-terminal), and Snul 14p with Prp8p (WT and rp mutants) were analysed by 
co-immunoprecipation of HA-tagged Prp8p using anti-HA antibodies. The precipitates were 
fractionated on a 4-12% PAGE gel, blotted and probed with anti-Aar2p, anti-Myc, and anti-
Snul 14p antibodies. Deletion-NLS-Prp8p, and rp mutants showed increased Aar2p pull-
down, but decreased Brr2p pull-down when compared to VT Prp8p pull-down. B) snRNAs 
co-precipitated by Prp8p were analysed by Northern blotting. WT Prp8p precipitated U4, 
US, and U6 snRNAs, but C-terminal mutated Prp8p (rp5) only precipitated one species of 
U5 (L) and trace amounts of U5S, U4, and U6. snRNAs pulled down by deletion-NLS-Prp8p 
are consistent with a previous observation (Figure 4.2C). 
The distribution of Aar2p, Brr2p, and Snul 14p in complexes was analysed, using a 
combination of glycerol gradient centrifugation and immunoprecipiation using Prp8p as bait. 
Alternate fractions from the glycerol gradient were immunoprecipitated with anti-HA 
agarose, and subjected to Western blotting. Co-precipitation of Aar2p was found to be 
increased in KL3-Brr2 strains that harboured pJU204ANLS or pJU204-rp5 (Figure 4.8B & 
4.8C, fractions 1-13) when compared to the same strain that harboured pJU204 (WT) (Figure 
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Figure 4.8. Distribution of Prp8p associated complexes. Splicing extract (80 .tl) was 
diluted with 120 .tl GG buffer, and layered onto and sedimented through a 10-30% linear 
glycerol gradient and 400 1AI fractions were collected. The odd-numbered fractions were 
incubated with 25 il anti-HA agarose, on a rotating wheel for overnight, at 4°C. The 
precipitates were fractionated in a 4-12% PAGE gel, blotted and probed with anti-Aar2p, 
anti-Myc, and anti-Snul 14p antibodies. WT Prp8p (A) showed increased levels of Snul 14p 
that co-isolated with Brr2p at the bottom layer. Both Prp8p (rp5) mutant (B), and deletion-
NLS-Prp8p (C) splicing extracts showed increased levels of Snul 14p in the lower density 
fractions that co-isolated with Aar2p. 
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In the WT extract, Snul 14p was more concentrated in the bottom fractions (Figure 
4.8A, fractions 1&3) that co-localised with Brr2p, which is present only in the absence of 
Aar2p. In Prp8p-rp5, the distribution of Snul 14p was different, being concentrated in 
fractions where Aar2p was present (Figure 4.813, lane 7-11), and only trace amounts of Brr2p 
were associated with Prp8p (Figure 4.813, fraction 1), even after a long film exposure. This 
could be due to the mutation of Prp8p disrupting the association of Brr2p, leading to 
accumulation of the Prp8p-Snul 14p-Aar2p complex. Snul 14p in ANLS Prp8p extract was 
evenly distributed between the fractions where Brr2p and Aar2p localised (Figure 4.8C, 
fractions 1-11). The even distribution of Snul l4p could be due to Prp8p-Snul 14p-Aar2p and 
Prp8p-Snul 14p-Brr2p being in equilibrium. The defect in iNLSPrp8p-Snu1 14p-Aar2p 
import to the nucleus should accumulate substantial amounts of cytoplasmic ANLSPrp8p-
Snul 14p-Aar2p, however, unlike for Prp8p-rp5, the nuclear NLSPrp8p-Snul 14p-Aar2p 
complex does not have difficulty in Brr2p association. 
The localisations of Brr2p and Prp8p in the prp8p-rp5 yeast strain were then 
investigated. Despite the previous report by Achsel el al. (1998), showing that Prp8p stably 
associated with Brr2p even in 0.2 M of the chaotropic salt sodium thiocyanate, 
immunoflourescent staining showed that Brr2p and Prp8p were not co-localised, even in the 
WT Prp8p strain (Figure 4.10A). Also, an increased level of cytoplasmic Prp8p signal was 
detected after prp8-rp5 was shifted for 2 h from 30°C to 37°C growth condition (Figure 4.913 
and 4.9C). This observation may be similar to the report of increased level of point mutated 
PRPF31 in the cytoplasm, which could be due to the protein mis-folding, leading to 
insoluble aggregates in the cytosol (Deery et al., 2002). An interesting observation is that the 
prp8p-rp5 protein's patchy staining towards the periphery of the nucleus was increased 
(Figure 4. lOB) when compared to the WT Prp8p (Figure 4.9A). 
The association and distribution of Brr2p was investigated by using KL1-Brr2 
(Brr2p is tagged at the C-terminal with TAP, otherwise as KL1) habouring either pJU204 
(WT, PRP8-3HA), pJU204ANLS or pJu204-rp5, because Myc-tagged Brr2p (KL3-Brr2) 
was found poorly iinmunoprecipitated. The combination of glycerol gradient centrifugation 
and immunoprecipitation analysis was used as mentioned above. The precipitates were 
fractionated in 4-12% PAGE gel, blotted, and probed with anti-Snub l4p, and anti-Aar2p 
antibodies. The Brr2p-TAP in the precipitates was detected due to Protein A binding IgG. 
Brr2p was found distributed in fractions 1-17 (Figure 4.10 A, B & C) regardless of the 
presence of WT or mutated Prp8p. A Brr2p that free from Snu 1 14p was found in fractions 
13-17, and Aar2p is constantly absent in all the Brr2p precipitates. Interestingly, Snub l4p 







increased portion of Brr2p was shifted to the lower density fractions (Figure 4. lOB, lanes 11-
17). On the other hand, ANLS-Prp8p caused Brr2p to be distributed more in fractions 5-11 
when compared to the WT Prp8p. Yeast two hybrid results (van Nues and Beggs, 2001) 
showed that both N- and C-termini of Prp8p interact with Brr2p. The Brr2p relocated to 
lower density fractions could be due to the disruption of the Brr2p-Prp8p interaction caused 
by the Prp8p aa96-1 17 deletion, which happens to be the NUS of Prp8p. 
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Figure 4.9. Prp8p and Brr2p localisations analysis. Localisation of triple-HA tagged 
Prp8p and 13-Myc-tagged Brr2p was detected with rat anti-HA, and mouse anti-Myc 
primary antibodies respectively, samples were subsequently probed with Alexa fluor 594 
anti-rat antibodies, and Alexa fluor 488 anti-mouse antibodies respectively. (A) Both WT 
Prp8p, and Brr2p showed sub-nuclear localisation, but were not co-localised to each other. 
(B) At 30°C growth conditions, the strain with mutant Prp8p (rp5) showed subnuclear 
localisation of Prp8p and Brr2p. C) When the rp5 strain was shifted from 30°C to 37°C for 2 
h, Prp8p was detected in the cytoplasm, but Brr2p nuclear localisation was not affected by 
the shift of temperature. 
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Figure 4.10. Distribution of Brr2p associated complexes. Splicing extract (80 .tl) was 
diluted with 120 i.tl GG buffer, and layered onto and sedimented through a 10-30% linear 
glycerol gradient and 400 .tl fractions were collected. The odd-numbered fractions were 
incubated with 25 .tl IgG-agarose, on a rotating wheel for overnight, at 4°C. The precipitates 
were fractionated in a 4-12% PAGE gel, blotted and probed with anti-Aar2p and anti-
Snul l4p antibodies. WT Prp8p (A) showed increased levels of Snull4p that co-isolated 
with Brr2p at the bottom layer. Both Prp8p-rp5 (B), and deletion-NLS-Prp8p (C) splicing 
extracts showed increased levels of Snul 14p in the lower density fractions. Aar2p was not 
detected in the precipitates. 
4,7 yeast U snRNP importin identification 
The results reported in the previous section suggest that US snRNP formation begins in the 
cytoplasm. This raised the question of how the cytoplasmic pre-U5 snRNP is imported into 
the nucleus. To investigate this, 3 importin-mutant yeast strains that show a defect in NLS 
protein nuclear import were tested. These are csel-1 (Solsbacher et al., 1998), kap95-lsIrsl1-
1 (Ueta et al., 2003), and NMD5 deletion strain (Boustany and Cyert, 2002). 
The csel-1 (CS), kap95-ts1rsl1-1 (TS), LtNMD5 (no phenotype), and BMA38a (WT) 
yeast strains were first grown in YPDA broth at 30°C, and subsequently immunoflourescent 
stained with anti-Snul l4.p antibodies (Figure 4.11). BMA38a and csel-1 yeast strains 
showed defined nuclear staining of Snull4p (Figure 4.11A & 4.1 1B), while the trace 
amount of cytoplasmic signal detected could be possibly due to non-specific staining. In 
LINMD5 strains, a slight increase of cytoplasmic signal was detected when compared to 
BMA38a strain, but the nuclear signal is clearly detected (Figure 4.11 D). In the a kap95-ts 
strain, an increased proportion of Snul l.4.p cytoplasmic signal was detected, and this 
cytoplasmic signal was observed in all the stained cells. Similar results were obtained by 
Nikolaev et al. (2003), who showed that Pdr3p was defective in nuclear localisation in kap95 
mutant strain even the strain was grown at permissive temperature (Nikolaev et al., 2003). 
I then further investigated the localisation of snRNAs (U2, U5, and U6), and a 
snoRNA (U3) by using kap95-ls and WT strains grown at permissive (30°C) or non-
permissive temperature (37 0C). At both 30°C and 37°C, U2 is consistently localised in the 
nucleus of the WT strain (Figure 4.12A & 4.1213). In the kap95-ts strain, a slight increase of 
U2 in the cytoplasm was detected when the cells were grown at 30°C (Figure 4.12C). And 
the U2 cytoplasmic signal was clearly increased when the kap95-ts was shifted to 37°C for 2 
h (Figure 4.12D). 
Also, the U5 snRNA distribution was investigated. In a WT strain, US snRNA was 
detected predominantly in the nucleus and slight signal from the cytoplasm (Figure 4.13A & 
4.1313). However, in the kap95-ts strain, U5 snRNA signal was increased in the cytoplasm. 
This result is complicated by the fact that the distinction between nucleus and cytoplasm was 
not clear in the hybridised cells that were grown at either 30°C or 37°C growth conditions 
(Figure 4.13C & 4.13D). The snoRNA (U3) distribution was investigated in kap95-ts strain. 
U3 nucleolar localisation was consistent in this temperature-sensitive yeast strain at either 
permissive or non-permissive temperatures (Figure 4.14A & 4.1413). Interestingly, nuclear 








kap95-ts strain was shifted for 2 h from 30°C to 37°C. The WT U6 snRNA nuclear 
localisation was not affected by the shift of temperature (Figure 4.14E). 
Figure 4.11. Snull4p distribution in importin-mutation yeast strains. Snull4p 
localisation was analysed in NNIT (BMA38a), csel-1, kap95-ts, and ANMD5 strains. Yeast 
cells were probed with rabbit anti-Snul H.p antibodies, and then with Alexa fluor 594 goat 
anti-rabbit secondary antibodies. A) WT yeast cells, and B) importin mutant, csel-1 yeast 
cells showed nuclear localised Snul 14p, with slight cytoplasmic signal that might be due to 
background staining. C) Yeast cells (kap95-ts) showed clear Snul 14p signal from the 
cytoplasm. D) Yeast cells with NMD5 deleted showed a slight increase of Snul 14p 
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Figure 4.12. U2 localisation in nuclear import mutant kap95-ts. 
Localisation of U2 snRNA in WT (W303a) and kap95-ts at 30°C and 37°C was detected with 
FISH. In the WT strain, U2 is consistently localised in the nucleus (A & B) in both 30°C 
and 37°C growth conditions. C) At 30°C, kap95-ts showed nuclear localised U2 snRNA, but 
also a detectable cytoplasmic U2 signal was observed. D) U2 was clearly detected in the 
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Figure 4.13. US localisation in nuclear import mutant kap95-ts. Localisation of U5 
snRNA in WT (W303a) and kap95-ts at 30°C and 37°C was detected with FISH. In the WT 
strain, US was detected in the predominantly in the nucleus, with a slight signal from the 
cytoplasm (A & B) at both 30°C and 37°C. At 30°C, (C) and 37°C (D) kap95-ts showed U5 
snRNA increased cytoplasmic signal. 
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Figure 4.14. U3 and U6 localisations in nuclear import mutant kap95-ts. Localisation of 
U3 snoRNA in kap95-ts yeast strain was consistently nucleolar, regardless of growth at 
permissive (A) or non-permissive (B) temperature. In 30°C growth conditions, U6 showed 
nuclear localisation in kap95-ts yeast strain, but when this strain was shifted to 37°C for 2 h, 
the U6 was found in both nucleus and cytoplasm. E) The WT (W303a) U6 nuclear 
localisation was not affected by the shift of temperature. 
M. 
4.8 Discussion 
In this chapter, I have identified that Prp8p aa96-117 encodes a functional NLS. Using a 
strain in which Prp8p is lacking this NLS, I looked into the localisation of other US snRNP 
proteins. Brr2p was consistently nuclear in both WT and LNLS Prp8p strains. In contrast, 
Snul 14p is in the nucleus in the WT strain and was delocalised to the cytoplasm in the 
LNLS Prp8p strain. This suggests that Brr2p nuclear localisation is Prp8p-independent, but 
that Snul 14p depends on Prp8p for its nuclear uptake or retention. The non-US snRNP 
components: U2 (Figure 4.40 & 4.4P), and U!, U6 snRNAs and the U6 core protein, 
Lsm8p, showed identical nuclear signals in both WT and ANLS Prp8p strains. In contrast, 
whereas US was predominantly in the nucleus in WT cells (Figure 43M), in the ANLS 
Prp8p strain, the US signal was increased in the cytoplasm (Figure 4.4N). 
Previous publications showed that the US snRNP is present in at least two forms. By 
using Aar2p as bait, Gottschalk and co-workers isolated a core US snRNP (Gottschalk et al., 
2001; Stevens et al., 2001). This core US snRNP consisted of Aar2p, Prp8p, Snull4p, Sm 
proteins, and US snRNA. At the same time, Stevens and co-workers isolated the more 
complex form of US snRNP by using Brr2p as bait. This U5 snRNP consisted of Brr2p, 
Prp8p, Snul l4p, Snu4Op, Prp28, Dibip, Sm proteins, and US snRNA. As shown by 
Gottschalk et al. (2001), Aar2p functions as an US snRNP re-cycling factor, as depletion of 
Aar2p abolished the later round of splicing in vitro. Interestingly, Aar2p was not precipitated 
by biotinylated pre-mRNA, suggesting that this protein is not involved in the precursor or 
active spliceosome (Gottschlak et al., 2001). Also, the immunoprecipitation of Brr2p did not 
detect the presence of Aar2p. This suggested that Aar2p was released from the US precursor 
complex before Prp8p associated with Brr2p to form a more complex U5 snRNP. In this 
case, the prp8-rp5 mutation may have two effects on US precusor and mature snRNPs 
transition, in which the binding between Prp8p and Aar2p is increased, and at the same time, 
the binding between Prp8p and Brr2p is decreased. Due to the reports of these two US 
snRNP complexes, I decided to look into the localisation of Aar2p and the Sm ring 
members: SmBlp, SmDlp, and SmEip. SmEip was localised predominantly in the nucleus 
in the WT Prp8p strain, and showed a slight increase in cytoplasmic signal in ANLS Prp8p 
strain. However, the SmBlp and SmDlp, which contain NI-Ss (Bordonne, 2000) were 
consistently localised in the nucleus. 
By immunoprecipitation of Prp8p, I showed that the levels of U4 and U6 snRNA 
that are bound to ANLS Prp8p were significantly down, unlike the level of co-precipitated 
US, which was comparable in mutant and WT, despite the fact that ANLS-Prp8p was 
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predominantly cytoplasmic. The reduction of tri-snRNP in the iNLS Prp8p strain, when 
compared to WT Prp8p strain, was observed as well in the glycerol gradient analysis. This 
suggests that the U5 snRNA might associate with Prp8p-Snul 14p to form a U5 precursor 
particle in the cytoplasm, that is imported into the nucleus where it forms a mature U5 
snRNP complex with Brr2p. This supports the existence of a cytoplasmic phase during the 
biogenesis of U5 snRNA in budding yeast. 
Aar2p was shown to be in both the nucleus and cytoplasm (Figure 4.4C). When 
Prp8p was over-expressed, Aar2p was found to be concentrated in the nucleus (Figure 4.5B, 
upper panel). When Prp8p was depleted, Aar2p was delocalised again to the cytoplasm 
(Figure 4.513, lower panel). This suggests that Prp8p functions in nuclear retention, or 
mediates the nuclear import of Aar2p. In Chapter III, I showed that Aar2p association with 
Prp8p was disrupted by one of the partition points of Prp8p (aa2 173). However, Aar2p was 
previously shown to be essential (Gottchalk et al., 2001), which suggests that the lethality of 
the yeast cell upon deletion of Aar2p may not be due to the disruption of association between 
Prp8p and Aar2p. As I proposed the formation of precursor US snRNP in the cytoplasm, I 
immunoprecipitated Aar2p and detected bound US snRNAs by Northern blotting. Despite 
the fact that iNLS Prp8p was delocalised to the cytoplasm, the U5 snRNA that was bound to 
Aar2p was increased in the pull-down when compared to the WT Prp8p pull-down (Figure 
4.5A). The increased amount of U5 detected could be due to the increased amount of US 
precursor complex that is deficient in nuclear import due to iNLS Prp8p. 
I also proposed that the mature U5 snRNPs are formed in the nucleus. Firstly, the 
nuclear localisation of Brr2p is not affected by the delocalisation of Prp8p (Figure 4.41). I 
utilised the yeast Prp8p mutants (rp), which are identical to human Prp8p mutants that cause 
Retinitis Pigmentosa (RP13) to support this proposal. The nuclear localisations of these 
Prp8p mutants are not affected by the mutation when the cells are grown at 30°C (Figure 
4.6C). This means that the precursor of Prp8p-Snul 14p-Aar2p-U5 that forms in the 
cytoplasm has no defect in nuclear import. The results also showed that the rp mutants are 
reduced in Prp8p and Brr2p binding (Figure 4.7A, lanes 8-10). In this situation, the binding 
of Brr2p to Prp8p was reduced, and Aar2p was precipitated in an increased level by Prp8p 
(rp mutants), when compared to the pull-down by WT Prp8p (Figure 4.8B, fractions 5-11). 
The data presented suggest that the rp mutations cause a defect in mature US snRNP 
formation, and increased levels of precursor US snRNP that localise to the nucleus. That 
Prp8p and Brr2p did not co-localise was rather surprising (Figure 4.9A, B & C), and the 
distributions of Brr2p in glycerol gradient centrifugation was not affected much by prp8-rp5 
protein (Figure 4. lOB), suggesting that the association of Prp8p and Brr2p could be transient, 
despite the strong interaction that was shown previously (Achsel et al., 1998). 
Subsequently, I identified Kap95p as the importin that is required for Snul 14p and 
snRNA (U2, U5, and U6) nuclear import. The Kap95p human homologue, Importin P, is 
required for U snRNP import in metazoa (Palacios et al., 1997) and for proteins containing a 
classical NLS. Saturation of importin n-mediated transport with the importin n-binding 
domain of importin a blocks U snRNP import both in vitro and in vivo. Immunodepletion of 
importin 0 inhibits both NLS -mediated and US snRNP import (Palacios et al., 1997). 
The following model is consistent with my observations (Figure 4.15). Prp8p-
Snul 14p-Aar2p-U5 complex exists as a U5 precursor particle in the cytoplasm, which is 
then imported into the nucleus, for which Kap95p is required. In the nucleus, Aar2p 
dissociates from the Aar2p-U5 complex, and subsequently the mature US snRNP complex 
with Brr2p is formed. The C-terminal region of Prp8p is required for this Brr2p association, 
as association between Prp8p and Brr2p is destabilised by the rp mutations in Prp8p. 










Figure 4.15. Model for US snRNP assembly pathway. In this model, the formation of the 
U5 snRNP precursor complex that consists of Prp8p-Snul 14p-Aar2p and US snRNA occurs 
in the cytoplasm. Deletion of the Prp8p NLS delays the nuclear import of this precursor US 
snRNP, thus immunoprecipitation and glycerol gradient analysis showed increased levels of 
this complex. The import of this complex is mediated by importin Kap95p. A temperature-
sensitive mutant of kap95 showed increased cytoplasmic accumulation of Snul 14p and US 
snRNA. Once the US precursor complex imported into the nucleus, Prp8p dissociates from 
Aar2p, and forms a more complex US snRMP with Brr2p. The C-terminal region of Prp8p is 
important in this association. Despite the fact that Prp8p C-terminus mutants (rp5, rpó, and 
rp7) showed no defect in Prp8p nuclear localisation, the mutants do show decreased Brr2p 
association and increased levels of Prp8p-Snul 14p-Aar2p complex. 
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Chapter 5 
Prp8p co-selected protein (Spp382p) analysis 
5.1 Introduction 
SPP382 is an essential gene on chromosome XII of S. cerevisiae (Giaever et al., 2002), and 
its product is present in the native splicing complexes (Pandit and Rymond, SGD). The 708 
amino acid (aa) long Spp382p has a molecular weight of 83 kDa, and contains a G-patch 
domain at aa6l-106 (Figure 5.1). The G-patch is found in a number of RNA binding proteins 
(Aravind and Koonin, 1999), which suggests that Spp382p may have an RNA binding 
function. Also, Spp382p was found on many occasions to be co-selected, or to have yeast-
two-hybrid interaction with other splicing factors (Gavin et al., 2002; Albers et al., 2003; 
I-Iazbun et al., 2003; Lebaron et al., 2005). Indeed, TAP tag affinity selection of Prp8p 
partition fragment (aa771-2413) also co-selected this protein (Figure 3.4A; Boon et al., in 
press in RNA). In addition, TAP tag purification using Spp382p as bait (Hazbun et al., 
2003) pulled down splicing factors from the US snRNP and the Prp19 complex. 
By using NCBI blast, Spp382p was shown to be conserved throughout many 
eukaryotes; Homo sapiens (GI:21619831), Canis familiaris (GI:57 105706), Gallus gallus 
(GI: 53135754), Mus musculus (GI: 10190660), Rattus norvegicus (GI: 56605648), Xenopus 
!a.evise (GI:51703472), and Schizosaccharomyces ponthe (GI:6523773). The Spp382p 
homologues in mouse (TFIP1 ip) and in S. ponthe (RAC; ribosomal assembly chaperone) 
show similarity with Spp382p throughout the protein (Figure 5.1). Recently, Wen et al. 
(2005) showed that mouse TFIP1 1 protein does not co-localise with any known splicing 
factors, indicating that the THP1 1 protein could have an as yet un-revealed function in 
splicing. Interestingly, the RAC complex exhibits no nuclease activity, and changes which 
disrupt RAC protein binding also inhibit Pacl nuclease cleavage at the 3' end of the 25S 
rRNA sequence (Spasov et al., 2002), which suggests a potential role for Spp382p in 
ribosomal RNA processing. The name SPP382 was given to the gene YLR424W to indicate 
its function in suppression of the prp38-1 mutation, which was found to be defective in 
spliceosome maturation (Xie et al., 1998). 
In this chapter, I demonstrate that Spp382p is spliccosome associated, as it co-
precipitated U2, US, U6, and excised intron. Depletion of Spp382p resulted in excised intron 
accumulation, and disruption of association of Prp43p and excised intron, which indicates 
that Spp382p is required for a late-stage of splicing. 
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Figure 5.1. The alignment of S. cerevisiae Spp382p with M.musculus (TFIP1 ip; 
01:21619831) and S. ponthe (RAC; GI:6523773) homologues. The sequences were 
identified using NCBI BLAST and then aligned using Clustal W (1.82). G-patch of S. 
cerevisiae Spp382p is underlined. According to Clustal W (1.82). 
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5.2 Co-immunoprecipitation of snRNAs and Spliceosome with Spp382p 
The association of Spp382p to snRNA was tested with co-immunoprecipitation of the 
spliceosomal U!, U2, U4, U5, and U6 snRNAs with Spp382-TAP protein. Splicing extracts 
(50 i.tl) from strain KL4T (Spp382-TAP tag), and non-TAP (BMA38a: negative control) 
were incubated with IgG-agarose and the co-precipitated snRNAs were detected by Northern 
analysis (as mentioned in 2.3.7). 
Under 150 mM salt precipitation conditions, Spp382-TAP tagged protein (KL4T) 
pulled down U2, US (L and 5), and U6 snRNAs, but no U! or U4 snRNAs (Figure 5.2A, 
Lane 4). As no ATP was added to the splicing extracts, this suggests that Spp382p associates 
with U2, U5, and U6 snRNAs under non-splicing conditions. The non-TAP extract that 
served as background control precipitated trace amounts of Ui (Figure 5.2A, lane 3), and the 
same Ui signal was observed in the tested sample. 
In order to determine the association of Spp382p with the spliceosome and pre-
mRNA, the Spp382-TAP tagged splicing extract was incubated under in vitro splicing 
conditions with radio-labelled pre-mRNA in a total of 60 RI splicing reactions (according to 
2.3.5), and then the 5pp382-TAP protein was precipitated with IgG-agarose. An aliquot of 
10 p.l splicing reaction mixture was analysed for splicing activity, while the remaining 50 p.1 
of splicing reaction mixture was incubated with IgG-agarose. Splicing extract with Prp8p 
TAP-tagged was used as the positive control, and non-TAP splicing extract was used as the 
background control. Prp8p is a US snRNP protein associated with the spliceosome 
throughout the splicing reaction and should therefore precipitate the pre-mRNA, 
intermediates, and products of the splicing reaction (Figure 5.213, lane 5), as shown 
previously by Teigelkamp et al. (1995). 
Compared to the Prp8p control, Spp382-TAP tagged protein efficiently co-
precipitated the pre-mRNA, and the excised intron (Figure 5.2C, lane 6). In extract without 
TAP-tagged protein, only very low levels of pre-mRNA was found in the precipitate (Figure 
5.213, lane 4), demonstrating the specificity of precipitation of Spp382p. These findings 
showed that Spp382p is associated with the spliceosome in the second catalytic step or later, 
when it is found associated with the excised intron. The precipitation of pre-mRNA by 
Spp382p could also suggest this protein could function as a recycling factor, which re-
assembles the other splicing factors onto pre-mRNA before the reoccurrence of splicing. 
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Figure 5.2. Spp382p associate with snRNAs and intron RNA 
(A) Co-precipitation of snRNAs with Spp382p. Splicing extracts (50 il) with non-tagged 
(BMA38a lane 3), or Spp382p-TAP (KL4T; lane 4) were mixed with an equal volume of 
precipitation buffer containing IgG-agarose beads and incubated at 4°C for 2 h. The beads 
were washed in buffer containing 150 mM NaCl, deproteimzed, and the RNAs were 
precipitated, blotted and probed for U!, U2, U4, US and U6 snRNAs. Total RNA extracted 
from 12.5 Rl  of each extract is shown in lanes 1-3. (B) Co-precipitation of splicing 
complexes by Spp382p. Splicing extracts derived from non-tagged (BMA38a; lanes 1 and 
4), Prp8p-TAP (RG8T: lanes 3 and 5), Spp382p-TAP (KL4T: lanes 3 and 6) strains were 
incubated under splicing conditions in vitro (60 jil total volume) with 32P-labeled ACT] pre-
mRNA as substrate. The reactions were stopped after 25 minutes and 10 p.1 were removed as 
the input controls. The remaining 50 p.1 were mixed with IgG-agarose beads and incubated at 
4°C for 2 h. Beads were washed in buffer containing 150 mM NaCl, deproteinized, and the 
RNAs were immunoprecipitated (IF). The RNAs were analysed by PAGE and 
autoradiography. The various RNA species are indicated diagrammatically on the right of 
panel B, with rectangles representing exons, a thin line representing the intron, and a 
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5.3 Depletion of Spp382p 
KL4G was used for further functional characterisation of the Spp382 protein. An interesting 
finding is that, despite the fact that SPP382 is required for cell viability, KL4G that was 
grown under repressive conditions (YPDA) only caused slow growth and formation of 
heterogenous colonies (Figure 53A). To analyse the effect of SPP382 turned off by GAL 
promoter, the KL4G was first grown in galactose medium and then shifted to glucose 
medium. As a control, a second culture was treated identically but was transferred back to 
galactose medium. Approximately two hours after the metabolic shift the growth of the 
culture was slowed considerably but the cells continued to grow slowly (approximately 4 
hours doubling time). 
A) 	 Vc3rp 	 YFDA 
Figure 5.3. A) KL4G was streaked on either a YPGR or YPDA plate, and incubated at 30°C 
for 4 days. KL4G grown on YPDA formed smaller, more heterogenous colonies when 
compared to KL4G that was grown on the YPGR plates. Growth rate of wild-type 
(BMA38a) and GAL::3HA-SPP382 (KL4G) strains following a transfer from permissive 
galactose medium to B) non-permissive glucose medium or C) galactose medium for the 
time indicated. Cells were grown at 30°C and maintained in exponential growth throughout 
the time course by addition of fresh medium. 
However, the splicing extract derived from KL4G shifted from galactose medium to 
glucose medium for 10 hr showed efficient depletion of Spp382p by Western blot analysis 
(Figure 5.413, lane 2) compared to KL4G that was grown in galactose medium (Figure 5.413, 
lane 1). Nopi protein that served as the loading control showed that approximately the same 
amount of depleted and non-depleted Spp382p splicing extract were loaded. In vitro splicing 
performed on Spp382p-depleted splicing extract showed accumulation of excised-intron, and 
reduced spliced mRNA (Figure 5.4C, Lane 6). Therefore, this suggests that Spp382p is 
required for excised intron metabolism in S. cerevisiae. Also, this suggests Spp382p could 
have a role in recycling the post-splicing components for a new round of splicing. 
The distribution of snRNPs in extracts from Spp382p-depleted and non-depleted 
cells was analysed by fractionation in glycerol gradients followed by Northern blotting. The 
most-dense fractions contained a mix of U4/U6.U5 tri-snRNPs, spliceosomes and/or post-
splicing complexes (Fig. 5.5A and B, fractions 1 to 5), then free U5 snRNP (fractions 5 to 9), 
U4/U6 di-snRNPs (fractions 9-13), and free U6 snRNP (fractions 15-19). 
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Figure 5.4. Effects of Spp382p depletion on splicing in vitro. KL4G cells were grown in 
YPGR medium to OD6 0.5, then spun down, washed with YPDA, respun, and resuspended 
in the original culture volume of YPDA and grown for 10 hours (the cells were maintained at 
log phase by adding fresh YPDA) before harvesting to produce a splicing extract. A control 
culture of KL4G was treated identically but was returned to galactose medium instead of 
glucose. A) Western blot showing the relative amounts of 3HA-tagged-Spp382p in KL4G 
cells at 0 h (lane 1) and at 10 hours (lane 2) after the shift to YPDA. Nopip was probed as a 
loading control. B) In vitro splicing assays with extracts derived from Spp382p-depleted 
(lanes 4 to 6) and non-depleted (lanes 1 to 3) cells. Aliquots (5 d) were withdrawn and 
halted after the incubation for 0, 10, and 25 min at 23°C. The RNAs were analyzed by PAGE 
and autoradiography. 
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In Spp382p-depleted extract there was a clear increase in the amount of U4 snRNA 
present in U4/U6 di-snRNP (Fig. 5.513, fractions 9-13), whereas the levels of free U5 snRNP 
(fractions 5 to 9), and free U6 snRNP (fractions 15-19) were reduced. The reduction of free 
US and U6 snRNPs (and presumably of free U2 snRNP, although this cannot be assessed 
with these gradients) and the accumulation of U4/U6 di-snRNPs suggests that free US and 
U6 snRNPs were not regenerated, as a consequence of the defective disassembly of post-
splicing U2/U5/U6 snRNP complex. Thus free US snRNP became the limiting factor for the 
conversion of U4/U6 di-snRNP to U4/U6.U5 tri-snRNP (as U6 snRNP is in excess), and 
presumably tri-snRNP and/or free U2 snRNP became limiting for spliceosome assembly. 
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Figure 5.5. Depletion of Spp382p leads to reduced free US and U6 snRNPs, but increased 
U4/U6 di-snRNPs and U2/U5/U6 snRNP complex. To examine the profile of snRNP 
distribution, (A) Spp382p non-depleted, and (B) Spp382-depleted extracts were centrifuged 
through 10-30% glycerol gradients and the snRNA contents of alternate fractions were 
analyzed by Northern blotting. Blots of the extracted RNAs were hybridized with probes for 
Iii, U2, U4, US, and U6 snRNAs. The sedimentation of US, U6, and U4/U6 is indicated. 
*Fractions 1 to 7 contain a mix of large complexes, including spliceosomes, U4/U6.U5 tn-
snRNPs and post-splicing complex. C) Co-precipitation of snRNAs by Prp8p in extracts 
from Spp382p-depleted (lanes 4 to 6) or non-depleted (lanes 1 to 3) cells. Pre-immune (P1) 
serum was used as background control. 
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Next, the Spp382-depleted and non-depleted extracts were incubated with anti-Prp8p 
antibodies. As expected, anti-Prp8p antibodies efficiently pulled down U5 5nRNP and 
U4/U6.U5 tn-snRNP from non-depleted extract (Figure 5.5C, lane 3). With Spp382p-
depleted extract, immunoprecipitation of Prp8p pulled down an eight-fold increased amount 
of U2 (compared to non-depleted extract and normalized against the total amounts in each 
extract), but only half the amount of U4 (Figure 5.5C, lane 6), and an equivalent amount of 
U6. The increased association of Prp8p with a U2 snRNA-containing complex and decreased 
association with U4 snRNP in Spp382-depleted extract most likely reflects accumulation of 
Prp8p in the U2/U5/U6 post-splicing excised intron-containing complex. 
5.4 Spp382p distribution and association with Prp43 protein 
The distribution of Spp382p in splicing extract derived from KL4G (strain with SPP382 
expressed under PGJ  promoter and triple-HA fused at the 5' end) and KL4T (strain with 
SPP382 TAP tag at the C-terminal) was investigated by glycerol gradient centrifugation (as 
described in 2.8). The glycerol gradient fractions were immunoprecipitated by anti-HA 
(KL4G) or IgG (KL4T) agarose, fractionated in a 4-12% PAGE gel, blotted, and probed with 
anti-HA (KL4G), or PAP for KL4T. Spp382p was found distributed in a broad range of 
fractions (Figure 5.6 A&B, lanes 1-21). The extra bands (Figure 5.2A, lanes 5-21) below 
Spp382p (*) were also observed in KL4T (strain with SPP382-TAP tagged) derived extracts 
(Figure 5.6 B, lanes 5-2 1). This could be an isoform of Spp382p, as the Spp382p mouse 
homolog (THP1 ip) was highly phosphorylated (Wen et al., 2005). 
Prp8p and the excised intron release factor, Prp43p, are amongst many proteins that 
have been found in affinity-selected complexes along with Spp382p (Gavin et al., 2002; 
Hazbun et al., 2003). To investigate this further, extract from KL4G cells was fractionated 
on a glycerol gradient and alternate fractions were analysed by precipitation with anti-HA 
antibodies, which showed co-precipitation of Prp8p and of Prp43p with 3HA-Spp382p in the 
same high density fractions 1 to 9 (Fig. 5.6C). As Spp382p pulls down Prp8p and Prp43p in 
the same high density fractions, it is most likely that these 3 proteins are present in the same 
high molecular weight complex. In addition, it is notable that the bulk of Spp382p and 
Prp43p occur in lower density fractions (Figure 5.6C, fractions 13-21). This likely represents 
an Spp382p/Prp43p complex that is non-snRNP-associated. Indeed, an interaction between 
Spp382p and Prp43pl.lA  could be demonstrated in the absence of other yeast proteins 
(Figure 5.61)). The Prp43p flA  was an ATPase-defective Prp43p that interfered in trans with 
the in vitro splicing function of wild-type Prp43. Prp43pfl23A did not affect the chemical 
steps of splicing or the release of mature mRNA from the spliceosome. However, it blocked 
the release of the excised lariat-intron from the spliceosome (Martinet al., 2002). 
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Figure 5.6. Glycerol gradient fractionation of Spp382p. KL4G cell extract containing A) 
triple-HA tagged Spp382p or B) C-terminal TAP tag was fractionated in a 10-30% glycerol 
gradient. Alternate gradient fractions were immunoprecipitated with (A) anti-HA agarose or 
(B) IgG agarose. The precipitated proteins were analyzed by Western blotting with (A) anti-
HA or (B) PAP. Asterisk (*) indicates the presence of alternate Spp382p bands. C) KL4G 
cell extract was fractionated in a 10-30% glycerol gradient and immunoprecipitated with 
anti-HA agarose as mentioned in (A), and the precipitated proteins were analyzed by 
Western blotting with affinity purified anti-Prp43 antibodies and with anti-Prp8p antibodies. 
D) PrP43TlA protein was incubated with recombinant GST-Spp382p or with GST alone at a 
concentration of 40 pg of each protein/mi. Following incubation with glutathione-Sepharose 
in IPP buffer (6 mM HEPES, pH7.9, 150 mM NaCl, 5 mM MgCl2, 0.1% (v/v) Nonidet 
P40), the beads were washed, incubated with SDS loading buffer. The precipitates were 
fractionated on a 4-12% PAGE gel and Western blotted, and probed with affinity purified 
rabbit anti-Prp43p antibodies, and rabbit anti-GST antibodies. (The Prp43.T l A protein is a 
stock protein in Beggs lab that was expressed and purified by Mr. A. Droop during his 
honours project in year 2003, Beggs lab). 
5.5 Spp382p mediates Prp43p function in post-splicing complex 
Figure 5.7 is provided by Dr. Gretchen Edwalds-Gilbert (a collaborator on the study of 
Spp382p). 
Martin et al. (2002) produced an ATPase defective mutation T123A in conserved motif I of 
the Prp43 RNA helicase that confers a dominant negative phenotype. The Prp43TlA protein 
interfered in trans with the in vitro splicing function of the wild-type Prp43 protein, blocking 
release of the excised-intron from the spliceosome (Martin et a!, 2002). We used purified, 
recombinant Prp43T1A protein to test whether Prp43p is able to associate with the post-
splicing excised intron complex produced in reactions with Spp382-depleted and non-
depleted extracts. As a control, anti-Prp8 antibodies were used to test for effects of Spp382-
depletion on the association of Prp8p with the excised intron. In Spp382-depleted extract, 
with or without addition of recombinant PrP43T1A  protein, Prp8p co-precipitated excised-
intron (Figure 5.7, lane 14). In contrast, Prp43TIA protein only co-precipitated excised-
intron from cell extract containing Spp382p (Fig. 5.7, lane 5). 
These results show that the presence of Spp382p is required for the interaction of 
Prp43p with the post-splicing excised intron complex and explains the observed 
accumulation of excised intron complex in Spp382-depleted extract. 
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Figure 5.7. Splicing extracts with depleted or non-depleted 3HA-Spp382p were incubated 
under splicing conditions in vitro with 32P-labeled ACT] pre-mRNA as substrate. The 
reactions were stopped and incubated at 4°C for 2 h with anti-8.6 or anti-Prp43p (antibodies) 
absorbed sepharose A beads in 150 mM NaCl. The precipitates were deproteinized, and the 
RNAs were analysed by PAGE and autoradiography. 
5.6 The localisation of Spp382p, and Prp43p in relation of Spp382p expression level 
Using endogenously expressed or over-expressed Spp382p yeast strains, the localisation of 
Spp382p in relation to its expression level was tested. The endogenous Spp382p-expressing 
strain was constructed by tagging the C-terminal of Spp382p with the TAP tag. By indirect 
immunoflourescent, Spp382p was shown to be nuclear localised (Figure 5.8A): the 496-
diamidino-2-phenylindole (DAPI) staining of DNA merged with the immunostaining 
obtained with anti-Protein-A primary antibodies. The over-expressing Spp382p strain 
(YLR424W::nat, [pGFP-N-424], otherwise as BMA38a) was constructed by inserting a 
plasmid (pGFP-N-424) encoding SPP382 with a GFP tag at its N-terminus, and under the 
control of P 5 promoter, while the endogenous SPP382 was deleted with natMX6. 
Surprisingly, the localisation of Spp382p was sub-nuclear (Figure 5.813). The mouse 
homolog of SPP382, TFIP1 1, was recently shown to be sub-nuclear localised in transfected 
cells (HEK293) (Wen et al., 2005). However, TFIP1 1 protein showed no co-localisation 
with any splicing factors tested so far: SC35 nuclear speckles, paraspeckles, Cajal bodies, 
Sm, hnRNP, PML, and Sam68 (Wen et al., 2005). 
The in vitro co-precipitation (Figure 5.613) showed that Spp382p interacts directly 
with Prp43p in the absence of other yeast proteins. To further the localisation analysis, I 
decided to investigate the localisation of Prp43p in relation to Spp382p expression level. 
Normally, Prp43p is localised in the nucleolus (SGD). Interestingly, in Spp382p 
overexpressed cells (KL4G), Prp43p showed aggregated sub-nuclear or sub-nucleolar 
staining (Figure 5.8C). When Spp382p expression is repressed (KL4G galactose to glucose 
shift for 4 hi), the Prp43p was relocalised to the nucleolus (Figure 5.8D). 
The Prp43p foci could potentially be part of a complex containing Spp382p, as 
overexpressed GFP-Spp382p also showed aggregated nuclear staining. In addition, the 
aggregates could also be present in the nucleolus (Figure 5.8C), but further localisation with 
a nucleolar marker is needed for this hypothesis. Interestingly, depletion of Spp382p in strain 
KL4G by galactose to glucose medium shift (2 hi) showed accumulation of 35S rRNA, 
whereas the parent strain (BMA38a) did not show any 35S rRNA accumulation (Christophe 
Dez, unpublished data). This suggests that Spp382p could potentially function in both rRNA 
processing and spliceosome processing. However, the accumulation of 35S rRNA in 

















Figure 5.8. Spp382p localisations. A) Endogenous Spp382p-TAP expressing yeast cells 
(KL4T) immunoflourescent staining revealed Spp382p nuclear localisation. B) Over-
expressed GFP-Spp382p yeast cells showed GFP-Spp382p sub-nuclear localisation. C) 
Prp43p was probed with affinity purified rabbit anti-prp43p antibodies, and then detected by 
anti-rabbit Alexa-fluor594 secondary antibodies. Prp43p showed aggregate nuclear staining 
in 3HA-Spp382p overexpressed yeast cells (KL4G that growed in YPGR). D) Prp43p was 
detected as mentioned in C), Prp43p was showed nucleolar staining in yeast cells (KL4G) 
that were shifted from YPGR to YPDA for 4 hr. 
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5.7 Discussion 
The precipitation of U2, US, U6 (Figure 5.2A), and mainly excised intron (Figure 5.213) by 
Spp382p suggests that the protein is present in post-splicing complex. Indeed, the depletion 
of Spp382p not only caused accumulation of excised intron following splicing in vitro 
(Figure 5.413, lane 6), but also reduced the levels of free US and U6 snRNPs (Figure 5.513, 
lanes 5-7 & lanes 15-19). In contrast, the levels of U4/U6 di-snRNPs were increased (Figure 
5.513, lanes 9-13). The snRNAs in splicing extracts derived from Spp382p-depleted cells 
showed increased levels of U2, but decreased levels of U4, pulled down by Prp8p (Figure 
5.5C, lane 6). All these data suggest that Spp382p is needed for snRNP regeneration. 
By micro-array analysis (Barrass and Beggs, unpublished data), Spp382p-depleted 
cells showed an increase of unspliced pre-mRNAs. Using a new method of micro-array 
analysis that targeted the lariat-intron structure of mRNA, David Barrass (unpublished 
results) showed that the lariat.-intron forms of mRNA were increased in vivo when Spp382p 
was depleted (the depletion of Spp382p was performed as mentioned in section 5.5). 
Spp382p-TAP purification showed that this protein associated with US snRNPs and 
the Prp19 complex (Hazbun et al., 2003). Indeed, this protein co-purified with Prp8p (Figure 
5.6C, lanes 1-9). In addition, this protein also interacts with Prp43p (Hazbun et al., 2003; 
Gavin et al., 2002), which was previously reported as a post-splicing complex disassembly 
factor (Arenas and Abelson, 1997; Martin et al., 2002). Interestingly, McPheeters and 
Muhienkamp (2003) reported an unidentified 80-kDa protein cross-linked near the branch 
site sequence upon completion of the second step of splicing. The predicted size of Spp382p 
is 83 kDa, and its function in late stage splicing and excised intron precipitation suggests the 
potential for Spp382p to be the unidentified protein, but this would need more biochemical 
proof in the future. 
Yeast cells with the SPP382 gene under the control of regulatable PGAJ  promoter 
were shown to be able to grow slowly in glucose medium (Figure 53A). A similar situation 
was found in cells with the PRP43 gene under the PGAL  promoter, in which Prp43p was not 
efficiently depleted under the galactose-regulated promoter (Martin et al., 2002). This 
suggests that yeast cells could survive with only minute amounts of Spp382p, possibly due 
to leaking of the PGJ  promoter. 
Spp382p was named after the role of this protein in prp38-1 suppression (SGD). 
Prp38p is the first tri-snRNIP-specific protein that has been shown to be dispensable in 
spliceosome assembly, but required for spliceosome maturation (Xie et al., 1998). The 
depletion of Prp38p caused a splicing complex maturation defect with accumulation of 
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U4/U6, and the temperature sensitive prp38-1 strain accumulated RP51A pre-mRNA in vivo 
at non-permissive temperature (Xie et al., 1998). The suppression of prp38-1 by Spp382p 
suggests an additional role(s) of this protein in splicing complex maturation. 
Spp382p and Prp43p co-fractionated in snRMP-free fractions from a glycerol 
gradient, therefore they can apparently co-exist in a protein complex that may or may not 
contain other proteins. As the purified recombinant GST-Spp382p interacts with purified 
recombinant Prp43pflA , this is a direct interaction that does not require any other yeast 
protein. Thus Spp382p is a candidate cofactor for the Prp43 helicase and apparently targets it 
to the post-spliceosome complex. Spp382p contains a G-patch domain (Aravind and Koonin, 
1999) near its N-terminus (amino acids 61 to 106) that is the most highly conserved region 
of this protein. It will be interesting to determine whether the G-patch in Spp382p binds 
RNA and functions to promote the interaction of Prp43p with the intron RNA in the post-
spliceosome complex. 
As a splicing factor, Spp382p nuclear localisation (Figure 5.8A) is expected. But the 
detection of Spp382p in sub-nuclear bodies (Figure 5.813) when this protein is over-
expressed is rather surprising. Furthermore, these sub-nuclear bodies did not co-localise with 
any other known splicing bodies in yeast or mammalian cells (Wen et al., 2005) indicates 
this could be a new uncharacterized splicing structure. However, yeast two hybrid results 
(Tsai et al., 2005) showing that Spp382p bait interacted with Spp382p prey can give a 
different explanation. This suggests that Spp382p could self-interact, and the sub-nuclear 
bodies could be due to the self-interacting Spp382p aggregates. The aggregated staining of 
Prp43p in Spp382p overexpressed condition (Figure 5.8C), and the fact that these two 
proteins could directly interact without any additional yeast protein suggests that the 
aggregates of Prp43p could be in a complex with Spp382p. However, further co-localisation 
study is needed to confirm this assumption. 
Chapter 6 
Final Discussion & Future Work 
The Prp8 protein is at the catalytic centre of the splicing machinery (section 1.7). Despite the 
fact that identification and analysis of this protein began in the 1980s, the complete function 
and mechanism of this protein in modulation of pre-mRNA splicing still remain to be 
elucidated. The large size of this protein with its lack of obvious domains, and its conserved 
homology across eukaryotes, emphasised the importance of analysis and understanding of 
this protein. 
In this study, I have utilised Prp8p partitioned clones (chapter 3) to reveal the 
protein-protein interaction sites between Prp8p and related splicing factors. This led me to 
identify that the Prp8p 437-770aa polypeptide associates with Snul 14p. Also, partitioning of 
Prp8p at position 2173 amino acid disrupts the Prp8p-Aar2p association. In addition, I have 
confirmed that the association of Snul 14p and Aar2p with Prp8p are not interdependent 
(Boon et al., in press in RNA). 
Assembly of the metazoan U snRNPs involves a multi-step process (section 1.6). On 
the other hand, the yeast U snRNP assembly pathway is still unclear. In chapter 4, 1 proposed 
a model for the yeast US snRNP assembly pathway: Prp8p associates with Snul 14p, Aar2p, 
and U5 snRNA in the cytoplasm, the import of this cytoplasmic US snRNP is mediated by 
Kap95p, and the association of Prp8p and Brr2p occurs in the nucleus. In addition, Prp8p C-
terminus mutations that resemble human Prp8p mutations in Retinitis Pigmentosa (RP) type 
13 decreased the association between Prp8p and Brr2p, and the RP mutations in yeast Prp8p 
resulted in increased levels of the Prp8p-Snul 14p-Aar2p complex. 
The affinity purification of Prp8p co-selected an uncharacterised protein, Spp382p 
(chapter 3, figure 3.4A). In chapter 5, I showed that the Spp382 protein immunoprecipitated 
the U2, US, U6 snRNAs, and excised-intron. Furthermore, the metabolic depletion of this 
protein resulted in accumulation of excised-intron. The Spp382 protein showed direct 
interaction with Prp43p, which is also a protein involved in late-stage of splicing (Martin et 
al., 2002). Interestingly, excised intron was not associated with Prp43p in the absence of 
Spp382p, but remained in a Prp8p-associated complex (Edwalds-Gilbert and Beggs, 
unpublished data). This suggested that Spp382p could function as a receptor, or by 
modulating the position of Prp43p in the late-stage of splicing to target the excised intron 
upon completion of the second step of splicing. 
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6.1 Future work - Part one 
A U5 snRNP assembly pathway model was proposed based on the analyses performed in 
chapter 4 (Figure 4.15). Interestingly, Prp8p co-selected Mlp2p through TAP tag purification 
(KL-Boon and D. Short, unpublished data). And both Prp8p and Mlp2p showed punctate 
perinuclear staining (Galy et al., 2004). Increased levels of Prp8p-Snul 14p-Aar2p complex 
accumulate in the nucleus in prp8-rp5 cells, and this complex might co-localise with Mlp2p 
in the pen-nuclear region. If true, this would suggest that Mlp2p might serve as a platform 
for Prp8p (Prp8p-Snul14p-Aar2p) before the formation of mature U5 snRNP with Brr2p. 
Interestingly, Mlp2p was shown to have the function of pre-mRNA nuclear retention 
(Galy et al., 2004). However, Mlp2p was not known to have any RNA binding function. On 
the other hand, Prp8p was previously shown crosslinked to pre-mRNA 5' splice site even in 
the absence of US loop 1 (which anchors the exons of pre-mRNA in splicing in vitro; section 
1.7). Based on the information stated above, Mlp2p could potentially dock Prp8p and its 
associated complex at the edge of the nucleus and, later Prp8p could prevent the leakage of 
pre-mRNA from the nucleus by binding pre-mRNA that is close to the pore site and 
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Figure 6.1. 
The proposed model for future analysis of the US snRNP assembly pathway. 
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6.2 Future work - Part two 
In chapter 5, 1 analysed the Prp8p co-selected protein, Spp382p. Later, this protein was 
shown to function in the late-stage of splicing. Interestingly, in Spp382p-depleted extract, 
Prp43p was not able to pull down the excised-intron (Edwalds-Gilbert and Beggs, 
unpublished data). Despite the fact that Prp43p is needed for post-splicing complex 
disassembly through its helicase activity (Martin et al., 2002; Arenas and Abelson, 1997), 
the direct binding of Prp43p to RNA substrate (snRNA, pre-mRNA, or excised intron) was 
not shown. Interestingly, Spp382p includes a G-patch domain (aa6l-106), and showed a 
direct binding to Prp43p in the absence of other yeast proteins (Figure 5.613). Therefore, it is 
possible that Spp382p binds to excised-intron, or even base-paired U2/U6 in the post-
splicing complex, and then serves as a platform for Prp43p, so that this protein can target the 
excised-intron or U2/U6 for unwinding or disassembly. The model for this hypothesis is 




The propose model of future work for analysis of the function of Spp382p in orienting 
Prp43p in U2/U6 or excised-intron release. 
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ABSTRACT 
We describe a novel approach to characterize the functional domains of a protein in vivo. This involves the use of a custom-built 
Tn5-based transposon that causes the expression of a target gene as two contiguous polypeptides. When used as a genetic screen 
to dissect the budding yeast PRP8 gene, this showed that Prp8 protein could be dissected into three distinct pairs of functional 
polypeptides. Thus, four functional domains can be defined in the 2413-residue PrpB protein, with boundaries in the regions of 
amino acids 394-443, 770, and 2170-2179. The central region of the protein was resistant to dissection by this approach, 
suggesting that it represents one large functional unit. The dissected constructs allowed investigation of factors that associate 
strongly with the N- or the C-terminal Prp8 protein fragments. Thus, the 1J5 snRNP protein Snul 14p associates with Prp8p in the 
region 437-770, whereas fragmenting Prp8p at residue 2173 destabilizes its association with Aar2p. 
Keywords: protein domains; protein interaction; RNA splicing; snRNP; transposon mutagenesis 
INTRODUCTION 
Studies of the structure, function, and molecular interac-
tions of very large proteins are often hindered by the diffi-
cult) in obtaining sufficient quantities of the intact protein. 
On the other hand, many proteins appear to have been 
assembled from several independently folding domains, 
each of which has a distinct function, such as catalysis, 
ligand-binding, protein or nucleic acid interaction, or 
membrane-spanning properties (Doolittle 1995). Thus, 
the ability to identify and isolate individual protein do-
mains offers a reductionist approach to facilitate protein 
characterization. However, in the absence of clear structural 
features it may be difficult to recognize domain structure in 
a protein. We describe here a novel approach to character-
ize the functional domains of a protein in vivo, using a 
custom-built Tn5-based transposon that causes the expres- 
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sion of a target gene as two contiguous polypeptides that 
must function in trans. We used this approach to investi-
gate the domain structure of the large (280 kDa in budding 
yeast) spliceosomal protein, Prp8p. Prp8p is known to have 
multiple interactions in ribonucleop rote in (RNP) com-
plexes, including the spliceosome (for review, see Grainger 
and Beggs 2005); however, despite the high level of con-
servation of this essential splicing factor, informatic analysis 
has provided few clues as to its likely domain structure. 
The spliceosonie is a dynamic complex that catalyses 
nuclear pre-mRNA splicing. It assembles on the pre-
mRNA in a series of steps, in which the UI, U2, U4, US, 
and U6 snRNAs in the form of small RNP particles 
(snRNPs) and a variety of non-snRNP proteins associate 
with the pre-mRNA. Prp8p is the largest and most highly 
conserved spliceosomal protein. Biochemical, genetic, and 
two-hybrid interaction data indicate that l'rpSp interacts 
physically and/or functionally with a large number of splic-
ing factors. It is a component of the US snRNP, a U5 
5nRNP/Prpl9p complex, the U5U4/U6 tri-snRNP, and 
the spliceosome (Grainger and Beggs 2005). It contacts 
the catalytic center of the spliceosome, as detected by 
photochemical cross-linking to functionally important 
regions of the US and U6 snRNAs and to the 5' splice site, 
the 3' splice site, and the branch point of the pre-mRNA 
(for review, see Grainger and Beggs 2005). In addition, 
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Prp8 protein dissection 
Prp8p has been implicated as a regulator of several con-
formational rearrangements in the spliceosome (Newman 
1997; Staley and Guthrie 1998; Collins and Guthrie 1999; 
Brow 2002; Kuhn et al. 2002). Achsel et al. (1998) showed 
that human Prp8p (hPrp8p) forms a stable RNA-free core 
complex with hl 16K (ySnul 14p),  h200K (vBrr2p), and 
h40K (no known yeast homolog). Thus Prp8p may func-
tion as a large protein scaffold in the spliceosome and play a 
key role at its catalytic center. 
Further characterization of Prp8 protein function(s) 
would be facilitated by knowledge of the domain structure 
of this very large 2413-residue protein. However, the 
sequence of Prp8p is largely novel and reveals little about 
the protein's domain structure or its possible biochemical 
activities. We show here, using a novel random transposon 
insertion strategy, that the PRP8 gene of Saceharomyces 
cerevisiae can be dissected at any one of three positions 
(amino acids 394-443, 770, and 2170-2179), such that the 
yeast Prp8p can function as pairs of separate, interacting 
polypeptides. These dissected constructs 
allowed us to identify amino acids 437-
770 of Prp8p as being associated with 
Snul 14p, whereas disruption of Prp8p at 
2173 interferes with its association with 
Aar2p. The central region of Prp8p, from 
amino acids 770 to 2173, was resistant 
to dissection by this approach, suggest-
ing that it represents one large function-
al unit. 
signal (NLS). Insertion of this transposon will generally be 
lethal for five out of the six possible reading frames because 
in functional terms the gene will he truncated. However, in 
the remaining frame the transposon will direct the synthesis 
of an NLS-tagged downstream polypeptide fragment, 
resulting in two separate polypeptides encoded by distinct 
mRNAs. 
We reasoned that if Prp8p does indeed have a modular 
structure, a small fraction of transposon-dissected genes 
might he functional. For example, if the transposon inserted 
in a region between essential functional modules, the two 
Prp8p fragments might fold independently and associate 
with each other and/or with other spliceosome components 
to perform the protein's essential functions. We screened 
for functional transposon-dissected alleles of prp8 via plas-
mid shuffle in a yeast strain carrying a deletion of the 
chromosomal copy of PRP8. An estimated 60,000 transpo-
sition events occurred, of which at least 40,000 were located 
within the PRP8 open reading frame (i.e.,•n average of five 
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FIGURE 1. Structure of the gene dissection transposon and dissected prp8. The transposon 
ss . as custons-huilt from three main components: (I PRP8 gene downstream flanking region 
DFR) containing signals for transcription termination, polyadenvlanon, and stop codons in all 
three reading frames; (2) KanMX4 cassette (Wach et al. 1994) conferring Kanamycin-resistance 
in Esc/tericliia co/i and G418-resistance in yeast ( KanMX4); ( 3) PRP8 gene upstream flanking 
region (LJFR) containing signals for initiation of transcription and translation. The transposon 
is flanked by 19 bp 'Mosaic End' (ME) sequences recognized by Tn5 transposase. An example 
of the structure of one of a library of transposon-dissected prp8 genes is shown (not to scale). 
The transposon terminates transcription and translation of the upstream prpS gene sequences 
and drives expression of the prp8 gene sequences downstream, producing two contiguous 
protein fragments via translation of two separate mRNAs. Each fragment is tagged at its N 
terminus with a nuclear localization signal (NLS). The disrupted alleles were introduced into 
the TAP-tagged chromosomal copy of PRPS in yeast strain RG8l by homologous recombina-
tion using PCR-amplified DNA; the outer primer set was for partition after codon 436, and the 
inner primer set was for partition alter codons 770 and 2173 to avoid generating the 9-bp direct 
repeat (DR) generated during transposition. 
RESULTS 
Transposon insertion to dissect PRP8 
Our approach involves the random 
insertion of a custom-built Tn5-based 
transposori into the PRP8 gene to create 
a library of thousands of prp8 genes, 
each with a transposon sequence inter-
rupting the open reading frame. The 
transposon sequence is designed to ter -
minate translation of the upstream read-
ing frame and at the same time drive 
expression of the prp8 sequence down-
stream of the site of insertion. The trans-
poson consists of four elements (Fig. I 
inserted between the "Mosaic End" 
recognition sequences for Tn5 Tratis-
posase: (1) PRP8 gene downstream flank-
ing region; (2) Kan or KanMX4 cassette 
to mark the transposon in bacteria or 
yeast, respectively; (3) PRP8 gene 
upstream flanking region, including the 
promoter; and (4) translation start site 
upstream of an SV40 nuclear localization 
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FIGURE 2. TAP purification of Prp8-associated proteins. (A) TAP-
purified proteins were fractionated in a 4%-12% PAGE gel and 
analyzed by mass spectrometry. (B) Effect of salt on the association 
of the pairs of dissected Prp8 polvpeptides. Splicing extracts were 
incubated with lgG-agarose in the presence of 150, 300, or 500 mM 
NaCl. Proteins were fractionated, blotted, and probed with anti-8.6 
antibodies. (Lanes 1) Nontagged full-length Prp8p, (lanes 2) Tap-
tagged full-length Prp8p, (lanes 3) TAP-tagged Prp8p dissected at 
residue 770, (lanes 4) TAP-tagged Prp8p dissected at residue 2173. 
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to six transposition events per nucleotide of coding se-
quence), and DNA digests showed a broad spread of in-
sertion points (data not shown). As expected, the majority 
of prp8 alleles carrying a transposon were unable to support 
growth, but a small number did survive the selection. The 
prp8::Tn plasmids from these strains were isolated and 
retested, and the transposon locations were determined by 
restriction mapping and DNA sequencing. 
Several transposons mapped within the first 80 residues 
of Prp8p, a region containing multiple Proline-rich tracts 
that are found only in plant and fungal Prp8 proteins 
(Grainger and Beggs 2005) and are not essential in yeast 
(K.-L. Boon and J.D. Beggs, unpubl.); these alleles were not 
analyzed further. Of the remaining gene dissection points, 
several mapped close together in the vicinity of amino acids 
394-443 (specifically, after codons 394, 413, 416, 428, 436, 
and 443), and there were functional alleles with transposons 
inserted after codons 770, 2170, and 2179. Significantly, we 
screened through many thousands of transposons in the 
interval between 770 and 2170 in Prp8p in an effort to 
identify additional viable alleles, but none emerged. Wes-
tern blotting confirmed that Prp8p fragments of the 
expected sizes were produced in place of full-length 
Prp8p, and sequence analysis showed that the trarisposon 
was inserted in the correct frame to drive expression of an 
NLS-tagged downstream Prp8p fragment (data not shown). 
Finally we found by subcloning fragments of dissected pip8 
genes to separate plasmids and transforming them individ-
ually into yeast cells that for each dissected prp8 allele, 
expression of both the N- and the C-terminal Prp8p frag-
ments was required for growth (data not shown). 
TAP-tag purification of Prp8p complexes 
Yeast strains were constructed in which PRP8 is C-termin-
ally TAP-tagged (Prp8T) and dissected immediately after 
codon 436 (strain KL8TG/436 produces Prp8T/436p, con-
sisting of polypeptides 1-439 plus 437-2413), codon 770 
(strain KL8T/770 produces Prp8T/770p, consisting of poly-
peptides 1-770 plus 771-2413), or codon 2173 (strain 
RG8T/2 173 produces Prp8T/2173p, consisting of polypep-
tides 1-2173 plus 2174-2413). Western blotting confirmed 
that the Prp8p C-terminal fragments produced in the wild-
type and the dissected strains were the expected sizes (data 
not shown, but see below). When tested for growth at 
various temperatures (18' , 23, 30°, and 37CC) the strains 
producing full-length Prp8p (BMA38a and RG8T) or Prp8/ 
2173p grew at all the temperatures, although the Prp8T/ 
2173 strain grew more slowly, and the strains producing 
Prp8T/436p or Prp8T/770p were slow-growing and heat-
sensitive, failing to grow at 37°C (data not shown). 
To determine the extent to which Prp8p complexes were 
intact or were disrupted by the dissection, extracts from 
parent (RG8T) and dissected strains, KL8T/770 and RG8T/ 
2173, were subjected to the TAP affinity-selection proce- 
dure (Rigaut et al. 1999) and the coselected proteins were 
separated by SDS-PAGE and analyzed by mass spectro-
metry. Proteins that were coselected with full-length 
Prp8p included Aar2p, Brr2p, Prp3p, Prp4p, Prp6p, and 
Snul 14p, and several Sm and Lsm proteins (Fig. 2A). These 
represent a subset of the proteins that were previously 
shown to be components of the U5 snRNP or U4/U6.U5 
tri-snRNP (Gottschalk et al. 1999; Stevens et al. 2001, 2002). 
The Prp8T/770p C-terminal fragment (771-2413) cose-
lected Aar2p, Brr2p, Prp3p, Prp4p, Prp6p, and Spp382p. 
The Prp8T/2173p C-terminal (2174-2413) coselected a 
protein similar in size to Brr2p, whereas other coselected 
proteins were in very low abundance due to the reduced 
stability of this complex. Association of Brr2p with the 
extreme C terminus of Prp8p was observed previously in 
two-hybrid interaction studies (van Nues and Beggs 2001). 
Interestingly, Snul 14p was hardly detectable in associa-
tion with Prp8T/770p, whereas the amount of Aar2p asso- 
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ciated with Prp8T/770p was increased compared to the full-
length Prp8p. Aar2p was previously found associated with a 
16S form of yeast U5 snRNP that contained Prp8p, 
Snu 1l4p, and the Sm proteins but lacked other known 
Prp8-associated proteins, including Brr2p. It was suggested 
that the Aar2-U5 snRNP complex represents an intermedi-
ate particle in U5 snRNP biogenesis (Gottschalk et al. 
2001). Also, Spp382p was associated with Prp8T/770p but 
was not detectable with full-length Prp8p or Prp8T/2173p. 
Spp382p has been affinity-selected previously with Prp8p 
and other splicing factors (Gavin et al. 2002) but is not 
known to be a stable component of U5 snRNPs. Thus, 
Prp8T/770p produced a different profile of coselected pro-
teins compared to full-length Prp8p and this likely includes 
an Aar2p-U5 snRNP precursor complex related to that 
described by Gottschalk et al. (2001). 
As Western blotting indicated that the N-terminal frag-
ments (1-770 and 1-2173) were detectable in the TAP-
purified fraction, albeit at a low level (data not shown), 
the effects of different salt concentrations were tested in 
order to establish conditions that gave complete separation 
of the N- and the C-terminal Prp8p fragments. The Prp8p 
C-terminal TAP-tagged fragment was affinity-selected using 
IgG agarose beads, and the presence of the Prp8p N-term-
inal fragment in coprecipitates was investigated by Western 
blotting with anti-8.6 antibodies (which recognize the N-
terminal fragments of Prp8p but also interact with the 
protein A moiety of the TAP-tag on the C-terminal frag-
ments). This single-step affinity selection in the presence of 
150 mM or 300 mM salt did not disrupt the association of 
the N- and the C-terminal Prp8p fragments; however, with 
500 mM salt, only C-terminal TAP-tagged Prp8p polypep-
tides were selected (Fig. 213). It should be noted that 500 
mM salt also disrupted the association of the U5 snRNA 
with Prp8p (data not shown). 
Association of Snul 14p and Aar2p with Prp8p 
The association of N- and C-terminal fragments of Prp8p 
with other splicing factors was investigated in the presence 
of 500 mM NaCl. TAP-tagged C-terminal Prp8p fragments 
were pulled down with IgG-agarose, and the supernates 
were then incubated with anti-8.6 antibodies to pull down 
the N-terminal Prp8 polypeptides (Fig. 3A), and these 
immune precipitates were analyzed by Western blotting 
for the presence of Prp8p N-terminal fragments, Snul 14p, 
or Aar2p (Fig. 3). 
Snull4p was detected associated with TAP-tagged full-
length Prp8p (Fig. 313, lane 1) and with C-terminal Prp8p 
437-2413 (Fig. 313, lane 3) but not with Prp8p 771-2413 or 
2174-2413 (Fig. 313, lanes 4,5). Following the precipitation 
with anti-8.6 antibodies, Snul l4p was found associated 
with non-TAP-tagged Prp8p (Fig. 313, lane 7) and with 
N-terminal poly peptides 1-770 and 1-2173 of Prp8p (Fig. 
313, lanes 9,10) but not with full-length TAP-tagged Prp8p 
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FIGURE 3. Detection of proteins associated with the N- or C-term-
nal fragments of Prp8p. (A) Splicing extracts were first incubated with 
horse lgG agarose in 500 mM NaCl to pull down only the C-terminal 
Prp8p fragments (lanes 1-5). The supernates were then incubated with 
anti-8.6-adsorbed protein A Sepharose beads (lanes 6-10). After 
PAGE, Prp8p fragments that bound to the beads were detected by 
Western blotting, using anti-8.6 antibodies. (Lanes 1,6) full-length 
TAP-Prp8 protein; (lanes 2,7) full-length nontagged Prp8p; (lanes 
3,8) l'rp8T/436p; (lanes 4,9) Prp8T/770p; (lanes 5,10) Prp8T/2413p. 
The blot from A was stripped and reprobed with anti-Snu 114 anti-
bodies (B) or with anti-Aar2p antibodies (C). (1)) Splicing extracts 
from strains producing nontagged full-length Prp8p (lane 1), Prp8T/ 
770p (lanes 2-4), Prp8T/2173p (lanes 5-7), and full-length Prp8Tp 
(lanes 8-10) were incubated with lgC-agarose in the presence of 150 
mM NaCl. The precipitates (Co-IP), 10% total, and 10% supernates 
(Sup) after the pulldown were analyzed by Western blotting with both 
anti-8.6 and anti-Aar2p antibodies. 
or with amino acids 1-439 (Fig. 313, lanes 6,8), as most 
Snul 14p had already been pulled out of these samples 
during the first-round precipitation of the TAP-tagged 
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FIGURE 4. Glycerol gradient fractionation of Prp8p, Snul ]4p, and 
i\ar2p. RG8T cell extract containing full-length Prp8Tp (i) and 
RG8172173p extract containing 1'rp8T/2173p (B) were fractionated 
in 10%-30 0% glycerol gradients. Alternate gradient fractions were 
anal red by Western blotting with anti-Smi I 14p and anti-Aar2p anti-
bodies. (fl' Aar2p near the top of the gradient (lanes 25). 
C-terminal polypeptides (Fig. 3B, lanes 1,3). Thus, Snul 14p 
associates with the region 437-770 of Prp8p. 
Aar2p was present in precipitates with TAP-tagged full-
length Prp8p and with Prp8p residues 437-2413 and 771-
2413 (Fig. 3C, lanes 1,3,4) but not with untagged Prp8p, or 
with Prp8p amino acids 2174-2413 (Fig. 3C, lanes 25). 
Even when the Prp8T/2173p immunoprecipitation was per-
formed under conditions (150 mM NaCl) that did not 
disrupt the association of the N- and the C-terminal 
Prp8p fragments (or of the US snRNA), Aar2p was not 
coprecipitated (Fig. 3D, lane 7). In addition, centrifugation 
through a 10%-30% glycerol gradient (100 mM KCI) 
showed that Aar2p mostly cofractionates with full-length 
Prp8p and Snul I4p (Fig. 4A, lanes 5-11), although some 
Aar2p was also detected near the top of the gradient (Fig. 





ii 	 11111  
4A, lane 25) as was observed previously (Gottschalk et al. 
2001). In contrast, the Aar2p in Prp8T/2173 extract was 
mostly found in the lower density fraction (Fig. 4B, lane 
25). Thus, the interaction of Aar2p with Prp8p was dis-
rupted by dissecting Prp8p at position 2173. 
DISCUSSION 
Yeast Prp8p is highly conserved in both its sequence (619 10 
identical to human) and its large size. Bioinformatic 
approaches predicted an MPN (Mpr-1,  Pad-I, N-terminal) 
domain, defined by amino acids 2173-2310, an RRM (RNA 
Recognition Motif) in the region 1059-1151, and potential 
NLS(uciear localization signals, residues 96-156 (Grainger 
and Beggs 2005), but there is no other obvious structural 
domain within this huge protein. By functional, genetic 
classification, Kuhn et al. (Kuhn and Brow 2000; kuhn et 
al. 2002) designated five regions: a (residues 233-365), b 
(residues 608-687), c (residues 785-864), d (residues 1091-
1197), and e (residues 1621-1878). 
Figure 5 illustrates the sites of the viable disruptions that 
we identified relative to these other known features of 
Prp8p. Considering (1) that a very large number of dis-
rupted prp8 alleles were screened for viability (in excess of 
40,000 within the PRP8 open reading frame), (2) the broad 
spread of insertions observed by DNA digest analysis, and 
(3) the evidence that Tn5 insertions occur essentially ran-
domly (Shevchenko et al. 2002), it seems unlikely that the 
three regions of J'RP8 in which viable insertions were iso-
lated might represent hotspots for Tn5 insertion. This is 
further supported by the fact that many viable insertions 
were found in the nonessential N-terminal proline-rich 
region of Prp8p. Therefore, the failure to obtain viable 
constructs with transposon insertions in the 771-2173 
region of Prp8p suggests that the genetically defined regions 
c, d, and e and the RRM function as one indivisible unit. 
Thus the results presented here show that Prp8p can be 
dissected into four functional domains: domain 1, residues 
1-394; domain 11, 443-770; domain III, 771-2170; and 
domain Ill 	 domain IV 
2170 2179 
Snull4p 
a 	 b 	c 	d 
233-365 C 	87 795-564 1091-1197 
YN X 
Aar2p 	Brr2p 




FIGURE S. Diagram showing the positions of viable breakpoints relative to other known features in l 3 rp8p (not to scale). Vertical lines above the 
protein indicate the positions at which Prp8p can he split in two and still function in trans, in vivo. The domains identified in this work are 
indicated. Numbers refer to amino acid residues. PPP, proline-rich region; NLS, putative nuclear localization signal; RRM, RNA recognition 
motif; 3.2, a region of particularly high amino acid sequence conservation; MPN, predicted Mpr-1, Pad-I, N-terminal domain; a, h, c, d, and e, 
genetically defined regions (Kuhn and Brow 2000); 5'SS X-link, a five-amino-acid region identified by photocross-linking to contact the 5' splice 
site in pre-mRNA (Reyes ci al. 999). For further details about features in Prp8p, see Grainger and Beggs (2005). 
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domain IV, 2179-2413. The dissection points near the C 
terminus of Prp8p (2170-2179) lie precisely at one bound-
ary of the predicted MPN/JAB domain (2173-2310). This is 
consistent with the notion that these transposon insertions 
may be tolerated because they have targeted a "linker" 
sequence upstream of this functional module. Furthermore, 
the predicted NLS and the genetically defined region a lie 
within domain 1, region h is within domain 11, and the 
RRM and regions c, d, and e are within domain III. 
To investigate which other splicing factors interact with 
the different domains of Prp8p, 500 mM salt was used to 
disrupt the associations of the N- and the C-terminal Prp8 
polypeptides. The need for such stringent conditions to 
separate the pairs of dissected Prp8 polypeptides shows 
that strong intra- and/or intermolecular interactions hold 
the two ends of the protein together. Kuhn and Brow 
(2000) proposed the existence of a coiled-coil interaction 
between residues 640-670 and 1625-1650 and, if this phys-
ical interaction exists, it might be responsible for reconsti-
tuting the Prp8p molecule that is split at 770/771. 
The strong association of the pairs of Prp8 polypeptides 
limited their utility as a tool to investigate which domains 
of Prp8p interact with other splicing factors, as 500 mM salt 
also disrupted the association of Prp8p with US snRNA. 
Nevertheless, using a two-step imniunoprecipitation strat-
egy (Fig. 3), the association of Snul 14p with Prp8p was 
found to require Prp8p residues 437-770, which is in close 
agreement with two-hybrid interaction data in which 
Snul 14p as bait selected multiple Prp8p fragments that 
had amino acids 420-464 in common (I. Dix and J.D. 
Beggs, unpubl.). The strong association between Prp8p 
and Snu 1 14p is not surprising, as the human homologs 
(h220K and h  16K) have been identified in an RNA-free 
complex and remain associated in 0.4 M of the chaotropic 
salt sodium thiocyanate (Achsel et al. 1998). 
Interestingly, even at moderate salt concentrations (150 mM 
NaCl or 100 m KCI), the association of Aar2p was disrupted 
by dissecting Prp8p at residue 2173. Previously, Gottschalk et 
al. (2001) purified yeast Aar2p associated with Prp8p and 
Snul 14p. Here we show that 1 3 rp8p/771-2413p could coselect 
Aar2p in the absence ofSnul 14p  (Fig. 3C, lane 4), and Prp8T/ 
2173p could coselect Snu 1 I4p in the absence ofAar2p (Figs. 3B 
]lane 10], 4B). This suggests that the associations of Snul 14p 
and Aar2p with Prp8p are not interdependent. 
In summary, we describe here a novel approach to charac-
terize the functional domains of  protein in vivo and demon-
strate its utility by identifying four functional domains within 
the very large yeast Prp8p splicing factor, one of which—
domain Ill—appears to require a continuous stretch of 1400 
amino acids. Although Prp8p has been demonstrated to func-
tion when expressed as pairs of trans-acting potypeptides, each 
of these disruptions was detrimental to growth; the 2173 dis-
section caused slower growth and the 436 and 770 dissections 
resulted in heat sensitivity. For the 2173 dissection at least, the 
integrity of Prp8p's interaction with another protein was de- 
stabilized. Therefore, this approach has also confirmed the 
functional significance of the very large size of this highly 
conserved protein that has been proposed to function as a 
scaffold for molecular interactions in the spliceosomc. 
MATERIALS AND METHODS 
Plasmids and yeast strains used in this work are listed in Table I 
and oligonucleotides are listed in Table 2. 
Transposition methods 
The gene dissection transposon was assembled in the vector 
pMOD(MCS) (Epicentre) by inserting three PCR products as 
follows: (I) PRP8 gene downstream flanking region (EcoRl 
site), (2) Kanarnycin-resistance cassette (BamHI site), and (3) 
PRP8 gene upstream flanking region (Hindill site). An SV40 NLS 
tag was then inserted into the unique Aflil site near the down-
stream end of the transposon. The structure of the transposon in 
the resulting pMOD-Tn plasmici is therefore as follows: MEPRP8 
gene downstream flanking region Kan PRP8 gene upstream 
flanking region ATG-NLS ME where "ME" denotes the Mosaic 
End sequences recognized by Tn5 Transposase (Fig. I). Transpo-
son DNA was released from the pMOD-Tn plasmid for in vitro 
transposition reactions by cleavage with PvuII and gel purifica-
tion. For random insertion of the transposon into the entire 
PRP8 ORE the target DNA was pRS314 carrying a 9.6-kb frag-
ment of yeast genomic DNA including the PRP8 open reading 
frame and flanking sequences with unique NheI and MIul sites 
introduced at the N and the C terrnini of the coding sequence, 
respectively. An SV40 NLS tag was also introduced at the NheI 
site (oligonucleotides AW40 and AW41) prior to the transposi-
tion step so that both Prp8p fragments can be localized to the 
nucleus after gene dissection. Target DNA (1 jig) was incubated 
in a 10-iiL reaction with a molar equivalent of the transpcson in 
the presence of0.I U/pL EZ::TN transposase (Epicentre) at3TC 
for 2 h, according to the manufacturer's instructions. The reac-
tion was stopped by addition of 1 pL l%  SDS followed by 
TABLE 1. Plasmids and yeast strains 
Name Details of plasmid/genotypes of yeast strains 
pMod-Trr PRP8 transposon plasmid. Contains PRP8 
downstream flanking region. KanMX4 cassette, 
PRP8 upstream flanking region, SV40 NLS. 
pBS1479 PCR template for TAP-tagging (Rigaut et al. 1999). 
SC26IA8BI MATa, ura3-52, /eu2, tip!, pep4-3, prh'-1 132, 
prc 1-407, prp8::B/asticidin 1pRS3 1 6-PRP8I 
BMA38a MA Ta, his3A200, /eu2-3, 112, urai- 1, trp /A!, 
ade2-1, can/ - TOO 
RG8T PRP8:TAP-TRP!. otherwise as BMA38a 
RG8T/2 173 PRP81 1-21 ZJ):Th:PRP8(2 174-241 3):TAP-TRPI, 
otherwise as BMA38a 
KL8T/770 PRP8( I -770):Tn:PRP8(771 -2413): TAP- TRPJ, 
otherwise as BMA38a 
KL8TG/436 Hi53-PG4L ,-HA :PRP8(l-439):Tn:PRP8(437-24 13): 
TAP-TRP!, otherwise as BMA38a 
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TABLE 2. Oligonudeotides 
AW40 and A'v\'41 introduce an SV40 NIS at Nhel site 
(N terminus of Prp8p) 
AW40 CTAGCACCTCCAAAAAGAAGAGAAACGTAGCT  
AW4 1 CTAGAGCTACCTTTCTCUCTmTTGGAGGTG 
AW21 and AW22 for prp8 3'UTR lEcoRli 
AW2 1 GCAGCAGAATTCTGACTGACTGpTATAHCC 
AW22 TGCTGCGAATTCGATCAGTTAAATATATATAAG 
AW25 and AW26 for Kan gene PCR lBamHll 
AW25 GCAGCAGGATCCAAAGCCACGHGTGTCAA 
AW26 TGCTGCGGATCCTTAGAAAAACTCATCGAGCA 
AWl 7 and AW18 for prp8 5'UTR PCR HindlIll 
AWl 8 GCTGCTAAGCTTAAGCATCTUCmGACGCTAU 
AW23 and AW24 produce an SV40 type NLS when cloned into 
the Aflll Site ICTTAAGI introduced by AW17/18PCR 
AW23 TTAAGCCTCCAAAAAAGAAGAGAAAGGTAGCTCCC 
AW24 TTAAGGGAGCTACCmCTCT[CUTmGGAGGC 
Prp8-Tap-F and Prp8-Tap-R produce the TAP construct from 





Prp8-770- F and Prp8-770-R introduce the transposon construct 





Prp8-21 73-F and Prp8-21 73-R introduce the transposon construct 
from pAW28 into PRP8 after codon 2173 
Prp8-2 173-F CTAATACACTAUATATTTGAGGTTAAAAAACATTT 
ATGTFTCGGATCATCGATGAATTCTGACT 
Prp8-2 1 73-R TTTTTTGGAAGGACGTAAACATTCTGTTCCTCCAC 
GAAATCATCACTGAAGCTTAAGGGAGCT 
F-Prp8-938 and R-Prp8-1 956 introduce the transposon construct 
from M529 into PRP8 after codon 416 
F-Prp8-938 GGTTATCAACGCCACTTAGAG 
R-Prp8-1 956 ACCATCTGCTAACTGGAAGG 
heating to 70C for 10 mm. Aliquots (1 pL) of the transposition 
reaction were transformed by elect roporation into XEIO Gold 
cells (Stratagene), and plasmids that had been targeted by the 
transposon were recovered by selection for ampicillin and kana-
mycin resistance. Plasmid DNA was prepared from the pooled 
transformants, and suitable fragments of the prp8 ORF contain-
ing transposons were excised, gel purified, and recloned into 
"gapped" pRS3 I 4-PRP8 vector, again selecting for ampicillin 
and kanamycin resistance. Plasmid DNA was prepared from the 
pooled transformants to produce a library in which each indivi-
dual carries a transposon inserted in a region of the prp8 ORF. 
Functional copies of PRP8 were identified by plasmid shuffle 
after transformation into haploid yeast strain SC26IABI in 
which the genomic copy of PRP8 is deleted and survival is 
dependent on a copy of PRP8 on pRS316 (marked with URA3). 
Cells harboring a functional transposon-tagged copy of PRP8 
were isolated by growth on plates containing 5-fluoroorotic 
acid (5-FOA) to select for loss of the URA3-marked plasmid 
copy of PRP8. Plasmid DNA was isolated from these cells and 
retested by plasmid shuffle. The location of the transposon was 
determined approximately by restriction mapping and con-
firmed by DNA sequencing. Note that the transposition event 
results in the duplication of three amino acids at the site of 
insertion; e.g., insertion after codon 2170 results in the N-term-
inal polyp terminating with amino acid 2173 and the other 
starting with amino acid 2171. 
Construction of yeast strains with dissected 
chromosomal prp8 alleles 
Strain RG8T was made by integration of a linear DNA cassette, 
generated by PCR, that encodes the TAP tag sequence (from plasmid 
pBS1479) (Rigaut et al. 1999), fused in-frame with the 3' end of the 
PRP8 open reading frame, plus the TRPJ gene as selectable marker. 
For insertion of pseudotransposons (mosaic regions omitted) into 
this chromosomal TAP-tagged copy of PRP8 the Kanamycin-resis-
tance marker was replaced with a KanMX4 cassette (used for dissec-
tion after codon 436) (Wach et al. 1994), or, alternatively, a copy of 
the LJRA3 gene from Kliiyieromyces lactis was inserted between the 
unique Xhal and Pstl sites downstream of the Kanamycin-resistance 
marker (used for dissection after codons 770 and 2713) and PCR-
generated DNA was used for yeast transformation, inserting at spe-
cific positions in the TAP-tagged chromosomal copy of I'RP8 by 
homologous recombination. For dissection at position 436, the PCR 
product was generated with primers in the flanking PRP8 sequences. 
For dissection at positions 770 and 2173, flanking PRP8 sequences 
were included in the PCR primers and added directly to the trans-
poson downstream and upstream flanking elements (Table 2). G418 
(geneticin( resistant or Ura transformatits were selected, correct 
integration of the cassettes was checked by PCR, and production of 
the TAP-tagged Prp8p was monitored by Western blotting. 
Purification of Prp8p complexes by TAP 
Yeast whole-cell extracts were produced (Umen and Guthrie 1995) 
from 30 L of log phase cells, and tagged proteins were isolated 
(Rigaut et al. 1999). The purified proteins were resolved on a 
Novex NuPAGE 4%-12% his-Tris gel (Invitrogen), using mor-
pholinepropanesulfonic acid (MOPS) running buffer and stained 
with Sypro ruby (Biorad), and the stained bands were subjected to 
mass spectrometric analysis by the "FingerPrints" Proteomics 
Facility (Wellcome Trust Biocentre, University of Dundee) and 
EPIC Proteoniics service (Wellcome Trust Centre for Cell Biology, 
University of Edinburgh). 
Immunoprecipitation and immunoblotting 
Immunoprecipitations were performed (leigelkamp et al. 1995) 
using IgG-agarose (Sigma) or anti-8.6 Prp8 polyclonal antibodies 
(raised against an N-terminal peptide) in 500 mM NaCI unless 
stated otherwise. Proteins were resolved in Novex NuPAGE 49/o-
12% bis-Tris gels (Invitrogen), electroblotted to a polyvinylide 
difluoride membrane (Hyborid-P, Amershani Bioscience), probed 
with anti-Snu II 4p antibodies (Bartels et al. 2003) or anti-Aar2p 
antibodies (Gottschalk et al. 2001), and detected using horseradish 
peroxidase-conjugated goat anti-rabbit antibodies and ECL 
reagents (Amersham Bioscience). 
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Glycerol gradient analysis 
Glycerol gradient analysis was performed (10%-30% glycerol gra-
dient containing GG buffer; Bartels et al. 2003) using 80 p1 splicing 
extract diluted with 120 p1 GG buffer (20 mM HEPES at pH 7.0, 
100 mM KG!, 0.2 mM EDTA; final glycerol concentration 8%). 
After sedimentation at 37,000 rpm for 17 h in a SW40 Ti rotor 
(Beckman) at 4°C, 400-p.L fractions were collected and stored at 
- 70'C. Alternate fractions were phenollchloroform extracted, and 
proteins were acetone precipitated and assayed by Western blotting. 
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